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Abstract
Neisseria gonorrhoeae has been on the rise in the State of Florida since 2013. Florida
currently follows the Centers for Disease Control and Prevention guidelines for
identifying those at-risk for gonorrhea and drug resistant gonorrhea infections. These
groups are narrowly defined and do not consider the different population dynamics
throughout the State. This study examined the question of who is at-risk for contracting
drug resistant strains of gonorrhea in the eight different regions of Florida based on the
prescribed use of last-line-of-antibiotic-defense. Florida’s Surveillance Tools and
Reporting System provided 12 years of secondary data from 2007 to 2018. The data
included 34 risk and demographic variables equaling over 9.5 million data points. The
data were analyzed through chi-square, cross tabulation, and multiple logistic regression
calculations. The findings indicated that each region had statistically significant unique
risk and demographic factors as predictors of drug-resistance. Some of the regions shared
similar risk and demographic factors such as age, condom use, and oral sex, with age
being the most common factor across most of the regions. Conclusively, the regional
findings were not identical to each other, indicating that a uniform application of a
statewide intervention is not applicable. These varying factors, most of which are
behavioral risk factors, are indicative of the Health Belief Model and the Theory of
Reasoned Action. Intervention strategies will need to target specific demographics and
risk factors in each region to institute social change and prevent the spread of drugresistant gonorrhea.
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Chapter 1: Introduction to the Study
Introduction
Neisseria gonorrhoeae, or more commonly known as gonorrhea, is a pathogenic
bacterium that is generally transmitted sexually, but can also be transmitted by other
means (Giguère & Alary, 2015). Gonorrhea has been well documented for centuries and
was first described by the Greeks in 130 A.D. (Black & Black, 2016). The term
gonorrhea in Greek means “flow of seed,” indicating that the common form of
transmission was sexual (Black & Black, 2016). It was not until 1916, when Albert
Ludwig Sigesmund Neisser was able to identify the pathogenic bacterium that caused
gonorrhea, hence creating the taxonomic name Neisseria (after himself) gonorrhoeae
(supporting and giving credit to the original Greek name; Black & Black, 2016).
In the United States alone, there are over 800,000 identified cases per year
(United States Centers for Disease Control and Prevention (CDC), 2017). Many more
cases are not recognized due to the asymptomatic infectious behavior of the bacteria.
Most individuals are asymptomatic; thus, they do not seek medical treatment (Maraynes
et al., 2017). There are significant risks associated with this infection, including but not
limited to, sterility, ectopic pregnancy, increased risk of contracting HIV, and necrosis
(CDC, 2017).
Background
There are many publications on the behavior of Neisseria gonorrhoeae but no
current peer reviewed works on at-risk groups in Florida were identified. This
dissertation studied the relationship between the use of last-line-of-antibiotic-defense
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treatment as a method of predicting at-risk groups for drug resistant variants of
gonorrhea. The following articles support this study. Alirol et al. (2017) published
information on the history of drug-resistant gonorrhea and noted that there has been little
to no research on the at-risk groups. They discussed the need for more research in this
area as well as their anticipation that gonorrhea would become completely drug-resistant
in the very near future. Tuite et al. (2017) examined ciprofloxacin, azithromycin, and
ceftriaxone antibiotics and their effectiveness on resistant strains of gonorrhea. They
claimed that interventions were necessary or else there would soon be incurable strains of
gonorrhea. Maraynes et al. (2017) discussed the difficulties of diagnosing cases of
gonorrhea due its asymptomatic behavior. Their work supported the position of this
dissertation: that the CDC only narrowly and limitedly focuses on at-risk groups on a
national level and does not take into consideration regional differences. They supported a
more targeted approach and the identification of the regional at-risk groups for effective
interventions.
Kirkcaldy (2016) published the most current surveillance information on
gonorrhea from limited locations. There are only 27 clinical sites across the United States
that monitor for drug-resistant strains of gonorrhea and, due to financial restraints, not
every individual is tested for drug resistance. Only those who fall under the CDC criteria
are tested. This indicates that regional data collection is not occurring, and thus creating a
gap in data as well as potentially misdirecting intervention strategies. The sites were
chosen to detect changes in antimicrobial sensitivity across a wide range of national

3
geographies and was not designed to be nationally representative. This suggests a need
for more targeted regional approaches.
Whiley et al. (2012) placed emphasis on the concern that it is only a matter of
time before gonorrhea becomes completely drug resistant. They also emphasized the need
for more research, and that a targeted approach will be necessary to intervene in the
evolution of drug resistance. Giguère and Alary (2015) and Grad et al. (2015) discussed
the importance of identifying and targeting specific groups. They sought to stop the
spread of drug-resistant gonorrhea. In their publications, they referred to these at-risk
groups as core groups, but on a worldwide scale. These core groups, as they have defined
are risky behavior, repeatedly infected, and sex workers. There was no identification or
discussion how to identify at-risk groups on a localized scale. National demographics
may vary from localized demographics; identifying at-risk groups at the local scale would
be of greater benefit and significantly more effective.
Problem Statement
Over the last 50 years there have been a variety of ever-changing medications to
treat gonorrhea (CDC, 2017). Unfortunately, due to the organism’s ability to adapt, all
but one of those treatment plans are now useless (Alirol et al., 2017; CDC, 2017;
Kirkcaldy, 2016). This bacterium is rapidly evolving to become drug-resistant and the
CDC stated in 2017 that this last drug treatment option will not last (CDC, 2017). The
CDC has stated that drug-resistant gonorrhea is now an urgent public health issue (CDC,
2017). There were many predictions beginning in 2015, that it would become drugresistant within as little time as this decade (Grad et al., 2015). Unfortunately, those
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predictions were correct and in March 2018, the first identified case of completely drugresistant gonorrhea appeared in a British male in the United Kingdom (Bello, 2018).
Although not completely drug resistant, in January 2019 two unrelated British women,
contracted variants that are resistant to the current prescribed recommended antimicrobial
treatments, indicating the progression to full drug resistance is nearing (Gallagher, 2019).
Although proclaimed as a major public health issue by the CDC, Florida has done
little to bring it to the attention of its citizens. Currently, Florida’s at-risk groups are the
same as those recommended by the CDC: men having sex with men, sex workers, and
pregnant women (CDC, 2017; 2018). Considering the vast variation in Florida’s
demographics, these three groups are too narrow ranging and do not take into
consideration regional demographics. Florida’s demographics are not evenly distributed
across the state. The demographical groups are concentrated in the different regions,
primarily due to historical events, immigration, and migration patterns. The details of the
demographic variations within Florida, is discussed in detail in Chapter 2.
Purpose of the Study
The purpose of this quantitative study was to identify the at-risk groups per
Florida region that are most likely to contract drug-resistant gonorrhea. Within the eight
Florida regions, there is a significant informational gap on those who are at-risk for
contracting gonorrhea and drug-resistant gonorrhea. Florida and CDC identify narrow
ranging at-risk groups that are vulnerable for contracting gonorrhea and drug-resistant
gonorrhea. The state does not focus on the regional demographics. In Florida, the
demographics vary by county and region. These vast cultural differences can contribute
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to the progression of sexually transmitted diseases because varying cultures view sexual
behaviors differently (Trecker & Dillon, 2014; Trecker et al., 2015). This dissertation
expands the currently limited demographical knowledge of infected groups, predicts
potential at-risk groups for drug-resistant gonorrhea, and creates a knowledge foundation
with which to develop targeted interventions.
Research Questions and Hypotheses
This study identified the at-risk groups for contracting drug-resistant gonorrhea on
a regional basis in Florida by evaluating (a) the currently prescribed last line of antibiotic
treatments and (b) the gonococcal infection risk factors. To fulfill the intention of this
study, the following questions were answered using secondary data provided by the State
of Florida.
Research Question 1: Are there differences in using last-line-of-antibiotic-defense
between Florida as a whole and each of the eight regions?
Research Question 2: Are there differences in using last-line-of-antibiotic-defense
among the eight Florida regions?
Research Question 3: What are the statistically significant factors associated with
being treated with last-line-of-antibiotic-defense in each of the eight regions
and the state of Florida?
Theoretical Framework
This dissertation fits well within the 1966 health belief model (HBM) and the
1975 theory of reasoned action (TRA). The HBM is based on four basic principles: (1)
perceived susceptibility, which means how a person perceives how much at risk there is
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for contracting the infection; (2) perceived severity, or how serious the consequences are;
(3) perceived barriers, such as what would interfere with or facilitate adoption; and (4)
perceived cost of dealing with an intervention (Rosenstock, 1974). With TRA, the
individual considers the consequences of their behavior before engaging in that behavior
(Ajzen, 1985). Currently the World Health Organization (WHO) and the CDC identify
the at-risk groups as sex workers, pregnant women, and men who have sex with men
(CDC, 2018). This leaves out a large number of other demographic groups, such as
heterosexuals, bisexuals, age ranges, and ethnic. Based on the HBM and TRA models,
many other groups may be at-risk because they do not believe they fit into one of the
proposed categories. Considering the many different demographics across the regions of
Florida, there are individuals who do not fit into the narrower reaching categories as
currently defined. Thus, the individuals may continue risky behavior, thinking they are
not at risk. This means it is necessary to identify the at-risk groups on a directed scale, so
that targeted interventions can be created.
Giguère and Alary (2015) and Grad et al. (2015) established models for
identifying at-risk groups on a global scale, based on behavior or antibiotic resistance.
They used existing large-scale data to focus their model on targeted core groups. Their
core groups have some similarities to the identified core groups, which the CDC have
also identified. All of the current models look at global or national applications. The
models created by Giguère and Alary (2015) and Grad et al. (2015) could be modified for
use on a more regionalized scale, as this dissertation sought to do.
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Nature of the Study
This study examined the relationship between gonorrhea infections and causes. A
quantitative study using government-provided secondary data was conducted. Florida and
the Federal government collect gonorrhea infection data, because gonorrhea infections
are mandated as a reportable disease (CDC, 2012). Using secondary data from a
government source indicated that the information has already been vetted and passed at
least one institutional review board (IRB) prior to collection. Use of the secondary data
required further IRB approvals. Additionally, to collect the amount of data that was
needed to complete this dissertation as primary data, was cost prohibitive. There was no
guarantee that grant monies would be successfully obtained at all or within the timeframe
to conduct this study. Thus, using existing government data was the most logical
approach. To successfully predict which risk and demographic factors by region were
most likely to acquire drug-resistant gonorrhea infections, statistical evaluations were
conducted. Thus, a quantitative approach was the strongest method to generate the
findings.
Types and Sources of Data
There were limited databases available for demographic factors, risk factors, and
prescribed last-line-of-antibiotic-defense treatments for Florida. To obtain this
information, the following two databases were used:
1. Florida’s Surveillance Tools and Reporting System (STARS) is a 20-year
database consisting of 78 risk-behavior data entries, additional associated
demographics, and prescribed modes of treatment with the infection. As a
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reportable disease, gonorrhea was in the database. However, such cases are
reported only if the individual has been medically diagnosed as positively infected
with the bacterium. Access to this database was provided upon execution of a
signed data use agreement (agreement number 2019-082).
2. Within the Florida Community Health Assessment Resource Tool Set (CHARTS)
system, information was limited to ethnic, sex, age, and location. This
information was used as a basis for targeted data mining.
Definitions
Age-range: Age group that an individual fall within (CDC, 2016b and FDOH, 2018).
Always used condoms: Individual always used a condom during a sexual act (FDOH,
2018).
Anonymous partner: Sex with and unknown individual (FDOH, 2018).
Condom use with main partner: Using a condom with the partner who is considered the
primary individual in the relationship (FDOH, 2018).
Condom use with other partner: Using a condom with an individual not considered as the
primary individual in the relationship (FDOH, 2018).
Drug use: Using legal or illegal drugs or medicine (FDOH, 2018).
Ethnic: Cultural factors including local culture, ancestry, nationality, and language (CDC,
1993).
Gender: The gender that an individual identifies themselves as (CDC, 2017).
Had a history of a STD: The individual had a STD prior to the current infection (FDOH,
2018).
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Had an STD in the last 12 months: The individual had a STD in the 12 months prior to
the current infection (FDOH, 2018).
Incarcerated in the last 12 months: Has been incarcerated within the 12 months prior to
the current infection (FDOH, 2018).
Initial antibiotic treatment: Medical intervention utilized by licensed medical doctors to
treat gonococcal infections (Hook III, Shafer, Deal, Kirkcaldy, & Iskande, 2013).
Intoxicated Alcohol or Drugs: Individual was either using alcohol or drugs at the time of
being infected (FDOH, 2018).
Knew self-HIV status: Individual who knows their HIV status at the time of the infection
(FDOH, 2018).
Meet through the internet: Individual meet sex partner through the internet (FDOH,
2018).
Men having sex with men: Biological male having sex with another biological male
regardless of their sexual orientation (FDOH, 2018).
Met partner in bar: Individual meet sex partner in a bar (FDOH, 2018).
Meet partner in bath: Individual meet sex partner in a bathhouse (FDOH, 2018).
Never used condom: Individual who never uses a condom during a sex act (FDOH,
2018).
New Partner in last 90 days: Individual has sex with a new partner that they have know
for 90 day or less (FDOH, 2018).
Number of Sex Partners: Total number of sexual partners listed on the interview (FDOH,
2018).
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Oral sex with a man: Individual had oral sex with a man regardless of sexual orientation
(FDOH, 2018).
Oral sex with a woman: Individual had oral sex with a woman regardless of sexual
orientation (FDOH, 2018).
Paid for sex: Individual gave drugs, money, or something in exchange for sex (FDOH,
2018).
Pregnancy: A pregnant female at the time of the infection (FDOH, 2018).
Race: An individual’s physical characteristics such as skin color, hair color, eye color,
and bone structure (CDC, 1993).
Region: Area of Florida consisting of a group of counties (Gaglioti et al., 2018).
Risk factor: A condition, behavior, or other factor that increases the risk of contracting
gonococcal infections (CDC, 2017; Kirkcaldy, 2016).
Self-reported gender: The gender that an individual identifies themselves as (CDC,
2017).
Sexual Assault: An individual who was a victim of sexual assault (FDOH, 2018).
Sexual orientation: A person’s sexual identity in relation to the gender in which they are
attracted to (CDC, 2017).
Sometimes used condoms: Individual who did not regularly use condoms (FDOH, 2018).
State: Refers to the state of Florida.
Unprotected sex with man: Sex with a male without protective barriers (Giguère, K.et al.,
2019).
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Unprotected sex with woman: Sex with a female without protective barriers (Giguère,
K.et al., 2019).
Vaginal or anal sex with man: Sex with a male either vaginally or anally regardless of
sexual orientation (FDOH, 2018).
Vaginal or anal sex with woman: Sex with a female either vaginally or anally regardless
of the sexual orientation (FDOH, 2018).
Was paid for sex: Individual who received drugs, money, or something in exchange for
sex (FDOH, 2018).
Assumptions
Within this study it was assumed that the secondary data were collected correctly,
and that the data were true and complete. Gonorrhea is a reportable disease in Florida and
at the Federal level (CDC, 2012). The information originates from the health care
provider or a designee. Due to the many different individuals who may be entering the
information there is no guarantee that the data were entered correctly or completely.
It is also assumed that not all cases of gonorrhea in Florida were reported. It was
assumed that in some instances, a medical professional, in protecting the interests of their
patients, may have omitted information or not reported the infection at all. Even if some
medical professionals failed to report, the information reported was considered a
representative group of identified cases in each region. Another reason for this
assumption was that gonorrhea has asymptomatic behavior characteristics (Maraynes et
al., 2017). Thus, many cases remain undetected and unreported. The number of
unreported cases is unknown, although there have been many estimates that the actual
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cases are significantly higher than what has been reported (CDC, 2017). It was assumed
that the unreported cases would follow the same demographic infectious trends as the
reported cases, thus the data that was available was considered representative of all cases.
Scope and Delimitations
Although the HBM and TRA fits this study well, there is still a lack of regional
specific information to the public. This lack of information inhibits individuals from
making informed health related choices. It was conjectured that the level of behavioral
driven susceptibility is associated to an appropriate level of knowledge base. This study
was not intended to answer all the possible questions that may arise, but it was intended
to gain a better understanding of at-risk groups on a regional basis. This then established
a foundation for future interventions and continued research in the areas of disease
prevention.
Limitations
This study used the guiding tenets of the HBM and TRA with a focus on those
perceived at-risk for drug resistant gonorrhea. The data for this study were secondary and
provided by FDOH. The study was limited to the data available and the methods by
which the data were collected. The information was collected from many sites across
Florida and it is unknown if all health professionals entering the information were
properly trained in the data collection process. This limited the ability to effectively
measure or mediate the potential for reporting bias. The secondary data were secured
data; there were no identifiers linking to the infected individual. Thus, it was impossible
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to return to question the individual or medical professional for further clarification of
information, if deemed relevant for this study.
Significance
There is a significant gap in the literature on any identified at-risk groups for
drug-resistant gonorrhea, on a per region basis, in the state of Florida. All gonorrhea
infections in Florida are reported through STARS and limited data is made available to
the public through CHARTS. Within CHARTS, gonorrhea infection data is limited to the
number of gonorrhea infections that occur per county per year along with basic
demographics. Florida’s reporting structure does not group counties into regions and has
no regional reporting. There is extremely limited data on gonococcal drug-resistant
infections in Florida, and there is no predictive reporting. Drug-resistant reporting for
Florida is provided by the Gonococcal Isolate Surveillance System (GISP), which is not
part of Florida’s monitoring program (CDC, 2016a). Also, GISP reported on only one
Florida county, Miami-Dade, for which reporting ceased in 2013. In addition, GISP only
requires sampling for drug resistance from select demographic groups and not all
identified cases (CDC, 2016a). Florida has not published any work on attempts to
identify at-risk groups for drug-resistant strains at either a state, regional, or county level.
Florida has currently failed to obtain a position or pursue further major research in this
area.
This particular bacterium has been rapidly evolving drug resistance. The first
drug-resistant case was identified in March of 2018 (Welch, 2018). The infected
heterosexual male did not fit into the current high-risk group categories of WHO or the
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CDC. This means that the generalized identified at-risk groups, such as homosexual
males, sex workers, and pregnant women, may be too narrow ranging. For the state of
Florida, each region needed to be evaluated for gonorrhea patterns that could lead to drug
resistance. This then set a foundation for prevention initiatives that could be customized
for each region. If effective interventions are implemented, there will be less of a need for
treating gonorrhea with medications and thus, slow down or even stop the increasing
foothold of drug-resistant strains.
Summary
Gonorrhea has been recorded since 130 A.D. and has most likely been in
existence for a much longer time. Not only is it one of the oldest recorded sexually
transmitted diseases, but it may also be even be one of, if not, the first. There is no
legitimate information beyond herbal remedy speculations on how gonorrhea was treated
prior to modern medicine. It was not until the first antibiotic was discovered in 1928 by
Alexander Fleming and came to market in 1942 with the onset of World War II that an
actual effective treatment for gonorrhea became available. Gonorrhea was first treated
with antibiotics in 1943. In just over 70 years, society has gone from being able to simply
and effectively treat gonorrhea to uncurable strains. This supports the concept that
gonorrhea is an extremely resilient and highly adaptable pathogen. As a society we
cannot continue to assume that science will be able to continuously find effective
treatments for gonorrhea. The ability to cure gonorrhea is additionally compounded by
the fact that it has asymptomatic behaviors that effectively camouflages it from detection
by the host.
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Public health professionals need to investigate non-drug treatment methods to
stop the spread of this infection. Like any pathogen, if one can interrupt the lifecycle by
not providing future hosts, then eradication and extinction is possible. Instead of
continuously creating more medications that eventually become ineffective, interventions
and safe sex practices would be of greater benefit. This study identified at-risk groups for
drug-resistant strains of gonorrhea at regional levels and at the statewide level for future
focused interventions. Many factors such as ethnic, age, culture, and the like can affect
sexual behaviors. These can vary from state to state and region to region within the states.
This study identified regional-based trends within Florida so that future effective
interventions beyond drug treatments can be developed and more clearly focused on the
regional populations.
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Chapter 2: Literature Review
Introduction
The purpose of this quantitative study was to identify the groups that are most
likely to contract drug-resistant gonorrhea in a given Florida region. Florida follows the
guidelines recommended by the CDC for intervention strategies. Florida is diverse and
has regional demographic variations. The recommended target groups do not uniformly
match the demographics of each region. Drug resistance is driven by misuse or overuse
of antimicrobial agents. This study compares the-last-line-of-defense treatments to the
different demographic and risk factor characteristics in order to develop a predictive
model for those who most likely will be at risk to contract drug-resistant variants of
gonorrhea in each region and the state.
The pathogenic sexually transmitted bacterium Neisseria gonorrhoeae has been
well documented for centuries and was first described by the Greeks in 130 A.D. (Black
& Black, 2016). The term gonorrhea in Greek means “flow of seed” indicating that the
common form of transmission was sexual (Black & Black, 2016). In the United States
alone, there are over 800,000 identified cases per year (CDC, 2017). There are many
more cases that are not recognized due to the asymptomatic behavior of the bacteria; the
overall numbers may be much higher than what is being reported (Maraynes et al., 2017).
Over the last 50 years there have been a variety of ever-changing medications to
treat gonorrhea (CDC, 2017). Due to the organism’s ability to adapt, all but one of those
antibiotic treatment plans are now useless (Alirol et al., 2017; CDC 2017; Kirkcaldy,
2016). The CDC stated in 2017 that cefixime and ceftriaxone together or in combination
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with azithromycin is last drug treatment option. The CDC stated that this will not last,
which makes drug-resistant gonorrhea an immediate and urgent public health issue
(CDC, 2017).
Literature Review Methodology
The literature for this review was collected through various media. The initial
review began with the CDC website on gonorrhea. The CDC is the leading authority in
the United States for all reportable infectious diseases in the United States (U.S.) and its
territories. Information on gonorrhea and gonococcal infections outside of the U.S. was
also taken into consideration. The CDC site was reviewed extensively to gain a better
understand of the core nature of gonorrhea and its drug-resistant behavior. The CDC site
provided access to other published works. This “chain referencing” was a beneficial tool
in identifying relevant works.
The second area of review evaluated the WHO’s website for additional
information and trends. Although this work focused on Florida, since gonorrhea is
becoming a global crisis, it was considered a significant source to investigate. It is also
important to understand that global transportation is relatively quick and affordable.
Diseases can be transported in a matter of only a few hours through mechanisms such as
air travel and longer for travel by sea. Florida, especially Disney World, is a common
vacation destination for visitors from all over the world (Fyall, 2019). Thus,
asymptomatic gonococcal infections can be easily transported into Florida. The other
aspect is the sex trade, which is legal in other countries such as Germany and Canada
(Weitzer, 2017). The chances of gonorrhea being brought back to the United States
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through American sex tourists is significant (Weitzer, 2017). This also means there is a
potential for introduction of new strains into the United States. The third area of review
was the Florida Department of Health (FDOH) website on gonorrhea. This study focuses
on gonococcal infections in Florida, thus the FDOH was an excellent site of information
as well as another source of “chain referencing.”
Upon complete review of the aforementioned websites, the literature search
commenced. There were two different approaches to identify applicable literature. The
first approach was to use Google Scholar. Google Scholar is not a complete database of
information and it often presented irrelevant literature, but it is a useful tool that aided in
“chain referencing.” The second source of literature was to search through Walden
University’s database subscriptions such as Walden University’s database PubMed,
ProQuest, and Science Direct. These were cross-discipline databases in medicine, public
health, and science providing a comprehensive search.
The literature review for the majority of this study was intentionally limited to
literary works published in the last 5-years from the start of this dissertation and
pertaining directly to the dissertation topic. The key terms used were gonorrhea,
gonorrhea infections, drug resistance, drug-resistant gonorrhea, Florida and history of
Florida. The phrase drug-resistant gonorrhea revealed the most direct and compelling
research; gonorrhea, drug resistant, and gonorrhea infections were too broad. The
acquisition of general gonorrhea knowledge used the term phrase history of gonorrhea.
This provided literary works discussing the core epidemiology and etiology of gonorrhea.
These literary works established foundational information for this dissertation. Literary
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works that did not discuss drug-resistant gonorrhea or the history of gonorrhea were
reviewed for pertinent information, but often were excluded.
Theoretical Framework
The purpose of theories in health is to provide a comprehensive understanding of
factors that need to be considered for the designing, implementation, and evaluation of a
health promotion program (Rimer & Glanz, 2015). Human behavior is complicated, and a
theoretical understanding can be beneficial to the health professional. A health
professional who has a working and grounded understanding in human behavior allows
that professional to better support a person, family, group, or large community to improve
their health status (Rimer & Glanz, 2015). The theories in health are designed as a guide
in the understanding of why and how people and communities make health related
choices (Rimer & Glanz, 2015). The theories in health offer an organized mechanism of
grasping situations, appraising relationships, and forecasting outcomes (Rimer & Glanz,
2015). Theories in health will also explain the need for interventions, the best prescribed
course of an intervention, and how to assess the successes or failures of an intervention
(Rimer & Glanz, 2015). In the works of Rimer and Glanz (2015) they stated that theories
help practitioners to interpret the findings of the research and make the jump from facts
written on a piece of paper to comprehending the dynamic interactions between the
environmental context and human behavior. Where theories provide a broad roadmap that
aid in the explanation of the dynamics of human health behavior, identifying effective
interventions, selecting suitable target audiences, and evaluating; outcome models narrow
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down the approach and provide specific targeted structure for the health professional
(Rimer & Glanz, 2015).
Health Belief Model (1966)
The foundation of the HBM of 1966 still holds true today. A review of literary
works indicated that there is a considerable lack of knowledge within the public in regard
to the transmission of gonorrhea, transmission of drug-resistant gonorrhea, and the reality
of that everyone is susceptible to this infection. Current interventions are only targeting
men who have sex with men, individuals in the sex trade industry, and pregnant women.
In the eyes of the general public, the majority of individuals do not fall into these
categories. This perpetuates the notation that most individuals are unlikely to contract
gonococcal infections. In contrast to individual beliefs, a number of literary works
indicate that there is a growing number of groups exclusive of the aforementioned three
that are being infected by this bacterium. From a health theory standpoint this problem
fits ideally with the 1966 HBM.
The 1966 HBM is based on four constructs (Hayden, 2017; McWhirter &
Hoffman-Goetz, 2016). The first construct is perceived susceptibility (Hayden, 2017;
McWhirter & Hoffman-Goetz, 2016). Perception is an influential mechanism directing
individual behaviors. As mentioned, it is plausible that many individuals may think that
since they do not fall within one of the three aforementioned identified categories, they
are not susceptible to gonococcal infections. Unfortunately, this is a blind interpretation.
Although they as an individual may not fall into one of these categories, their partner
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could have been and still be, an unknowing asymptomatic carrier. Open relationships and
relationships where one or more partners are unfaithful can also be problematic.
The second construct is perceived severity (Hayden, 2017; McWhirter &
Hoffman-Goetz, 2016). Humans in this world have become reliant on the notion that
medicine can cure all. This creates the false sense of health safety for individuals. It
perpetuates the belief that even if they do acquire a gonococcal infection it will be easily
cured through medical invention. This generates an appearance that a gonococcal
infection is no more than a minor inconvenience. Perceptions as these, are extremely
disconcerting and can perpetuate the spread infections.
The third construct is perceived barriers (Hayden, 2017; McWhirter & HoffmanGoetz, 2016). Barriers, in relationship to gonococcal infections, are that gonorrhea is
becoming drug resistant. There is a significant lack of information to the public educating
them that gonococcal infections are not only on the verge of being completely drug
resistant, but there has now been at least one documented case. The lack of information to
the public, may cloak the perception that there are barriers of incurable gonococcal
infections. The greatest unseen current barrier is the actual lack of public knowledge
regarding this bacterium.
The final construct is the perceived cost of adhering to the propose intervention
(Hayden, 2017; McWhirter & Hoffman-Goetz, 2016). There is a perception that most
antibiotics are relatively inexpensive. This can lead to a false interpretation that it is
relatively inexpensive to treat a gonococcal infection. The medications currently being
used cost insurance and government-based insurance approximately $162 million per
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year or $202 per person per year (Chesson et al., 2014). Overall, this is not too great of a
financial burden on an individual. Leading them to be unconcerned if they contract a
gonococcal infection.
Theory of Reasoned Action (1975)
The (TRA) the is based on the assumption that an individual considers the
consequences of their behavior before engaging in that particular behavior (Ajzen, 1985).
Within this model there are three constructs. The first is behavioral attitude (Ajzen,
1985). This construct states that the behavior intention is a function of that individual’s
attitude about the behavior and subjective norms (Ajzen, 1985). The second is attitude
and it can be understood as the decision of one’s behavior based on how others would
perceive that individual if the behavior is or is not conducted (Ajzen, 1985). The third is
the subjective norm and is based on the perceived expectations by key individuals in that
individual’s life.
TRA can be influential in the decision-making process of and for sexual activity
associated with the risk of contracting a gonococcal infection. The WHO and the CDC
have currently identified the at-risk groups for contracting gonorrhea as pregnant women,
sex workers, and men who have sex with men (CDC, 2018). Under the TRA model an
individual who does not fall within any one of these categories would not consider
themselves at risk. The perception would then be that they would not need to worry how
others perceive them since they would not be subject to contracting the pathogen. From a
TRA standpoint there would be no judgement and they would most likely proceed
forward with the risk behavior. If the at-risk groups can be narrowed down to a regional
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level, this may then change the perception of who is at-risk. This in turn changes how an
individual evaluates the outcome of their action in conjunction of how others perceive
them based on their actions.
Basics about Gonorrhea
History
Neisseria gonorrhoeae, or gonorrhea, is considered one of the earliest known
human pathogenic bacteria (Morgan & Decker, 2016). It is not known how long
gonorrhea has been plaguing humankind. It is safe to state, that it has been known for at
least 2000 years. The historical roots of this bacterium are vastly deep and impactful on
human health, so much so that it has even been documented within the biblical scriptures
(Morgan & Decker, 2016). Circa 130-200AD, the Greek physician Galan was the first to
name and describe gonorrhea. The term is based in the ancient Greek language and
translates as an “unwanted excretion of seamen” (Morgan & Decker, 2016). Other
scholars have translated it literally from Latin as “flow of seed” (Black & Black, 2016).
Regardless of which translation is used, both the ancient Greek and Latin languages
indicate that N. gonorrhoeae has an association with sexual transmission.
Gonorrhea has a secondary name that is believed to have arisen from geographical
origins. It for centuries has been referred to as “the clap” (Black & Black, 2016). Circa
1378 there was an area of Paris known for prostitution as Les Clapiers (Black & Black,
2016). It is believed this geographical location supported the spread of gonorrhea and
originated the street term the “clap.” For centuries gonorrhea was only identified by its
symptoms. It was not until the invention of the microscope that Albert Ludwig
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Sigesmund Neisser in 1916 was able to successfully taxonomically describe gonorrhea as
gram-negative diplococci (Black & Black, 2016). It was from a combination of Neisser’s
work and the symptomatic description from ancient Greece, that gonorrhea has earned its
modern taxonomic binomial name Neisseria gonorrhoeae.
Etiology
Gonorrhea is a gram-negative diplococcus bacterium. It has an affinity for, and
infects the mucosal surfaces of the genital tract (Sherrard, 2014). Gonorrhea will infect
the urethra as well as the genital glands, uterine cervix, fallopian tubes, epididymites,
anal canal, distal rectum, oropharynx, and eyes (Sherrard, 2014). Under specific
conditions or anatomical position, a female with an active vaginal gonorrhea infection
can then become anally infected (Morgan & Decker, 2016). This cross contamination is
due in part to the close proximity of the vagina and anus, and that gonorrhea can cause
fluid discharge from the vaginal cavity (Morgan & Decker, 2016). Although gonorrhea
can be a discomforting and an irritating infection, it also has the ability to be extremely
dangerous. There are a multitude of associated risks. It has been documented that an
individual infected with gonorrhea may eventually acquire pelvic inflammatory disease,
sterility, septicemia, and necrosis as well as having a greater chance of contracting HIV
infections (CDC, 2017).
There is also a 30% risk of vertical transmission from infected mothers to babies
during the birthing process (Sherrard, 2014). Within a few weeks of birth, babies will
exhibit ophthalmia neonatorum and if left untreated, will cause blindness (Sherrard,
2014). There are instances of neonatal sepsis infection occurring specifically in cases
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when there has been prolonged rupture of membranes or preterm delivery (Sherrard,
2014). Neonatal sepsis can lead to infant death. If an infant (non-newborn) or a child
contracts gonorrhea, experts advise that it may be related to sexual abuse and will require
authoritative and legal intervention (Sherrard, 2014).
Antimicrobial History
The sulfonamides were considered the first antimicrobial agents affective against
gonorrhea and were discovered by Gerhard Domagk in 1935 (Unemo & Shafer, 2014).
The sulfonamides had an 80% to 90% success rate (Unemo & Shafer, 2014). By 1944 the
sulfonamides were no longer effective. Luckily in 1928 Alexander Fleming discovered
penicillin (Black & Black, 2016). Due to production costs, it was not affordably produced
until 1942. In 1943 the medical community was able to begin using it on gonorrhea. The
effectiveness did not last long. Only three years later in 1946 gonorrhea became resistant
to penicillin (Unemo & Shafer, 2014). Tetracycline discovered by Benjamin Dugger was
the next antimicrobial used to treat gonorrhea infections. By 1986 gonorrhea was
resistant to that antimicrobial. Within the same time-period, around 1967 spectinomycin
was also rendered useless (Unemo & Shafer, 2014). As time passed, each antimicrobial
for gonorrhea became obsolete. Macrolide (azithromycin) in 1999, Cephalosporins in
2003, and Quinolones in 2007 (Black & Black, 2016).
Treatment
The treatment of gonorrhea has been complicated due to its ability to develop
antibiotic resistance quite quickly (Morgan & Decker, 2016). There is a growing concern
in the medical community over this issue. Gonorrhea is now resistant to multiple classes
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of antimicrobial drugs including sulfonamides, penicillins, tetracyclines, macrolides,
fluoroquinolones, and just recently cephalosporins (Morgan & Decker, 2016). Only in the
last few years gonococcal antibiotic resistance has become a worldwide problem
(Morgan & Decker, 2016; Sherrad, 2014). Pharmaceutical companies are scrambling for
new chemical controls. A review (2018) of the Federal Drug Administration Clinical
Trials website indicated that there are at minimum 60 clinical trials being conducted to
find antibiotic treatments for gonorrhea. Over the last 50 years there have been a variety
of medications to treat gonorrhea (CDC, 2017). The constant changing of drug treatment
protocols are a direct result of the resilience of gonorrhea (CDC, 2017). The treatment
medicines and modes of treatments are changing every few years (CDC, 2017).
Gonorrhea as a survival tactic, has evolved to become drug resistant over and
over. Every time a new antibiotic is introduced, the bacterium becomes resistant in as
little as one decade to that drug or treatment plan (CDC, 2017). Gonorrhea has been so
successful that all but one of the many drug treatment plans are now useless (Alirol et al.,
2017; CDC, 2017; Kirkcaldy, 2016). Cefixime and ceftriaxone in combination or in
combination with azithromycin is considered the last treatment left to combat gonorrhea
(Morgan & Decker, 2016). These antibiotics are used in series as a combined treatment
because they are not effective enough to be used as standalones (Kirkcaldy, 2016)
Unfortunately, gonorrhea is showing signs of resistance to these treatments (Morgan &
Decker, 2016). In March 2018, the first case of complete drug-resistant gonorrhea or
“super gonorrhea” was documented (Ducharme, 2018). Additionally, although not
completely drug resistant as in the March 2018 case, in January 2019 two unrelated
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British women contracted variants that are resistant to the current prescribe recommended
treatments (Gallagher, 2019).
Current Issues
Neisseria gonorrhoeae ranks second as the most common notifiable sexually
transmitted disease in the United States (Morgan & Decker, 2016). In the United States
alone, there are over 800,000 identified cases of any strain of gonorrhea per year (CDC,
2017). The estimated medical cost is $162 million per year (Chesson et al., 2014).
Worldwide there are approximately 62 million cases diagnosed (Sherrad, 2014).
Researchers believe that this is too low of an estimate, that the current numbers are
grossly inaccurate, and the actual rates are significantly higher (Maraynes et al., 2017).
The belief that the information is inaccurate is based in part within the unique
behavior of the bacterium. In adults, gonorrhea is almost always transmitted sexually
(Sherrard, 2014). The classical presentation of a gonococcal infection for a male is white
to yellow discharge from the urethra (Kerani et al., 2015). In more advanced cases, green
discharge from the urethra (Kerani et al., 2015). The male individual will at times have
painful and burning sensations in the urethra and glans during urination (Kerani et al.,
2015). Females also exhibit white to yellow and in some cases green discharge, but it will
come from the cervix and not the urethra (Kerani et al., 2015). The female infected with
gonorrhea will also have abdominal pain and in some cases leading toward Pelvic
Inflammatory Disease (PID) (Kerani et al., 2015). Gonorrhea has a dark side where it can
also exhibit asymptomatic behavior in 40% of the infected males and 60%-80% of the
infected females (CDC, 2017). The literature indicates that up to 60% of all individuals
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infected with gonorrhea are unaware of their infection (CDC, 2017). Gonorrhea
transmission is more efficient from male to female due to anatomical characteristics
(Sherrard, 2014). The risk of acquiring gonorrhea from an infected partner, only having a
single unprotected sexual intercourse act, is estimated at 30% to 70% regardless of
anatomical sex (Morgan & Decker, 2016; Sherrard, 2014). The physiological design of
females versus males coupled with the bacterium’s behavior, is why females will be more
asymptomatic than males (Kerani et al., 2015). Gonorrhea’s asymptomatic behavior
makes it very difficult to diagnose (CDC, 2017). Characteristically if an individual is not
presenting signs or symptoms, they will not seek out medical intervention (CDC, 2017).
They will instead become a biological vector for this bacterium (CDC, 2017). Based on
these percentages alone, it could be elucidated that the true number of infected
individuals globally are in the hundreds of millions.
There may be some hope on the horizon. There are times during the drug-resistant
evolution of a bacterium they lose resistance to earlier historical treatments. There have
been some studies indicating that azithromycin is having an increased effectiveness
against gonorrhea (Martin et al., 2016). Although this may be a positive indication,
gonorrhea, at one time became fully resistant to azithromycin. This then leaves the
possibility of gonorrhea becoming resistant again and in a much shorter time period than
before.
The issue of drug-resistant gonorrhea could be overcome by simple interventions.
Regrettably, currently there is little discussion outside of the medical community
regarding gonococcal drug resistance. An uninformed public will fuel this growing issue.
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Adding to the lack of information, or more so of isolating the general public’s mind set,
the targeted groups as recommended by the CDC and the WHO for gonococcal infection
interventions are men who have sex with men, individuals who work in the sex trade such
as escorts, exotic dancers, and prostitutes, and pregnant women (CDC, 2017). This
creates an ideological thought with the common public, perpetuating the behavior
because the mindset is; that if a person does not fall into one of these categories, they are
not at risk for contracting this infection. Unfortunately, this is may not be the case and the
current recommendations for targeted intervention may in fact be exasperating the spread
of the infection through basic unawareness and misinforming of the general public.
Recent Research on Drug-Resistant Gonorrhea
There are currently different methods being implemented to combat drug-resistant
gonorrhea. The works that approach from a surveillance and intervention standpoint are
Barbee (2014), Chesson, Kirkcaldy, Gift, Owusu-Edusel Jr., and Weinstock (2014);
Fingerhuth, Bonhoffer, Low, and Althaus (2016); Golparian, and Shafer (2014);
Kirkcaldy et al. (2016); Mackenzie and Decker (2016); Martin et al. (2016); Sherrard
(2014); Town et al. (2015); Unemo and Shafer (2014); Unemo (2014); Wi et al. (2017);
and Ventola (2015). The works that are confronting this issue from the molecular and
cellular viewpoint in order to gain a better understanding of the genomic complexities of
why the bacterium is drug resistant and how it becomes drug resistant are Alm et al.
(2014); Allan-Blitz et al. (2017); Allan-Blitz et al. (2018); Basarab et al. (2015); Baym,
Stone, and Kishony (2016); Buono et al. (2014); Jacobsson et al. (2014); Unemo, del Rio,
and Shafer (2016); Unemo (2015); and Goparian, Shafer, Ohnishi, and the Unemo (2015)
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The surveillance researchers are studying gonococcal infection rates. The work of
Ventola (2015) identifies nationwide gonococcal infections basing those infections on the
number of prescriptions written on a state-by-state basis. They are also studying over
prescribing of antibiotics for both individual and commercial purposes with the
expectations of detecting potential zones of drug resistance. Unemo and Shafer (2014)
take a different approach. Their surveillance program collects information based on
positive laboratory identification of drug-resistant strains of gonorrhea. The Gonococcal
Isolate Surveillance Project (GISP) is utilized by Chesson et al. (2014), Fingerhuth et al.
(2016) and Kirkcaldy et al. (2016). They collect their information through GISP which in
turn gathers its data from participating clinics and laboratories. The information provided
directly to GISP has been vetted through the CDC for accuracy in reporting. Kirkcaldy et
al. (2016) compile this data and track the evolution of drug-resistant strains. Kirkcaldy et
al. (2016) have stated that currently, GISP is the only source of national and regional
gonococcal antimicrobial susceptibility data in the United States. Unemo (2015) and
Unemo and Shafer (2014), are using data collected from other literary works to develop a
complete comprehensive overview of the extent of gonorrhea drug resistance.
The understanding of where these infections are happening, how extensive the
prevalence rates are, and the number of drug-resistant strains is invaluable. It is unlikely
that a gonococcal infection can be stopped without some form of medical or public health
intervention. Unless the mechanisms of how drug resistance and susceptibility are
understood there may be no future medicinal options. Jacobsson et al. (2014); Allan-Blitz
et al. (2017); Allan-Blitz et al. (2018); Basarab et al. (2015); Buono et al. (2014); and
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Unemo et al. (2016) are investigating the mechanism in which the gonococcal bacterium
uptakes or blocks antimicrobial medicines. The main research focus targets the
mechanism(s) in which the antimicrobial drugs pass through the cellular membrane.
These researchers are also investigating what happens when the medications enter the
cellular matrices. Jacobsson et al. (2014) has elucidated that there is a significant genetic
link to antimicrobial resistance. The team investigated the DNA Gyrase Inhibitor
AZD0914 and manipulated it to have the ability to activate or deactivate it. The motive
was to determine if this genome has a role in gonococcal drug resistance. Similarly, Alm
et al. (2015) studied the same genome but used a different approach. Instead of
controlling the genome which could add bias to the study. They used strains of gonorrhea
which already have both active and inactive AZD0914 genomes. This was then used as a
comparison for antimicrobial effectiveness.
Genetics
From the studies it is been found that N. gonorrhoeae has an extraordinary
capacity to alter its genetic material (Golparian & Shafer 2014). Other species within the
Neisseria genera share this ability (Golparian & Shafer 2014). Gonorrhea has the ability
to transfer partial or whole genes during its entire life cycle. This means it can effectively
change its genome through all types of mutations. It incorporates these mechanisms to
quickly adapt and survive to changing environmental factors. This rapid evolutionary
ability has allowed gonorrhea to survive in the most hostile environments of the human
body such as the mucosa of the urinary tract or the vaginal cavity (Golparian & Shafer
2014). Its abilities to rapidly mutate through genomic exchange indicates it has either
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mutated, acquired, or developed all of its known physiological mechanisms for
antimicrobial resistance. The findings in the literary works elucidate that gonorrhea’s
antimicrobial resistance is imbedded in its chromosomes. It has been directly identified as
chromosomes blaTEM gene and the tetM gene (Unemo & Shafer, 2014). It is these genes
that have resulted in a high level of resistance for penicillin and tetracycline. Within the
bacterial cell this drug-resistant genetic material is found in the plasmid. There is
significance in where this critical information is housed in the cell. It is being and has
been well documented and known that bacteria as well as all cells participate in
molecular level cellular communication (Black & Black, 2016). It is not been known
until recently what the is the significance of this ability. In the works of Unemo and
Shafer (2014) they have reported that gonococcal antibiotic resistance can be passed
through gene transfer. Bacteria conduct genomic transfer by interlocking to each other’s
plasmids. Thus, the storage of critical genomic information within the plasmid means a
more rapid transfer of the genomic code. The other significance of this molecular level
communication is that if there is at minimum of one bacterium within the genus Neisseria
caring antibiotic resistant genetic mutations, that bacterium can then pass that specific
genetic code onto another Neisseria sp. including the gonorrhea bacterium. There is twofold significant concern with this behavior. First, if someone is carrying any drugresistant Neisseria sp., even those that are commensal; if that individual is exposed to a
drug susceptible gonorrhea strain, once that drug susceptible strain exchanges genomic
information in situ it becomes instantaneously drug resistant. The other concern, to put it
simply, if you have just one bacterium per antimicrobial drug that carries resistance, each
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of those bacteria can then transfer those antimicrobial drug genetic codes to a common
colony; developing a strain of “super bugs” that are resistant to all antimicrobial drugs.
There is thought that gonorrhea may soon be classified as a genetic a reservoir of
the antimicrobial resistant genes (Golparian & Shafer 2014; Unemo & Shafer, 2014). It
has been found that there is an entire group of commensal bacteria in the Neisseria
genera that frequently inhabit human anatomical sites including but not limited to the
pharynx (Neisseria spp.) (Unemo, 2015). These areas are often exposed to antimicrobial
medication for the treatment of other infections. Because Neisseria has such an affinity
for survival, these commensal bacteria may also be creating drug-resistant variants to
antimicrobial medications that have not yet been tested or evaluated for curing
gonococcal infections (Unemo, 2015). Studies also indicate Neisseria spp. through
transformation (transfer of genetic material from one bacterium to another) pass these
drug-resistant genes to other species in their same genera (Black & Black, 2016). It is
believed that this horizontal gene transfer is what may have plausibly played a pivotal
role in the transfer of and spread of the mosaic penA allele creating cephalosporin
resistance (Baym, Stone, & Kishony, 2016). The transfer and uptake of DNA between
species within the same genera is quite rapid (Golparian & Shafer 2014). These
antimicrobial resistant gonococcal strains spread rapidly and quickly within their
geographical region and eventually establish an international presence (Unemo & Shafer,
2014). There has been cause for concern but has yet to be proven that gonococcal strains
could share antimicrobial resistant genes with other non-like genera and species
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(Golparian & Shafer 2014). Currently there is no proven cause for concern, but it may
become problematic in the future.
Antimicrobial Defense
Antimicrobials medications attack bacteria by binding to specific targets that are
critical for the vitality and function of the bacterium (Unemo & Shafer, 2014). Through
this molecular binding the bacterium’s functions are interrupted, and death occurs
(Unemo & Shafer, 2014). The bacterium overcomes this issue is by altering its binding
sites through genomic mutation (Unemo & Shafer, 2014). This renders the antimicrobial
chemical ineffective. Cleverly the changing of the antimicrobial binding side is only
enough to stop the antimicrobial chemical but not enough to interfere with the ongoing
functions of the bacterium cell. This does not affect or lower the overall physiological
fitness of the bacterium (Unemo & Shafer, 2014). It has also been found that in some
variants of N. gonorrhoeae, it instead enhanced the biological fitness of the bacterium
(Unemo & Shafer, 2014). Interpretively, not only have antimicrobial medications been
rendered ineffective, but they have also strengthened the bacteria.
Fitness
There is evidence in the research that in the absence of antimicrobial medications,
gonorrhoeae may become less fit. This indicates that the resilience and fitness of
gonorrhea coincides with environmental pressures (Golparian & Shafer 2014). The
greater the environmental pressure, the greater its fitness. Gonorrhea has also derived
mechanisms of self-preservation regardless of the presence of antimicrobial chemicals.
During the infection, the human body is bombarding the bacteria with antibodies and
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other antimicrobial attacks (Black & Black, 2016). The bacterium will mutate to
strengthen and protect itself from the immune system (Unemo, del Rio & Shafer, 2016).
As part of its defensive strategy, gonorrhea will incorporate host-derived compounds to
protect itself from antimicrobial attacks (Unemo et al., 2016). One of the best examples
of this, is gonorrhea using polyamines that are found in the male genitalia tract as a
coating for itself (Unemo et al., 2016). Thus, the bacteria will camouflage itself from the
host’s immune system (Unemo et al., 2016). The coating also inhibits complementmediated killing from the hosts immune system (Unemo et al., 2016). Gonococci have
been documented in laboratory conditions creating biofilms that help make it resistant to
antimicrobials (Unemo et al., 2016). This only emphasizes that gonorrhea is an extremely
resilient, highly fit, bacteria and why it has survived thousands of years.
History and Geography of Florida
Florida Historical Origins
Florida was once Spanish owned. Juan Ponce de Leon was the first to lead a
European expedition to Florida in 1513 (Arnade, 1961; Greenberger, 2005; Worth, 2014).
It is believed and has been historically documented, that he made landfall just south of
Cape Canaveral Florida (Worth, 2014). He originally named the state “Pascua Florida” or
feast of flowers as a tribute to Spain’s Easter celebration (Worth, 2014). Over time,
Spanish influenced increased with other explores such as Lucas Vázquez de Ayllón in
1526, Pánfilo de Narváez, in 1527, Hernado De Soto in 1539, and Tristán de Luna y
Arellano in 1559 all bringing European diseases and decimating upwards of 90% of the
native population (Moore, 2013).
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In 1565 the Spanish created the first permanent European settlement in North
America in Saint Augustine Florida (Moore, 2013; Worth, 2014). To this day Saint
Augustine is a thriving successful city. In 1562 the French attempted to explore and settle
parts of Florida under Jean Ribault, bringing French culture into the mix (Broussard,
2003). By 1581 African slaves were being introduced into Florida through the city of St.
Augustine (Johnson, 2002). In 1586 the British began to see value in Florida and Sir
Francis Drake attacked and burned down Saint Augustine in an attempt to establish an
English settlement (Keeler, 2017). The Spanish continued for the next hundred years to
colonize Florida as a Spanish territory and spreading religion by establishing over 100
missions throughout the northern region of Florida up and into Georgia (Moore, 2013;
Worth, 2014). In 1702 the British again made a move to out the Spanish from Florida by
destroying all the Spanish missions (Childers, 2004). Again in 1740 the English General
James Oglethorpe invades Saint Augustine (Childers, 2004). By 1763 England is now the
ruling faction over Florida (Halbirt, 2004). But this role did not last long and the Spanish
in 1783 took back Florida (Childers, 2004). During this time, the United States was
establishing itself as a strength to be reckoned with.
At one time Florida’s panhandle stretched from the Savanna River to the
Mississippi. Over time the boundaries were pushed back due to battles and skirmishes
until it is reached its present boundaries (Cusick, 2007). Finally, in 1819 the Spanish
realized they could no longer hold Florida and relinquished it to the United States by
leaving the state (Cusick, 2007). Thus, handing control over to the United States. Once
the United States gained control of Florida, many southern Americans began to migrate
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into its northern sections. It was sometime before the southern part of Florida became
populated. Florida was approved on March 3, 1845 to enter the union. It was officially
designated as the 27th state (Weitz & Sheppard, 2018). Not long after statehood, Florida
in 1851, established two colleges which to this date are still some of the most recognized
institutions in the country. They are the now Florida state University (formerly West
Florida Seminary) and the University of Florida (formally East Florida Seminary) (Weitz
& Sheppard, 2018). Although Florida was the only southern state who avoided its capital,
Tallahassee, from being captured by the Union, the suicidal death of Governor John
Milton force Florida to become Federally controlled and no longer a Confederate state in
1865 (Weitz & Sheppard, 2018).
Florida Demographical History
From a demographic standpoint one can say that the northern part of Florida has a
southern personality whereas the southern part of Florida has a northern personality.
Florida could be considered a patchwork of cultures. The early Spanish around 1500 to
1600 settled primarily in the panhandle and along the northern coast (Arnade, 1961;
Greenberger, 2005; Worth, 2014). The central part of Florida around 1800 was settled by
a collage of individuals such as native Americans, farmers, escaped slaves, and ranchers
who to this day are commonly referred to as crackers (Otto, 1987). The farming industry
became an important cultural draw to the State. To meet the growing demands for
farmland, in 1901 the Everglade drainage projects began (Light & Dineen, 1994).
Besides dramatically changing the landscape negatively from an environmental
standpoint, it dried a significant number of wetlands to the south (Light & Dineen, 1994).
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This then created more inhabitable land for both the farmer and entrepreneur. This new
organically rich and now inhabitable land was an attraction for more people to move to
the southern parts of the State.
Starting in the mid-1900s until present Southern Florida has seen an influx of the
modern pioneer. Americans from all over the country, different states, and different
cultures have established themselves in many parts of the southern areas of Florida. The
primary demographics of south Florida consisted of mixed Europeans moving down from
the northern States. Then in 1980 there was a dramatic cultural shift to the southernmost
part of Florida (Hause, 2016). In an effort to aid political refugees from communist Cuba,
the Mariel boatlift occurred. This caused a major influx of Latin culture into the
southernmost part of Florida (Alberts, 2016). It created a dramatic change in the
demographics and behaviors. With the Cuban influx and primarily Spanish speaking
population, the southern part of Florida, principally Miami-Dade, began attracting more
Spanish speaking individuals from other nations (Alberts, 2016). It became an area where
English speaking was not needed to thrive. This created a very unique demographic
population in the Miami-Dade area with cultural beliefs that are very different than the
rest of the state (Alberts, 2016). The movement to Florida in the 1900’s was exponential.
It is estimated that since 1950 the population of Florida has grown over 700% (U.S.
Census, 2018).
Florida Geography
Florida is the Southernmost state in the continental United States. It is located
along the eastern seaboard and is a peninsula (Cooke, 1945; Sellards, 1919). It is
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surrounded by the Atlantic Ocean to the East and the Gulf of Mexico to the West. It is
58,560 square miles and it is 447 miles long by 361 miles wide (Cooke, 1945; Sellards,
1919). The highest natural point is only 345 feet above sea level. It hosts 1,197 statute
miles of coastline, 663 miles of beaches, over 7,700 lakes, and over 4,500 islands (Cooke,
1945; Sellards, 1919). The largest lake in the state which is also the drinking water
reserve for Central Florida, Lake Okeechobee is 700 square miles connected to the
longest river in the State, the St. Johns River as 273 miles in length (Corrales, Naja, Bhat,
& Miralles-Wilhelm, 2017).
There are three primary geographical land formations in the state which define in
part how individuals settled within Florida attracted by areas to settle for farming,
mining, and other commercial interests (Odum, 2018). The South Atlantic Coastal Plain
(SACP) includes northeastern Florida's coast. It extends from Florida's northern border
on the Atlantic seaboard, southward about 150 miles to the area around Cape Canaveral.
It then turns and runs northwesterly and inland toward the New York-Alabama
Lineament, the suspected slip-strike fault on the eastern edge of the Mississippi Valley.
The SACP features barrier islands with both sand dunes and maritime forests of southern
sugar maple and white ash. These areas are backed by salt marshes. The bays support
forested wetlands, such as mangroves and mangrove swamps (Ramos-Fregonezi, et al,
2015).
The Atlantic Coastal Plain (ACP) is divided by the South Atlantic Coastal Plain.
The ACP extends from the south shore of Long Island, New York, all the way to the
southern tip of Florida in the Dry Tortugas which are a chain of five islands west of the
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Florida Keys. The plain then runs northward along the state's Gulf coast to Apalachicola,
where it is bounded by the East Gulf Coastal Plain. The ACP lacks the hilly upland areas
that characterize the SACP, but it includes the beaches found on both coasts of the
peninsula and the Everglades. The Everglades is also well known as the "river of grass"
due to its high content of wetland grasses that eventually lead out to seagrasses in the
saltier marshes. The Everglades constitutes much of the southern tip of the state (Rovere
et al., 2015).
The East Gulf Coast Plain (EGCP) is another coastal plain with the same general
geographic characteristics as the SACP and the ACP. Unlike the SACP and the ACP it
includes much of the coastal areas of the Gulf of Mexico as far north as Panama City.
The geology is very unique on side of the state and the EGCP. Most of the coastal side of
the EGCP hosts white-sand beaches from as far south as Tampa Bay to the panhandle of
Florida. This is due to erosion from the high calcium carbonates found sediments of the
area (Sluijs et al., 2014).
Florida Statewide Demographics
There is no doubt that Florida has experienced historical immigration and
emigration of many different ethnic and cultural groups over the centuries. From the
earliest of settlers to the present, Florida continues to be an ever-expanding melting pot of
genetic diversity. Florida hosts approximately 20.984 million residents (U.S. Census,
2018). The key demographics of the state breaks down and are estimated as the
following: 54.9% of the population is White alone, 16.8% Black alone, and 24.9%
Hispanic alone; 51.1% female gender with 54.3% of the total female population being
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employed; 53.1% of the population is between the ages of 18 and 65; over 80% of the
population is American born (U.S. Census, 2018); and the median income for the state is
$48,900 per year, with 64.8% of the houses owner occupied (U.S. Census, 2018). Only
14.7% of the total population is living in poverty. The population per square mile is 350.6
persons. It is important to realize that these are estimates. The last census was conducted
in 2010 and the ethnic demographics were the following: 57.9% White alone, 15.2%
Black alone, 0.3% Native alone, 2.4% Asian alone, 0.1% native Hawaiian alone, 1.5%
two races, 22.5% Latino or Hispanic, and 0.3% other race (U.S. Census, 2018). Based on
that same census the total population at the time was 18,801,310 persons and is currently
estimated at 20,984,400 (U.S. Census, 2018).
Florida Regional Demographics
Florida’s demographics are not evenly distributed across the state for some of the
ethnic groups. It is concentrated into the different regions primarily influenced by
historical events and immigration and migration pattern. Florida itself is divided into 67
counties (U.S. Census, 2018). For this study Florida was divided into eight regions
(Figure 1). The Northwest which includes Escambia, Santa Rosas, Okaloosa, Walton,
Holmes, Washington, Jackson, Bay, Calhoun, Gulf, Liberty, and Franklin counites. The
North Central hosts Gadsden, Leon, Wakulla, Jefferson, Madison, Taylor, Lafayette,
Hamilton, Suwanee, Dixie, Columbia, Gilchrist, Union, Bradford, Alachua, Levy,
Marion, and Citrus counties. The Northeast consists of Nassau, Baker, Duval, Clay,
Putnam, and St. Johns county. The East Central includes Sumter, Lake, Flagler, Volusia,
Seminole, Orange, Osceola, and Brevard counties. West Central has Hernando, Pasco,
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Pinellas, Hillsborough, Polk, Manatee, Sarasota, Hardee, Desoto, and Highlands. The
Southwest hosts Charlotte, Glades, Lee, Hendry, and Collier. The Southeast is home to
Indian River, Okeechobee, Saint Lucie, Martin, and Palm Beach. The Southern hosted.
Broward, Monroe, and Miami-Dade. When evaluating Florida at a region by region level
it has vast differences in the demographic distribution in relationship to the state as a
whole.
Figure 1
The Eight Regions of Florida

Note. Depicts the eight regions of Florida and counties within. Image adopted and
modified from
https://www.flcenterfornursing.org/RegionalData/FCNRegionalWorkforceReports.aspx.
and the FDOH http://www.flhealthsource.gov/bgs-providers 2018. Florida Center for
Nursing and the FDOH.
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Using the known census data and not estimates, the Northwest region has the following
demographics: 77.7% White alone, 13.6% Black alone, 0.7% Native alone, 1.1% Asian
alone, 0.1% native Hawaiian alone, 2.1% two races, 4.6% Latino or Hispanic, and 0.1%
other race (Figure 2). Total population was 1,039,053 persons and 5.5% of the total
population of the state (U.S. Census, 2018).
Figure 2
Demographic Distribution of the Northwest Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the Northwest region of Florida. The
data were provided by the U.S. Census Bureau (2018).
The North Central region has the following demographics: 70.7% White alone, 20.3%
Black alone, 0.4% Native alone, 0.8% Asian alone, 0.0% native Hawaiian alone, 1.3%
two races, 6.4% Latino or Hispanic, and 0.1% other race (Figure 3) (U.S. Census, 2018).
Total population was 1,504,399 persons and 8% of the total population of the state (U. S.
Census, 2018).
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Figure 3
Demographic Distribution of the North Central Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the North Central region of Florida.
The data were provided by the U.S. Census Bureau (2018).
The Northeast region has the following demographics: 77.7% White alone, 13.3% Black
alone, 0.3% Native alone, 1.8% Asian alone, 0.1% native Hawaiian alone, 1.6% two
races, 5.8% Latino or Hispanic, and 0.1% other race (Figure 4) (U. S. Census, 2018).
Total population was 1,419,960 persons and 7.5% of the total population of the state
(U.S. Census, 2018).
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Figure 4
Demographic Distribution of the Northeast Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the Northeast region of Florida. The
data were provided by the U.S. Census Bureau (2018).
The East Central region has the following demographics: 67.4% White alone, 11.1%
Black alone, 0.3% Native alone, 2.4% Asian alone, 0.1% native Hawaiian alone, 1.6%
two races, 16.9% Latino or Hispanic, and 0.3% other race (Figure 5) (U.S. Census, 2018).
Total population was 3,361,496 persons and 17.9% of the total population of the state
(U.S. Census, 2018).
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Figure 5
Demographic Distribution of the East Central Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the East Central region of Florida. The
data were provided by the U.S. Census Bureau (2018).
The West Central region has the following demographics: 69.0% White alone, 9.0%
Black alone, 0.3% Native alone, 1.7% Asian alone, 0.0% native Hawaiian alone, 1.3%
two races, 18.6% Latino or Hispanic, and 0.1% other race (Figure 6) (U.S. Census, 2018).
Total population was 4,248,998 persons and 22.6% of the total population of the state
(U.S. Census, 2018).
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Figure 6
Demographic Distribution of the West Central Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the West Central region of Florida. The
data were provided by the U.S. Census Bureau (2018).
The Southwest region has the following demographics: 61.5% White alone, 13.3% Black
alone, 1.2% Native alone, 1.2% Asian alone, 0.0% native Hawaiian alone, 1.1% two
races, 21.5% Latino or Hispanic, and 0.1% other race (Figure 7) (U.S. Census, 2018).
Total population was 809,009 persons and 4.3% of the total population of the state (U.S.
Census, 2018).
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Figure 7
Demographic Distribution of the Southwest Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the Southwest region of Florida. The
data were provided by the U.S. Census Bureau (2018).
The Southeast region has the following demographics: 68.9% White alone, 11.4% Black
alone, 0.3% Native alone, 1.4% Asian alone, 0.0% native Hawaiian alone, 1.2% two
races, 16.6% Latino or Hispanic, and 2.1% other race (Figure 8) (U.S. Census, 2018).
Total population was 1,922,265 persons and 10.2% of the total population of the state
(U.S. Census, 2018).
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Figure 8
Demographic Distribution of the Southeast Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the Southeast region of Florida. The
data were provided by the U.S. Census Bureau (2018).
The Southern region has the following demographics: 43.38% White alone, 16.01%
Black alone, 0.2% Native alone, 1.9% Asian alone, 0.05% native Hawaiian alone, 1.26%
two races, 36.91% Latino or Hispanic, and 0.28% other race (Figure 9) (U.S. Census,
2018). Total population was 4,317,591 persons and 23% of the total population of the
state (U.S. Census, 2018).
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Figure 9
Demographic Distribution of the Southern Region Based on U.S. Census Data

Note. Pie chart of the demographic distribution of the Southern region of Florida. The
data were provided by the U.S. Census Bureau (2018).
From the census data there is a significant trend that shows an inclination towards ethnic
diversity with significant increases in Latino populations and decrease in White
populations towards the southern end of the state with less ethnic diversity and decrease
in Latino populations towards the northern end of the state (Figure 10). Black, Native
American, Asian, and two races seem to be relatively distributed evenly across the entire
State.
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Figure 10
Demographic Distribution of the Regions Based on U.S. Census Data
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Each of the ethnic groups have ethnic sub-groups within them increasing the cultural
diversity within the census. For example, those who identify as Latino may have cultural
origins from Spain, Brazil, Puerto Rico, Colombia, Peru, Cuba, Mexico and the like.
Each of these ethnic subgroups has its own unique culture and heritage (Molina, Phillips,
& Sidanius, 2015). Their approach to topics such as family, health habits, sexual
behaviors, and sexual knowledge can vary dramatically (Jackson, Karasek, Dehlendorf,
& Foster, 2016). Florida in the near future, will have to delve a bit deeper with the
approach on sexual health in relationship to sexually transmitted diseases (STD) as it
pertains to the different populations per region across the State.
Gonorrhea in Florida
Florida has seen an increasing trend in gonorrhea infections. In 2017 there were
31,710 cases with a rate of 154.3 per 100,000 population (FL Health CHARTS, 2018).
Six years earlier in 2011 there were 19,704 cases with a rate of 104.0 per 100,000
population. Over this six-year time frame Florida has seen a 60.9% increase in gonorrhea
infections and a 48.4% increase in rates (FL Health CHARTS, 2018). Nationally in 2011
there were 321,849 reported cases of gonorrhea at a rate of 103.3 per 100,000 population
and in 2017 there were 555,608 cases at a rate of 171.9 per 100,000 population. Over the
six-year term the nation saw a 72.6% increase in cases and a 66.4% rate increase
(Braxton et al., 2018). Although Florida is below the national trends none the less this is
still a significant increase overall. In this same time frame, as a comparison (Figure 11),
in Florida infectious syphilis had 1,257 cases in 2011 at a rate of 6.6 per 100,000
population and 2,391 cases in 2017 at a rate of 11.6 per 100,00 population (FL Health
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CHARTS, 2018). This is a 90.2% increase in syphilis cases and a 75.8% increase in rates
in the six-year period. Nationally there were 46,040 cases of infectious syphilis in 2011 at
a rate of 14.8 per 100,000 population and in 2017 101,567 cases at a rate of 31.4 per
100,000 population (Braxton et al., 2018). There was a 120.6% increase in cases
nationally and 112.2% increase in rate over the six-year period. Florida cases of
Chlamydia in 2011 were at 76,050 at a rate of 407.3 per 100,000 and in 2017 there were
100,057 cases at a rate of 486.8 per 100,000 (FL Health CHARTS, 2018). This is a
31.6% increase in cases and a 19.5% increase in rates in the six-year time frame.
Nationally in 2011 there were 1,412,791 cases of Chlamydia at a rate of 453.4 per
100,000 population and in 2017 there were 1,708,569 at a rate of 528.8 per 100,000
population (Braxton et al., 2018). Over the six-year period nationally there was a 20.9%
increase in Chlamydia cases with a 16.6% increase in the rate.
Overall, Florida has been below the national levels for bacterial STD infection
rates, but it has still seen a significant increase in cases and rates (Figure 12). The
increases are large percentage jumps, which is disconcerting. In regard to gonorrhea this
is an alarming trend. This trend can lead to the rapid evolution of completely drugresistant gonorrhea strains. There is also been a greater increase of male infections vs.
female infections in the same six-year period. Gonorrhea infections in males has
increased 95.1% whereas in females the increase has only been 27.9% (FL Health
CHARTS, 2018). The cause of this increase dramatically slanting towards the male
population may be due to the behavior of the bacterium or ethnic and cultural reasons.
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Figure 11
Comparison of the 2017 Bacterial STI Rates per 100,000 Population: Florida VS. USA

Note. Bar graph comparing Florida to the USA regarding bacterial STI rates. The data
were provided by Braxton, et.al. (2018) and the Florida Department of Health (2018).
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Figure 12
Graph of the Increase in Gonorrhea Rates in Florida Between 2011 to 2017

Note. Line graph demonstrating an increasing trend in gonorrhea rates in Florida between
2011 to 2017. The data were provided by the Florida Department of Health (2018).
Florida states that any sexually active person can contract gonorrhea through
unprotected sex vaginally, anally, or orally (CDC, 2017). This is a generalized blanket
statement that protects the state from any liabilities of not protecting the public. Although
it is true that anyone can contract a gonorrhea infection, the state focuses primarily on
sexually active men who are gay, bisexual, or have sex with men. The state also states
that women who are sexually active under the age of 25 years or older women with
certain risk factors such as multiple sex partners are also at risk (FL Health CHARTS,
2018). There is no focus on those who may be at risk for drug-resistant variants.
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Drug-Resistant Variants and the state of Florida
The CDC monitors drug resistance through the Gonococcal Isolate Surveillance
Program (GISP) (Kirkcaldy, 2016). As of 2016 there are 27 participating clinical sites
that collect gonorrhea samples to be sent off for drug-resistant analysis (Kirkcaldy, 2016).
The clinical sites cater to the local demographics of the area. After 2013 there are no
more participating clinical sites in Florida (Kirkcaldy, 2016). Prior to 2013 there were
two participating clinical sites, and they were Miami-Dade from 1998 to 2013 and West
Palm Beach from 1987 to 1998 (Kirkcaldy, 2016). There is no current data for any area
of Florida. The lack of participation of Florida in the monitoring of drug resistance is
problematic. This means that Florida will have to rely on data from other monitoring
locations to develop statewide interventions. The other option, is to utilize the mode of
treatment as a determinate of who would be most likely to contract a drug-resistant
variant and build a predictive model from mode of treatment in conjunction with most
dominate group of infected individuals. Considering Florida is demographically diverse,
the monitoring needs to come from within and not be based on other areas of the United
States. Additionally, full drug resistance has occurred in March 2018. After 2013 and
later, has been some of the most critically important years for the evolution of gonorrhea
drug resistance (CDC, 2017).
Summary
It was aforementioned that there are two core approaches for studying Neisseria
gonorrhoeae, its increasing antimicrobial resistance, and the way it is spreading through
the population by human behavior. The surveillance approach is necessary to maintain
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and gain the understandings of the origin of the infection; infection rates for past, present,
and future; the location of the infections for past, present, and future; affected groups; and
different drug-resistant variants. The findings of those research teams who conducted
surveillance, all shared a commonality. The common findings in the simplest terms, is
that cases of gonococcal infections are increasing. They are increasing at the local,
national, and worldwide levels. Those findings also indicate that gonococcal infections
are not limited to the three simplified groups of; men who have sex with men, workers in
the sex trade, and pregnant women as identified by the WHO and the CDC. Gonococcal
infections are spreading to other groups. The researchers also share findings that indicate
a correlation between a lack of public education and the perpetuation of an increase in
antimicrobial drug resistance cases.
From the conflicting literary works, it is possible that the CDC could be
unintentionally misrepresenting the at-risk groups. The literature does clearly state that
those who have gonococcal infections are at a greater risk for contracting HIV. This
could possibly be the reason why the CDC has focused on men having sex with men as
one of the at-risk categories for gonococcal infections. The second at-risk group that the
CDC discusses are those working in the sex industry. One needs to take into
consideration that prostitution is illegal in most of the United States. Because of this there
are no routine health inspections nor sexual health safety training for these individuals.
The lack of education and medical inspections only aides in the spread of the gonococcal
bacterium. The final group targeted by the CDC are pregnant women. The CDC may be
targeting this group because women can be asymptomatic, and that bacterium can easily
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affect the fetus and a newborn child. The governmental representation of at-risk groups,
in this instance appears to be contradictory to some of the findings in the literature.
Unfortunately, the current presented information maybe misdirecting the public.
There is another aspect regarding the race to stay ahead of drug-resistant
gonorrhea. Science needs to evaluate affective approaches that can control or kill the
bacterium at the molecular level. Gonorrhea just like any other single celled organism has
the same basic structures. Gonorrhea is diplococcus meaning there always two cells
grouped together and the cells are round in shape. These cells are surrounded by gram
negative phospholipid membrane. It is this phospholipid membrane that plays a role in
drug resistance. Imbedded within the membrane are a series of trans-membrane proteins.
These proteins control all the materials entering and exiting the cell. Often it is found in
nature there may be some variances of a species that are naturally resistant. Through
artificial directional selection those resistant strains survive and are the only strains left to
reproduce. If a better understanding of the molecular pathways can be identified, a better
drug delivery at the molecular level can be incorporated.
Antimicrobial resistant gonorrhea is a rarely publicly discussed sexually
transmitted infection. This lack of discussion is ironic considering that gonorrhea is the
second most reported sexually transmitted disease in the United States as well as being
extremely resilient with amazing adaptability to almost any environment. The aptitude is
for it to adapt to almost any environment and quickly embed the adaptions within its
genomic code. It also has the ability to receive and donate different segments of its and
other’s genomic code. This is conducted between other species within the genera as well
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as to its own species. The bacterium does not need to go through asexual reproduction
and hope a mutation occurs, it can just pass segments of its code through the method of
conjugation and transference. This rapid transfer gives gonorrhea the ability to gain
antimicrobial resistance almost instantaneously provided the correct genomic code exists.
Gonorrhea is becoming a “super bug.” The CDC and WHO have stated that
gonorrhea may soon become completely drug resistant. If this happens, the United States
and the world will be facing the next great epidemic. In March 2018 with the emergence
of the first case of completely drug-resistant gonorrhea may be an indication that this
epidemic is just around the corner. It is unknown if any new antimicrobials that can fight
gonorrhea will be entering the market in the very near future. As of now there is only one
effective treatment and it is believed that there are only a few years left before becomes
that treatment becomes ineffective. The first instance of this was documented in January
of 2019 where two unrelated women who contracted gonorrhea were unable to be
affectively treated with the current recommended treatment protocol. One thing is for
certain, there are other at-risk groups beyond men having sex with men, individuals who
work in the sex trade, and pregnant women. Review of the literature indicates that there is
a significant lack of research at the regional level. These at-risk groups need to be
identified at the regional levels and targeted interventions will then need to be developed.
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Chapter 3: Research Method
Introduction
The purpose of the study was to identify which category or categories of
individuals in each Florida region were most likely to contract drug-resistant strains of N.
gonorrhoeae. The study used data collected from 2007 to 2018. From this data, infectious
trends were evaluated and determined. Due to the nature of the bacterium and its ability
to share genomes, identification of the at-risk groups can be determined based on use of
last-line-of-antibiotic-defense.
This quantitative study used secondary data provided by the FDOH Bureau of
Communicable Diseases. Since gonorrhea infections are mandated as a reportable
communicable disease, the FDOH independently and continually collects gonococcal
infection data; the Federal government collects similar data through the Gonococcal
Isolate Surveillance Project (GISP) (CDC, 2012). The advantage of using secondary data
is that that the information has already been vetted and passed governmental IRB
protocols. The use of secondary data significantly lowers the research costs and often
provides large scale data.
Research Design and Rationale
The approach to this study determined what variables were useful from the
existing secondary data to identify those who are at risk for contracting drug-resistant
strains of gonococcal bacteria. The outcome is already known. What was not known was
the variables that caused this outcome. The methodology (discussed later in this chapter)
was designed to discover the causes of the outcome. Since the demographics in Florida
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vary regionally, it was assumed that the risk factors (significant variables) in each region
would also vary. In order to determine which variables were significant, a series of
questions were answered. From those answers, predictive, regionally focused models
were constructed. This information can be used to develop applicable and more
successful preventative interventions. The data were analyzed swiftly. Since this study
used secondary data, the data points already existed and thus it was completed within a
short timeframe.
Methodology
Florida is divided into 67 counties (U.S. Census, 2017). These counties were
grouped into eight regions for this study. Grouping the counties into regions provided
enough data points to be statistically significant. This study utilized existing secondary
data provided by the state of Florida. Data from the Gonococcal Isolate Surveillance
System (GISP) from the Federal government was going to be used as a comparison for
drug-resistant strains. But the GISP data were limited and could not be effectively used as
a comparison, because Florida closed its only collection site for monitoring drug-resistant
strains in 2013, and thus was no longer participating in GISP drug-resistant data
collection.
Florida uses two systems to house its data. The first is CHARTS, which is open to
the public with limited accessible data points. The second is STARS, which requires
permission from the state to access but has a much greater source of data points.
CHARTS allowed for a general understanding of the need for this study. STARS is a
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more in-depth data source, which provided a more focused study. Each system has its
benefits but also has its limitations. These will be discussed later in this chapter.
CHARTS
The Florida (CHARTS) system. Within this system there is limited information
available but there is enough information to use for generalizations. This data set is
directly available to the public with interactive capabilities. Regarding gonorrhea
infections, CHARTS provides sex, race, and age for each county and statewide in an
interactive format. It lacks the necessary detailed information such as mode of treatment,
religion, sexual behavior, drug use, and the like. It also lacks the raw data for additional
statistical manipulation, and it limits the user to only building graphs, charts, and rates.
STARS
Florida STARS is a database of all reportable diseases and the associated
demographics with the disease. Gonorrhea is considered a reportable disease and is in the
data base. STARS host the raw gonorrhea data as well as over 100 different data points
regarding gonorrhea infections in the State. The system is highly restricted and in order to
access the information one must either be an employee of the Florida Department of
Health or be granted permission by the FDOH through a contractual agreement. In prior
email and phone discussion with representatives of the FDOH it was confirmed that
access to this data base was available provided a data use agreement is signed, a proposal
is submitted including Walden’s IRB approval, and FDOH’s IRB equivalent approves.
The data was provided and as part of the agreement, the FDOH requires all data
destroyed after the study is completed and all findings must be shared with the FDOH.
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GISP
The Gonococcal Isolate Surveillance System (GISP) is the federal system that has
national information regarding gonococcal infections. The GISP has data regarding only
one Florida county; of which that data is directly related to drug resistance. Regrettably
the collection site was closed in 2013 so there is no current data regarding drug resistance
in Florida. GISP also has data from 27 other national clinics that have been testing for
drug resistance which could be used for comparison. Unfortunately, GISP clinical sites
do not test everyone for drug-resistant variants but only test those that have been deemed
to fall within the at-risk categorization. This limited testing may be driven by cost, but
also limits the chances of discovery in other potentially at-risk groups. The GISP data
could not be used for this study.
Secondary Data from the State of Florida
Florida has in its data base 20 years of gonococcal surveillance. This study only
used the last 12 years (2007 to 2018) of data due to what was available and complete
from the FDOH. Considering there has been an upward trend in infections in the last 5
years (Figure 12) as well as a strong evolution towards drug resistance in the last decade,
this provided a historical base to build from. Based on the GPower calculation the
minimum number of data points required for significance for a two tailed multiple
logistic regression calculation at a p<0.05 requires a minimum sample size of 89, for a
comparison among the means; 210, and F test; 279. Using 12 years of data provided
enough power for statistical significance. It is financially unfeasible to conduct a oneyear study of this magnitude, let alone a 12-year study. Due to the significant cost and
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IRB concerns, the data provided by the state was cost effective and has already been
vetted through the State’s equivalent of an IRB for the data collection. The data usage
required more than one IRB evaluation.
Regional Distribution
Florida itself is divided into 67 counties (U.S. Census, 2017). A Power calculation
was conducted. Based on that calculation, individual counties did not hold enough data
points for statistical significance. In order to obtain statistical significance base on the
GPower calculation, the counties were grouped into the eight regions (Figure 1) and the
last eleven years of data were compiled for each of those regions. The Northwest region
included Escambia, Santa Rosas, Okaloosa, Walton, Holmes, Washington, Jackson, Bay,
Calhoun, Gulf, Liberty, and Franklin counites. The North Central region hosted Gadsden,
Leon, Wakulla, Jefferson, Madison, Taylor, Lafayette, Hamilton, Suwanee, Dixie,
Columbia, Gilchrist, Union, Bradford, Alachua, Levy, Marion, and Citrus counties. The
Northeast region consisted of Nassau, Baker, Duval, Clay, Putnam, and St. Johns county.
The East Central region included Sumter, Lake, Flagler, Volusia, Seminole, Orange,
Osceola, and Brevard counties. West Central region has Hernando, Pasco, Pinellas,
Hillsborough, Polk, Manatee, Sarasota, Hardee, Desoto, and Highlands counties. The
Southwest region hosted Charlotte, Glades, Lee, Hendry, and Collier. The Southeast
region included Indian River, Okeechobee, Saint Lucie, Martin, and Palm Beach
counties. The Southern region has Broward, Monroe, and Miami-Dade counties.
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Data Analysis
This quantitative study utilized secondary data provided by the FDOH. The
provided data contained over 37 million data points, 82 risk factors, and 16 demographic
factors. The majority of the data provided was categorical data and was listed by county.
When applicable, data that was not categorical such as age was converted into categorical
data by grouping. For instance, ages were grouped into age ranges. Within the categorical
data the responses were coded so that IBM SPSS could conduct the statistical
calculations (see Table 1). Each region was compared to each other region as well as
being compared to Florida as a whole. The extremely sensitive data, such as addresses,
was request but denied. Had the data been provided by the FDOH then spatial mapping
would have been incorporated using ArcView Geographical Information Systems (GIS).
The data analysis was conducted in a series of methodical stages so as to
systematically narrow down to the identifiable at-risk and demographic groups per
region. The data were assessed for missing data points. Any missing data points were
evaluated individually for inclusion or exclusion in the study. Once the data were
evaluated for completeness, the data were then evaluated to identify statistically
significant risk factors in each region and the state overall. Risk and demographic factors
that were not determined complete or significant were removed from further analysis.
The FDOH provided the last-line-of-antibiotic-defense data, thus a final analysis was
conducted comparing the methods of treatment.
There were 33 independent variables consisting of demographic data and risk
factor data that was identified as usable (see Table 1). After the variables were identified,
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they were evaluated for significance at state and regional levels using Chi-square, crosstabulation, and multiple logistic regression calculations as applicable. All 33 independent
variables were used at both the state and regional levels. Because there was only one
currently recommended prescribed treatment that is considered the last-line-of-antibioticdefense against gonococcal infections (variable 34), the reported prescribed mode of
treatment was evaluated for significance and was used as the dependent variable. The
evaluation was conducted at the state and regional levels inclusive of a comparison
between the state and regional levels. The statistically significant reported last-line-ofantibiotic-defense was then compared to the statically significant risk factors to evaluate
any relationships. This was conducted at the state and regional levels inclusive of a
comparison between the state and regional levels. The final narrowed resulting data were
analyzed using chi-square, cross tabulation, and logistic regression modeling in IBM
SPSS. The final results were used to predict which factors would contribute to future
drug-resistant infections. The literature has elucidated that prescribed last-line-ofantibiotic-defense are a factor in driving drug resistance. The statistically significant
reported last-line-of-antibiotic-defense was the dependent variable, and the risk and
demographic factors are the independent variables in the final calculations.
Table 1
Demographic and Risk Factor Data Types and Data Coding
Factor

Data Type

Data Coding

Gender

Categorical

1 = Female, 2=Male

Sexual Orientation

Categorical

1 = Heterosexual, 2 = Bisexual,
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3 = Homosexual
Race/Ethnics

Categorical

1 = Black/African American, 2 = Hispanic,
3 = White Non-Hispanic, 4 =Asian Non-Hispanic

Pregnancy

Categorical

1 = No, 2 = Yes

Initial Antibiotic Treatment

Categorical

1 = Last-line-of-antibiotic-defense,
2 = All Other Antibiotics

Age Range

Categorical

1 = 16-19 yrs., 2 = 20-24 yrs., 3 = 25-29 yrs.,
4 = 30-34 yrs., 5 = 35-39 yrs., 6 =40-44 yrs.,
7 =45-49 yrs., 8 = 50-54 yrs., 9 = 55-59 yrs.,
10 = over 60 years

Number of Sex Partners

Discrete

Numerical thus numbers were as reported.

Drug Use

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Intoxicated; Alcohol or

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Always Used Condoms

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Sometimes Used Condoms

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Never Used Condoms

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Condom Use with Main

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Anonymous Partner

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Meet Through the Internet

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

New Partner <90 days

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Met Partner in Bar

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Met Partner in Bath

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Knew self-HIV status

Categorical

1 = Yes, 2 = No, 3 = Unknown

Paid for Sex

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

(A.K.A. Multiple Partners)

Drug

Partner
Condom Use with Other
Partner

Was Paid for Sex

Categorical
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1 = Yes, 2 = No, 3 = Refused to Answer

Vaginal or Anal with

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Oral Sex with Woman

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Unprotected Sex with

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Vaginal or Anal with Man

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Oral Sex with Man

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Unprotected Sex with Man

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Men Having Sex with Men

Categorical

1 = Female, 2 = MSM, 3 = Male Heterosexual

Had a History of STD’s

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Has had an STD in the last

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Categorical

1 = Yes, 2 = No, 3 = Refused to Answer

Woman

Woman

12 Months
Incarcerated in the Last 12
Months
Sexual Assault

Data Analysis per Research Questions
This study intended to identify the at-risk groups for contracting drug-resistant
gonorrhea on a per region basis in Florida through the evaluation of current prescribed
last line of antibiotic treatments and gonococcal infection risk factors. The data were
normalized to rates, either per 1,000 or 100,000 as appropriate. The data were
accumulated by the previously defined Florida regions. The GPower calculations
indicated different minimum sampling sizes depending on the type of statistical
calculation utilized. The rates were computed for each available classification (see Table
1). The variables were then used to answer the following research questions.
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Research Question 1: Are there differences in using last-line-of-antibiotic-defense
between Florida as a whole and each of the eight regions?
Hypothesis 1:
H0: There is no statistical significance between each of the eight different regions
and Florida as a whole for the last-line-of-antibiotic-defense associated with
gonococcal infections.
Ha: There is a statistical significance between each of the eight different regions
and Florida as a whole for the last-line-of-antibiotic-defense associated with
gonococcal infections.
Data Analysis 1:
Chi-square and cross tabulations were conducted to compare the last-line-ofantibiotic-defense between Florida as a whole and the eight different regions.
Research Question 2: Are there differences in using last-line-of-antibiotic-defense
among the eight Florida regions?
Hypothesis 2:
H0: There is no statistical significance between the eight Florida regions in regard
to the last-line-of-antibiotic-defense for gonococcal infections.
Ha: There is a statistical significance between the eight Florida regions in regard
to the last-line-of-antibiotic-defense for gonococcal infections.
Data Analysis 2:
Chi-square and a cross tabulations were conducted to compare the last-line-ofantibiotic-defense between the eight different regions.
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Research Question 3: What are the statistically significant factors associated with being
treated with last-line-of-antibiotic-defense in each of the eight regions and the
state of Florida?
Hypothesis 3:
H0: There are no statistically significant factors associated with being treated with
last-line-of-antibiotic-defense in the eight regions.
Ha: There are statistically significant factors associated with being treated with
last-line-of-antibiotic-defense in the eight regions.
Data Analysis 3:
Multiple logistic regression models were conducted for all 33 independent
variables and the one dependent variable for each of the eight regions and Florida
as a whole.
Current Gonococcal Infection Distribution
Not all gonococcal data for Florida is available without special request. The
current freely accessible information through the Florida Department of Health CHARTS
is gender, age, race, ethnicity, and county. The number of infections and rates are only
stored to the last twenty years from the presence. This study is limited its evaluations
between 2007 to 2018 which incorporated time before and after 2013 when the gonorrhea
rates went on the rise. In addition, rates for 2019 were not available at the time of this
study. As discussed before, Florida follows the current CDC guidelines of identifying at
risk groups as being men having sex with men, sex workers, and pregnant women. None
of this data is available on the open access of the CHARTS site. The FDOH data
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dictionary was made available for this study. Within the dictionary there was evidence of
more inclusive information such as sexual behavior, sexual orientation, drug use,
demographic data, and treatment data. The actual data were made available upon written
request and IRB approval from both Walden University and the Florida Department of
Health.
The data available to the public is limiting. From the CHARTS system, on a
Statewide basis, there is an upward trend of gonococcal cases. Using the most recent
available data through CHARTS, the 2017 overall the rates of gonococcal infection vary
among the regions (Figure 13). This indicates that infected groups are not uniform ally
diluted throughout the State, which elucidated that there is a definitive demographic
influence on gonococcal infections. The data also indicated that there appears to be
significant infection rates within the non-Hispanic Black groups compared to nonHispanic White and Hispanic groups (Figure 14). Unfortunately, there is no other public
data to evaluate if the CDC recommendation are applicable at the regional level for the
state of Florida. From what publicly available data there is, evidence exists that the at-risk
groups were not what the CDC is reporting at the national level. This was found to be
true and Florida will need to change its limited intervention approach to a more targeted
regional approach.
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Figure 13
2017 Gonococcal Infection Rates Per Region

2017 Gonococcal Infection Rates per 100,000 by Region
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Note. Depicts gonococcal infection rates among the eight regions of Florida and Florida
Statewide. Image created from public data proved by FDOH CHARTS system.

73
Figure 14
2017 Gonococcal Infection Rates Per Region

2017 Gonococcal Infection Rates per 100,000 by Region
and Race
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Note. Depicts gonococcal infection rates among the eight regions of Florida and Florida
Statewide based on race. Image created from public data proved by FDOH CHARTS
system.
Data Criteria
The study population was all individuals who have been diagnosed and reported
as testing positive for Neisseria gonorrhoeae in the state of Florida. The data points that
were requested and provided included; tested positive for gonococcal infection, sexually
transmitted disease history (STD), race, ethnics, age, pregnancy, county of residence,
gender, self-reported gender, sexual orientation, number of sex partners, treatment
protocol, prescribed last-line-of-antibiotic-defense treatment and risk factors. Data that
was also requested but was not provided due to confidentiality or other concerns from
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Florida were city of occurrence, addresses, zip codes, neighborhood codes, and birth
year.
Threat to Validity
External
As previously discussed, this study used secondary data acquired from the state of
Florida. Since the data is not directly collected as would be in a primary data study, there
may have been some unanticipated introduced bias. It is this bias that could threaten the
validity of this study. The collected data is only as valid as the individual entering the
information into the system. It was assumed that the process in which the data were
entered is designed to be simple and easy. At times, the data may contain omissions or
entered incorrectly. The recording of the data may potentially threaten the validity of the
study. Although gonorrhea is considered a reportable disease, a medical professional may
opt to not report the information with the expectation of protecting doctor-patient
confidentiality. The failure to report all data points as required, creating data gaps
through omission, may occur and be in part due to lack of time or failure to question the
infected individual fully. Data that may have omission errors or appear to be collected
incorrectly was evaluated to determine if the particular omission would affect the
outcome. If it affected the outcome, that information was omitted from the evaluation and
was noted in the results and discussion sections of this study.
Internal
For this study a data dictionary was acquired. Review of the data dictionary
indicates that there were significant number of potential points of interest to compare.
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The information was narrowed down. During the narrowing process confounders may
have been overlooked. These confounders might be significant and the failure to
incorporate them could affect the validity of the study. To correct for this potential, all
data categories were evaluated against each other. Although this may be tedious it was
necessary so as to confirm the results are valid. Another internal threat to validity was the
number of data points available creating invalid and non-statistically significant results.
In order to reduce this threat, counties were grouped into regions and data over the last 12
years was utilized. This provided enough Power to produce valid results.
Ethical Procedure
The data provided from the FDOH does not contain the names of the individuals.
The names are coded and held with the FDOH. As per the FDOH data use agreement, the
data were kept in a protected location and was only accessed by the approved principal
investigator (PI). The data were not accessible by anyone who had not been approved by
the FDOH. The data were kept in a locked file by the PI when not in use and any
computer-based information was encrypted with access by only the PI. Once the study
was completed the data were destroyed per the FDOH agreement (Agreement No. 2019082). The FDOH required an IRB review and approval prior to their IRB review and
approval. Thus, a Walden University IRB review was conducted, and the approval,
number 04-24-19-0304414, was submitted to the FDOH along with the FDOH data use
agreement application package.
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Summary
This quantitative study used secondary data provide by the state of Florida. The
data were vetted through the State’s IRB and checked for validity. Although the state
confirms the validity of its data there was always the chance some data points may have
been missed. This study also reviewed the data provided and reviewed it for validity. The
state provided data is broad reaching and provides informational data points that would
be otherwise impossible to obtain without significant financial investment, years of
collection, and a massive team of trained researchers to collect the data. Review of the
data dictionary and subsequence review of the data itself elucidated a comprehensive
collection of information. This study was limited to the data available and there was no
mechanism to be able to return to the individual if further questions arise. The GISP data
were extremely limited and only used for basic referencing since it is not as
comprehensive as the data provided by the state of Florida. The GISP data were not
incorporated into this study. The state did not restrict access to any of the non-identifiable
data that was available such as mode of treatment, location, sexual behavior, drug use,
sex, race, ethnics, and the like. Through evaluation of the state provided data, patterns
emerged indicating what regional groups will be at-risk for contracting drug-resistant
variants of gonorrhea.
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Chapter 4: Results
Introduction
Gonococcal infections have been on the rise in recent years. These increases are
predicted to lead to an increase in drug-resistant variants. The understanding of who is at
risk for drug resistance is critical in creating targeted interventions. These interventions
will lead to a reduction in overall infections, which should also have an effect in reducing
drug-resistant strains. Florida limits their targeted interventions based on national
statistics and recommendations from the CDC. Although the CDC does state
overarchingly that all sexually active individuals are at risk for gonococcal infections,
they specifically mention three groups: men who have sex with men (homosexual or
bisexual men), pregnant women, and sex workers. These identified groups are based on
national statistics, which do not always match Florida findings or Florida regions within
the state findings. Florida, as a whole, is not an across-the-board representation of the
demographics of the United States. Florida demographics change dramatically from
North to South. Each demographic group approaches sexual behavior differently. It is
necessary to evaluate each region to gain a better understanding of the driving forces for
gonococcal infections and how antimicrobial treatments are rendered. This information
can then identify who would be most likely at risk for contracting drug-resistant variant
of gonorrhea. From these findings, a more targeted regional approach can be created.
This would be more effective than using the national recommendations as the standard.
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Data Collection
This quantitative study used secondary data provided by the FDOH through the
STARS system under a contractual agreement. Over 37 million data points were
available, spanning 78 FDOH-identified risk factors. The data provided included all
available demographic data and all available risk factors from 2007 to 2018. This is the
most recent and complete information available. The FDOH did not provide data for
individuals under the age of 16 years. A telephone discussion with a representative of the
FDOH elucidated that under the age of 16 years indicated nonconsensual sexual contact
with a minor. Such data is considered sensitive and thus was excluded from the data
provided.
Data Evaluation
The over 37 million data points provided were obtained in string text format. The
data were converted into categorical data in Microsoft Excel and then imported into IBM
SPSS (Version 25) for analysis. The data were further separated into regions, as outlined
in Figure 1. Although rare, line segments with missing data were excluded from the
calculations. Many of the variables presented as FDOH-identified factors had sections of
“did not ask” or “refused to answer” as a response. Those responses were excluded from
calculations as necessary and reported as such. Considering the magnitude of the
available data and that there were very few missing data rows, the rejection of missing
data or the inclusion or exclusion of “did not ask” or “refused to answer” when necessary
did not affect the overall results. On the contrary, it provided clarity in the weakness in
the data collection process. Seventy-eight risk factors were evaluated, repetitive ones
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were excluded or combined into single groupings. For instance, risk factors such as “used
heroin” or “used cocaine” were combined into “used drugs.” Risk factors included
information such as drug use, number of sexual partners, condom use, type of sexual
contact, and the like. It was found, that quite often within all of the risk factors, the data
collector “did not ask” or the participant “refused to answer.” Data were evaluated at the
statewide and regional level. Data that were found to be not statistically significant were
eliminated from the final analysis and excluded from reporting. Only statistically
significant data and results of interest were included in this study.
Dependent Variable
This study focuses on predicting the at-risk groups anticipated to contract drugresistant strains of gonorrhea. Drug resistance occurs through the repetitive exposure of a
bacterium to an antibiotic. Considering that there are only a select few antibiotics that are
effective for the treatment of gonococcal infections, it is understood that there is limited
time until the bacterium becomes resistant to these last-lines-of-antibiotic-defenses. The
dependent variable for this study is reported gonococcal infections that required the lastline-of-antibiotic-defense. The antibiotic data were grouped into two categories (Table 1).
The results of the evaluated data are summarized in the following sections and are based
on the three proposed research questions.
Florida Descriptive Statistics
Statewide more males (52.5%) than females (47.3%) were infected. The
difference between the sexes overall is only a few percentage points indicating the male
to female distribution across the state is relatively equal. Of the infected, only 8.6% were
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males who had sex with males (MSM). Indicating on a statewide level, infections
affected those males who identified as heterosexuals more than men who have sex with
men (homosexual or bisexual). In regard to sexual orientation, 71.3% of the cases were
reported as unknown. Of 28.7% reporting their sexual orientation (81,106 individuals),
regardless of being female or male, 74.2% considered themselves heterosexual, 22.95%
homosexual, and 2.84% bisexual. Again, indicating that gonococcal infections are more
prominent in heterosexual populations. Race/Ethnicity are a factor in gonococcal
infections (Figure 15). Black/African American Non-Hispanic are 52.9% of the
gonococcal infections followed by White Non-Hispanic (19%), Hispanic (9.9%), Asian
Non-Hispanic (0.4%), and unknown Race/Ethnicity (17.8%).
Figure 15
Percentage of Gonococcal Infections Per Race/Ethnicity Statewide
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The results indicate that young adults under the age of 30 years made up the
majority of infected individuals. The data can be further expanded into the 5-year age
categories. Ages 20 to 24 years made up 32.1% of all those infected, followed by 16 to 19
(21.5%), 25 to 29 (19.4%), 30 to 34 (10.2%), 35 to 39 (5.9%), 40 to 44 (3.9%), 45 to 49
(2.9%), 50 to 54 (2%), 55 to 59 (1.1%), and over 60 years (0.9%) (Figure 16).
Figure 16
Percentage of Gonococcal Infections Per Age Group Statewide

Pregnancy did not appear to be a determining factor regarding gonococcal infections. Of
the infected women, only 14.4% of the women infected were pregnant. Although on the
national level pregnant woman are considered as one of the at-risk groups for gonococcal
infections, is it apparent that for Florida they are not the majority of women becoming
infected.
Aforementioned in this dissertation, cefixime and ceftriaxone in combination
together or with azithromycin is considered the last line treatment left to combat
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gonorrhea (Morgan & Decker, 2016). Including unreported treatments, the last-line-ofantibiotic-defense made up 73% of the initial treatments. These were either azithromycin
and ceftriaxone in combination (35.7%) or ceftriaxone alone (37.3%). Cefixime or
combinations which is also considered a last-line-of-antibiotic-defense against
gonococcal infections, were less than 5% of all prescribed treatments (Figure 17).
Figure 17
Percentage of the Different Types of Last-line-of-antibiotic-defense Prescribed as Initial
Treatment

Risk Factor Statewide
The risk factors elucidated some trends (Table 2). Some of the trends do not fit
the current CDC recommendations for at-risk individuals. For instance, only 2.2% of the
individuals acquired gonorrhea from a sex worker and only 3.5% of those who contracted
gonorrhea were sex workers. Other trends were that 60.2% of the respondents had a
history of STD’s. A supporting trend was 32.6% stated they contracted gonorrhea
through men having sex with men. Having multiple sex partners was not a determining
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factor. At the time of infection 71.6% of the respondents stated they had only one partner;
13.7% had two partners; 5% had three partners; and 9.7% had four or more partners.
Table 2
Risk Factors Listed as Percentage Based on Respondents for the state of Florida
Percentage Yes
Percentage No
Risk Factor
Drug Use

41.6%

58.4%

Intoxicated; Alcohol or Drug

18.6%

81.4%

Always Used Condoms

5.3%

94.7%

Sometimes Used Condoms

78.9%

21.1%

Never Used Condoms

25.7%

74.3%

Condom Use with Main Partner

11.8%

88.2%

Condom Use with Other Partner

38.8%

61.2%

Anonymous Partner

31.5%

68.5%

Meet Through the Internet

22.1%

77.9%

New Partner <90 days

29.1%

70.9%

Multiple Partners

26.3%

73.7%

Met Partner in Bar

11.3%

88.7%

Met Partner in Bath

4.0%

96.0%

Knew self-HIV status

48.8%

51.2%

Paid for Sex

2.2%

97.8%

Was Paid for Sex

3.5%

96.5%

Vaginal or Anal with Woman

27.1%

72.9%

Oral Sex with Woman

27.3%

72.7%

Unprotected Sex with Woman

27.5%

72.5%

Vaginal or Anal with Man

84.9%

15.1%

Oral Sex with Man

70.4%

29.6%

Unprotected Sex with Man

68.9%

31.1%
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Men Having Sex with Men

32.6%

67.4%

Had a History of STD’s

60.2%

39.8%

Has had an STD in the last 12

28.0%

72.0%

7.4%

92.6%

3.6%

96.4%

Months
Incarcerated in the Last 12
Months
Sexual Assault

There are many risk factors and key demographics that are apparent for
gonococcal infections statewide. Black/African American non-Hispanic are the highest of
infected. Age is another key role and the majority of infected are under the age of 30
years. Initial treatment will be an issue in relationship to drug-resistant strains. The most
used medication is currently considered the last-line-of-antibiotic-defense by the CDC.
Lack of condom use and having a previous STD history are also key factors. Men having
sex with men is a factor but pregnancy and sex with a sex worker were not relevant.
Regional Descriptive Statistics
Regional Demographics and Last Line of Antibiotic Treatments
Each region has differences among and between in regard to the different
demographics and the prescribe antibiotic treatments. Evaluating the different regions for
gonococcal infections based on gender alone, the Northwest Region had more females
(52.1%) than males (47.9%), the Northeast Region had slightly more males (51.5%) than
females (48.5%), the North Central Region had slightly more females (52.6%) than males
(47.4%), the West Central Region had slightly more males (52.2%) than females
(47.3%), the East Central Region had slightly more males (54.1%) than females (45.9%),
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the Southeast Region had slightly more males (52.3%) than females (47.7%), the
Southwest Region had almost equal number of males (50.8%) and females (49.2%), and
the South Region had many more males (63.9%) than females (35.1%) (Figure 18).
Figure 18
Percentage of Gonococcal Infections of Males versus Females in each Region
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Men who have sex with men in general is a small percentage in some regions
such as the Northwest Region at 5.2%, North Central Region at 7.9%, East Central
Region at 8%, and the Southwest Region at 8.7%. Other regions were slightly higher with
the Northeast Region at 10.7%, West Central Region at 12.2%, and Southeast Region at
11.1%. The highest region was the South Region making up 29% of those reporting
(Figure 19).

South
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Figure 19
Percentage of Gonococcal Infections for Men who Have Sex with Men in each Region
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Those who reported sexual orientation also varied among the regions. Of the reporting
population, in the Northwest Region 8.1% self-reported as homosexual and 2.7%
bisexual, the Northeast Region 19.1% self-reported as homosexual and 1.8% bisexual,
the North Central Region 9.0% self-reported as homosexual and 2.3% bisexual, West
Central 17.0% self-reported as homosexual and 3.6% bisexual, East Central Region
22.9% self-reported as homosexual and 2.5% bisexual, Southeast Region 10.9% selfreported as homosexual and 2.3% bisexual, Southwest Region 11.0% self-reported as
homosexual and 3.3% bisexual and 2.6% bisexual, and the South Region 48.2% selfreported as homosexual and 3.3% bisexual (Figure 20).
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Figure 20
Percentage of Gonococcal Infections Based on Sexual Orientation in Each Region
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Ethnicity varies among the different regions. Within the Northwest Region
Black/African American Non-Hispanic are 43.7% of the gonococcal infections followed
by White Non-Hispanic (22.8%), Hispanic (1.7%), Asian Non-Hispanic (0.3%), and
unknown Race/Ethnicity (31.3%) (Figure 21). In the Northeast Region Black/African
American Non-Hispanic are 67.5% of the gonococcal infections followed by White NonHispanic (17.5%), Hispanic (2.5%), Asian Non-Hispanic (0.4%), and 12% were reported
as unknown Race/Ethnicity. In the North Central Region Black/African American NonHispanic are 59.0% of the gonococcal infections followed by White Non-Hispanic
(16.1%), Hispanic (2.2%), Asian Non-Hispanic (0.2%), and unknown Race/Ethnicity
(22.4%). In the West Central Region Black/African American Non-Hispanic are 53.3%
of the gonococcal infections followed by White Non-Hispanic (23.7%), Hispanic (8.0%),
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Asian Non-Hispanic (0.4%), and unknown Race/Ethnicity (14.6%). In the East Central
Region Black/African American Non-Hispanic are 47.6% of the gonococcal infections
followed by White Non-Hispanic (19.1%), Hispanic (10.1%), Asian Non-Hispanic
(0.4%), and unknown Race/Ethnicity (22.6%). In the Southeast Region Black/African
American Non-Hispanic are 58.0% of the gonococcal infections followed by White NonHispanic (22.4%), Hispanic (9.6%), Asian Non-Hispanic (0.4%), and unknown
Race/Ethnicity (9.5%). In the Southwest Region Black/African American Non-Hispanic
are 45.2% of the gonococcal infections followed by White Non-Hispanic (32.2%),
Hispanic (16.2%), Asian Non-Hispanic (0.5%), and unknown Race/Ethnicity (5.7%). In
the South Region Black/African American Non-Hispanic are 47.4% of the gonococcal
infections followed by White Non-Hispanic (12.9%), Hispanic (20.3%), Asian NonHispanic (0.4%) and 19.0% were reported as unknown Race/Ethnicity (Figure 21).
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Figure 21
Percentage of Gonococcal Infections per Race/Ethnicity per Region
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The percentage of women who reported as pregnant versus not pregnant during
the time of the gonococcal infection was relatively consisted among some of the different
regions. The Northwest Region was at 14%, Northeast Region at 14.7%, East Central
Region at 14.8%, Southwest Region at 14.5%, and the South Region at 13.9% were in the
middle and most closely related among the regions. The West Central Region at 15.4%
and Southeast Region at 16.3% were the highest. The North Central Region at 10.3% was
the lowest (Figure 22).
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Figure 22
Percentage of Pregnant Women with Gonorrhea in Each Region
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Consistently among all the regions the data indicated that young adults under the age of
30 years made up the majority of infected individuals. The data were further categorized
and evaluated in 5-year age increments. In the Northwest Region ages 20 to 24 years
made up 33.4% of all those infected, followed by 16 to 19 (24%), 25 to 29 (19.4%), 30 to
34 (9.9%), 35 to 39 (5.5%), 40 to 44 (3%), 45 to 49 (2.1%), 50 to 54 (1.5%), 55 to 59
(0.8%), and over 60 years (0.5%). In the Northeast Region ages 20 to 24 years made up
33.2% of all those infected, followed by 16 to 19 (20.3%), 25 to 29 (20.2%), 30 to 34
(10.7%), 35 to 39 (6.3%), 40 to 44 (4%), 45 to 49 (2.7%), 50 to 54 (1.7%), 55 to 59
(1.2%), and over 60 years (0.9%). In the North Central Region ages 20 to 24 years made
up 37.2% of all those infected, followed by 16 to 19 (24.8%), 25 to 29 (28.5%), 30 to 34
(8.9%), 35 to 39 (4.4%), 40 to 44 (2.4%), 45 to 49 (1.6%), 50 to 54 (1.1%), 55 to 59
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(0.6%), and over 60 years (0.5%). In the West Central Region ages 20 to 24 years made
up 32.2% of all those infected, followed by 16 to 19 (22.7%), 25 to 29 (19.2%), 30 to 34
(9.9%), 35 to 39 (5.8%), 40 to 44 (3.8%), 45 to 49 (2.7%), 50 to 54 (1.8%), 55 to 59
(1.1%), and over 60 years (0.9%). In the East Central Region ages 20 to 24 years made
up 32.8% of all those infected, followed by 16 to 19 (21.1%), 25 to 29 (19.8%), 30 to 34
(10.4%), 35 to 39 (5.9%), 40 to 44 (3.8%), 45 to 49 (2.7%), 50 to 54 (1.8%), 55 to 59
(1.0%), and over 60 years (0.8%). In the Southeast Region ages 20 to 24 made up 31.9%
of all those infected, followed by 16 to 19 (21.2%), 25 to 29 (19.3%), 30 to 34 (9.7%), 35
to 39 (5.7%), 40 to 44 (4.0%), 45 to 49 (3.2%), 50 to 54 (2.3%), 55 to 59 (1.4%), and
over 60 (1.4%). In the Southwest Region ages 20 to 24 made up 32.4% of all those
infected, followed by 16 to 19 (25.4%), 25 to 29 (18.0%), 30 to 34 (9.3%), 35 to 39
(5.2%), 40 to 44 (3.5%), 45 to 49 (2.6%), 50 to 54 (1.3%), 55 to 59 (1.2%), and over 60
(1.1%). In the South Region Ages 20 to 24 made up 28.8% of all those infected, followed
by 16 to 19 (18.9%), 25 to 29 (19.5%), 30 to 34 (11.1%), 35 to 39 (6.9%), 40 to 44
(5.2%), 45 to 49 (4.0%), 50 to 54 (3.0%), 55 to 59 (1.5%), and over 60 (1.1%) (Figure
23).
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Figure 23
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antibiotic-defense made up 90.5% of the initial treatments. Within the South Region, the
last-line-of-antibiotic-defense made up 74.6% of the initial treatments (Figure 24).
Figure 24
Percentage of the Different Last-line-of-antibiotic-defense versus Other Antibiotics
Prescribed as Initial Treatment in Each Region
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The last line of antibiotic treatments was further separated into the different last
line treatments in relationship to all antibiotic treatments. These last line antibiotic
treatments are azithromycin and ceftriaxone in combination, doxycycline and ceftriaxone
in combination, ceftriaxone alone, and cefixime alone or in combinations. In the
Northwest Region last line antibiotic treatments were prescribed as azithromycin and
ceftriaxone in combination (40.4%), doxycycline and ceftriaxone in combination (3.6%),
ceftriaxone alone (38.1%), or cefixime or combinations (2.7%). In the Northeast Region
last line antibiotic treatments were prescribed as azithromycin and ceftriaxone in
combination (31.9%), doxycycline and ceftriaxone in combination (1.7%), ceftriaxone
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alone (44%), or cefixime or combinations (2.9%). In the North Central Region last line
antibiotic treatments were prescribed as azithromycin and ceftriaxone in combination
(34.0%), doxycycline and ceftriaxone in combination (3.3%), ceftriaxone alone (40.5%)
or cefixime or combinations (3.6%). Within the West Central Region last line antibiotic
treatments were prescribed as azithromycin and ceftriaxone in combination (37.3%),
doxycycline and ceftriaxone in combination (2.5%), ceftriaxone alone (40.7%), or
cefixime or combinations (4.3%). In the East Central Region last line antibiotic
treatments were prescribed as azithromycin and ceftriaxone in combination (32.6%),
doxycycline and ceftriaxone in combination (2.5%), ceftriaxone alone (33.1%), or
cefixime or combinations (4.7%). In the Southeast Region last line antibiotic treatments
were prescribed as azithromycin and ceftriaxone in combination (42.3%), doxycycline
and ceftriaxone in combination (3.6%), ceftriaxone alone (37.4%), or cefixime or
combinations (2.0%). In the Southwest Region last line antibiotic treatments were
prescribed as azithromycin and ceftriaxone in combination (29.6%), doxycycline and
ceftriaxone in combination (3.2%), ceftriaxone alone (52.8%), or cefixime or
combinations (4.9%). Within the South Region last line antibiotic treatments were
prescribed as azithromycin and ceftriaxone in combination (37.1%), doxycycline and
ceftriaxone in combination (2.8%), ceftriaxone alone (29.8%), or cefixime or
combinations (4.3%) (Figure 25).
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Figure 25
Percentage of the Different Last Line of Antibiotics Prescribed as Initial Treatment in
Each Region
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Risk Factors
Northwest Region
The risk factors for the Northwest region can be found in Table 3. The risk factors
in this region do not fit the current CDC recommendations for at-risk individuals. For
instance, only 2.4% of the individuals acquired gonorrhea from a sex worker and only
2.2% of those who contracted gonorrhea were sex workers. Of the respondents 48.9%
had a history of STD’s and 11.5% stated they contracted gonorrhea through men having
sex with men which does not follow the CDC recommendations for being at risk for
contracting gonorrhea. Having multiple sex partners was not a determining factor. At the
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time of infection 72.3% of the respondents stated they had only one partner; 16.6% had
two partners; 4% had three partners; and 7.1% had four or more partners.
Table 3
Risk Factors Listed as Percentage Based on Respondents for the Northwest Region of
Florida
Risk Factor

Percentage Yes

Percentage No

Drug Use

37.5%

62.5%

Intoxicated; Alcohol or Drug

27.4%

72.6%

Always Used Condoms

8.3%

91.7%

Sometimes Used Condoms

92.7%

7.3%

Never Used Condoms

12.6%

74.3%

Condom Use with Main Partner

13.8%

86.1%

Condom Use with Other Partner

74.1%

25.8%

Anonymous Partner

27.7%

72.3%

Meet Through the Internet

12.6%

87.4%

New Partner <90 days

23.2%

76.8%

Multiple Partners

27.7%

72.3%

Met Partner in Bar

4.9%

95.1%

Met Partner in Bath

0%

100%

Knew self-HIV status

48.8%

51.2%

Paid for Sex

2.4%

97.6%

Was Paid for Sex

2.2%

97.8%

Vaginal or Anal with Woman

31.5%

68.4%

Oral Sex with Woman

38.5%

61.5%

Unprotected Sex with Woman

40.3%

59.7%

Vaginal or Anal with Man

75.2%

24.8%

Oral Sex with Man

57.3%

42.7%
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Unprotected Sex with Man

62.6%

37.4%

Men Having Sex with Men

11.5%

88.5%

Had a History of STD’s

48.9%

51.1%

Has had an STD in the last 12 Months

22.9%

77.1%

Incarcerated in the Last 12 Months

12.1%

87.9%

Sexual Assault

8.8%

91.2%

Note: * indicates there were not enough samples to meet Power. Note: Table created
from data provided by FDOH STARS system and using IBM SPSS version 25.
Northeast Region
The risk factors for the Northeast region can be found in Table 4. The risk factors
in this region do not fit the current CDC recommendations for at-risk individuals. Of the
reporting only 1.2% of the individuals acquired gonorrhea from a sex worker and only
2.4% of those who contracted gonorrhea were sex workers. Of the respondents, 61.1%
had a history of STD’s. 15.1% stated they contracted gonorrhea through men having sex
with men which does not follow the CDC recommendations for at-risk. Having multiple
sex partners was not a determining factor. At the time of infection 84.9% of the
respondents stated they had only on partner; 9.5% had two partners; 2.9% had 3 partners;
and 2.7% had 4 or more partners.
Table 4
Risk Factors Listed as Percentage Based on Respondents for the Northwest Region of
Florida
Risk Factor

Percentage Yes

Percentage No

Drug Use

9.2%

90.8%

Intoxicated; Alcohol or Drug

9.5%

90.5%
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Always Used Condoms

1.5%

98.5%

Sometimes Used Condoms

67.0%

33.0%

Never Used Condoms

10.9%

89.1%

Condom Use with Main Partner

5.9%

94.1%

Condom Use with Other Partner

35.0%

67.0%

Anonymous Partner

13.8%

86.2%

Meet Through the Internet

22.1%

77.9%

New Partner <90 days

12.4%

87.6%

Multiple Partners

25.1%

84.9%

Met Partner in Bar

4.6%

95.4%

Met Partner in Bath

1.7%

98.3%

0%

100%

Paid for Sex

1.2%

98.8%

Was Paid for Sex

2.4%

97.6%

Vaginal or Anal with Woman

21.9%

78.1%

Oral Sex with Woman

22.2%

77.8%

Unprotected Sex with Woman

22.8%

77.2%

Vaginal or Anal with Man

80.7%

19.3%

Oral Sex with Man

68.6%

31.4%

Unprotected Sex with Man

67.6%

32.4%

Men Having Sex with Men

15.1%

84.9%

Had a History of STD’s

61.1%

48.9%

Has had an STD in the last 12 Months

27.3%

72.7%

Incarcerated in the Last 12 Months

3.6%

96.4%

Sexual Assault

0.9%

99.1%

Knew self-HIV status

Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
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North Central Region
The risk factors for the North Central region can be found in Table 5. The risk
factors in this region do not fit the current CDC recommendations for at-risk individuals.
Of the reporting only 0.9% of the individuals acquired gonorrhea from a sex worker and
only 3.3% of those who contracted gonorrhea were sex workers. Of the reporting
respondents, 60.5% had a history of STD’s, 21.5% stated they contracted gonorrhea
through men having sex with men although does not follow the CDC recommendations
for at-risk, this is a greater percentage that in other regions. Having multiple sex partners
was not a determining factor. At the time of infection 76.4% of the respondents stated
they had only on partner; 15.3% had two partners; 4.1% had 3 partners; and 4.2% had 4
or more partners.
Table 5
Risk Factors Listed as Percentage Based on Respondents for the North Central Region of
Florida
Risk Factor

Percentage Yes

Percentage No

Drug Use

48.9%

51.1%

Intoxicated; Alcohol or Drug

30.0%

70.0%

Always Used Condoms

4.6%

95.6%

Sometimes Used Condoms

88%

12%

Never Used Condoms

22.2%

77.8%

Condom Use with Main Partner

13.2%

86.8%

Condom Use with Other Partner

54.4%

45.6%

Anonymous Partner

28.4%

71.6%

Meet Through the Internet

17.6%

82.4%
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New Partner <90 days

23.5%

76.5%

Multiple Partners

23.6%

76.4%

Met Partner in Bar

5.6%

94.4%

Met Partner in Bath

0.5%

99.5%

0%

100%

Paid for Sex

0.9%

99.1%

Was Paid for Sex

3.3%

96.7%

Vaginal or Anal with Woman

29.5%

70.5%

Oral Sex with Woman

29.3%

70.7%

Unprotected Sex with Woman

34.0%

66.0%

Vaginal or Anal with Man

89.4%

10.6%

Oral Sex with Man

71.9%

28.1%

Unprotected Sex with Man

77.2%

22.8%

Men Having Sex with Men

15.1%

84.9%

Had a History of STD’s

60.5%

39.5%

Has had an STD in the last 12 Months

26.6%

73.4%

Incarcerated in the Last 12 Months

10.7%

89.3%

Sexual Assault

10.7%

89.3%

Knew self-HIV status

Note: * indicates there were not enough samples to meet Power. Note: Table created
from data provided by FDOH STARS system and using IBM SPSS version 25.
West Central Region
The risk factors for the West Central region can be found in Table 6. The risk
factors in this region do not fit the current CDC recommendations for at-risk individuals.
Of the reporting only 2.1% of the individuals acquired gonorrhea from a sex worker and
only 4.7% of those who contracted gonorrhea were sex workers. 61.8% of the
respondents had a history of STD’s. 34.3% stated they contracted gonorrhea through men
having sex with men which supports the CDC recommendations for at-risk. Having
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multiple sex partners was not a determining factor. At the time of infection 71.4% of the
respondents stated they had only on partner; 15.1% had two partners; 4.8% had 3
partners; and 8.7% had 4 or more partners.
Table 6
Risk Factors Listed as Percentage Based on Respondents for the West Central Region of
Florida
Risk Factor

Percentage Yes

Percentage No

Drug Use

40.0%

60.0%

Intoxicated; Alcohol or Drug

23.8%

76.2%

Always Used Condoms

5.2%

94.8%

Sometimes Used Condoms

77.4%

22.6%

Never Used Condoms

24.3%

75.7%

Condom Use with Main Partner

10.9%

89.1%

Condom Use with Other Partner

37.8%

62.2%

Anonymous Partner

31.9%

68.1%

Meet Through the Internet

24.4%

75.6%

New Partner <90 days

33.5%

66.5%

Multiple Partners

28.6%

71.4%

Met Partner in Bar

12.6%

87.4%

Met Partner in Bath

3.6%

96.4%

0%

100%

Paid for Sex

2.1%

97.9%

Was Paid for Sex

4.7%

95.3%

Vaginal or Anal with Woman

33.7%

66.3%

Oral Sex with Woman

29.5%

70.3%

Unprotected Sex with Woman

31.0%

69.0%

Vaginal or Anal with Man

91.5%

8.5%

Knew self-HIV status
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Oral Sex with Man

70.1%

29.9%

Unprotected Sex with Man

71.3%

28.7%

Men Having Sex with Men

34.3%

65.7%

Had a History of STD’s

61.8%

38.2%

Has had an STD in the last 12 Months

28.3%

71.7%

Incarcerated in the Last 12 Months

12.5%

87.5%

Sexual Assault

5.1%

94.9%

Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
East Central Region
The risk factors for the East Central region can be found in Table 7. The risk
factors in this region do not fit the current CDC recommendations for at-risk individuals.
Of the reporting only 3.6% of the individuals acquired gonorrhea from a sex worker and
only 3.6% of those who contracted gonorrhea were sex workers. Those who had a history
of an STD made up 57.9% of the respondents. In addition, 29.3% stated they contracted
gonorrhea through men having sex with men which supports the CDC recommendations
for at-risk. Having multiple sex partners was not a determining factor. At the time of
infection 76.6% of the respondents stated they had only on partner; 12% had two
partners; 3.9% had 3 partners; and 7.5% had 4 or more partners.
Table 7
Risk Factors Listed as Percentage Based on Respondents for the East Central Region of
Florida
Risk Factor
Drug Use

Percentage Yes

Percentage No

58.9%

41.1%
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Intoxicated; Alcohol or Drug

22.0%

78.0%

Always Used Condoms

3.5%

96.5%

Sometimes Used Condoms

71.6%

28.4%

Never Used Condoms

20.8%

79.2%

Condom Use with Main Partner

8.7%

91.3%

Condom Use with Other Partner

40.9%

59.1%

Anonymous Partner

28.9%

71.1%

Meet Through the Internet

21.1%

78.9%

New Partner <90 days

21.4%

78.6%

Multiple Partners

23.4%

76.6%

Met Partner in Bar

7.1%

92.9%

Met Partner in Bath

1.2%

98.8%

0%

100%

Paid for Sex

3.6%

96.4%

Was Paid for Sex

3.6%

96.4%

Vaginal or Anal with Woman

28.1%

71.9%

Oral Sex with Woman

30.9%

69.1%

Unprotected Sex with Woman

31.6%

68.4%

Vaginal or Anal with Man

87.7%

12.3%

Oral Sex with Man

73.7%

26.3%

Unprotected Sex with Man

74.8%

25.2%

Men Having Sex with Men

29.3%

70.7%

Had a History of STD’s

57.9%

42.1%

Has had an STD in the last 12 Months

30.3%

69.7%

Incarcerated in the Last 12 Months

7.7%

92.3%

Sexual Assault

3.4%

96.6%

Knew self-HIV status

Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
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Southeast Region
The risk factors for the Southeast region can be found in Table 8. The risk factors
in this region do not fit the current CDC recommendations for at-risk individuals. Of the
reporting 8.47% of the individuals acquired gonorrhea from a sex worker which is much
higher than in other regions. Only 3.4% of those who contracted gonorrhea were sex
workers. Of those reporting, 49.2% of the respondents had a history of STD’s which
lower in other regions as well as comparing to Statewide. Only 17.6% stated they
contracted gonorrhea through men having sex with men which does not support the CDC
recommendations for at-risk. Having multiple sex partners was not a determining factor.
At the time of infection 79.9% of the respondents stated they had only on partner; 12.6%
had two partners; 2.6% had 3 partners; and 4.9% had 4 or more partners.
Table 8
Risk Factors Listed as Percentage Based on Respondents for the Southeast Region of
Florida
Risk Factor

Percentage Yes

Percentage No

Drug Use

52.2%

47.8%

Intoxicated; Alcohol or Drug

17.6%

82.4%

Always Used Condoms

6.9%

93.1%

Sometimes Used Condoms

77.5%

22.5%

Never Used Condoms

52.0%

48.0%

Condom Use with Main Partner

9.6%

90.4%

Condom Use with Other Partner

19.7%

80.3%

Anonymous Partner

31.8%

68.2%

Meet Through the Internet

19.8%

80.2%
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New Partner <90 days

27.9%

72.1%

Multiple Partners

20.1%

79.9%

Met Partner in Bar

7.4%

92.6%

Met Partner in Bath

0.6%

99.4%

0%

100%

Paid for Sex

8.5%

91.5%

Was Paid for Sex

3.4%

96.4%

Vaginal or Anal with Woman

37.3%

62.7%

Oral Sex with Woman

32.2%

67.8%

Unprotected Sex with Woman

35.8%

64.2%

Vaginal or Anal with Man

81.2%

18.8%

Oral Sex with Man

63.9%

36.1%

Unprotected Sex with Man

64.9%

35.1%

Men Having Sex with Men

17.6%

82.4%

Had a History of STD’s

49.2%

50.8%

Has had an STD in the last 12 Months

18.7%

81.3%

Incarcerated in the Last 12 Months

8.5%

91.5%

Sexual Assault

4.6%

95.4%

Knew self-HIV status

Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
Southwest Region
The risk factors for the Southwest region can be found in Table 9. The risk factors
in this region do not fit the current CDC recommendations for at-risk individuals. Of the
reporting 2.5% of the individuals acquired gonorrhea from a sex worker which is much
higher than in other regions. Only 2.8% of those who contracted gonorrhea were sex
workers. Lower than other regions as well as comparing to Statewide, 52.5% of the
respondents had a history of STD’s. Interesting, 22.6% stated they contracted gonorrhea
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through men having sex with men which slightly supports the CDC recommendations for
at-risk. Having multiple sex partners was not a determining factor. At the time of
infection 80.8% of the respondents stated they had only on partner; 11.8% had two
partners; 3.7% had 3 partners; and 3.7% had 4 or more partners.
Table 9
Risk Factors Listed as Percentage Based on Respondents for the Southwest Region of
Florida
Risk Factor

Percentage Yes

Percentage No

Drug Use

49.5%

50.5%

Intoxicated; Alcohol or Drug

27.8%

72.2%

Always Used Condoms

7.8%

92.2%

Sometimes Used Condoms

87.1%

12.9%

Never Used Condoms

38.1%

61.9%

Condom Use with Main Partner

14.7%

85.3%

Condom Use with Other Partner

51.3%

48.7%

Anonymous Partner

9.6%

90.4%

Meet Through the Internet

19.8%

80.2%

New Partner <90 days

25.1%

74.9%

Multiple Partners

23.2%

76.8%

Met Partner in Bar

6.7%

93.3%

Met Partner in Bath

0.6%

99.4%

0%

100%

Paid for Sex

2.5%

97.5

Was Paid for Sex

2.8%

97.2%

Vaginal or Anal with Woman

32.8%

67.2%

Oral Sex with Woman

32.5%

67.5%

Unprotected Sex with Woman

35.2%

64.8%

Knew self-HIV status
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Vaginal or Anal with Man

83.4%

16.6%

Oral Sex with Man

61.8%

38.2%

Unprotected Sex with Man

75.1%

24.9%

Men Having Sex with Men

12.0%

88.0%

Had a History of STD’s

52.5%

47.5%

Has had an STD in the last 12 Months

24.2%

75.8%

Incarcerated in the Last 12 Months

11.0%

89.0%

Sexual Assault

8.0%

92.0%

Note: * indicates there were not enough samples to meet Power. Note: Table created from
data provided by FDOH STARS system and using IBM SPSS version 25.
South Region
The risk factors for the South region can be found in Table 10. The risk factors in
this region do not fit the current CDC recommendations for at-risk individuals. Of the
reporting 2.0% of the individuals acquired gonorrhea from a sex worker which is much
higher than in other regions. Only 4.0% of those who contracted gonorrhea were sex
workers. Higher than other regions and the State, 66.7% of the respondents had a history
of STD’s. Supporting the CDC recommendations for at-risk groups, 55.3% stated they
contracted gonorrhea through men having sex with men. At the time of infection 55.9%
of the respondents stated they had only on partner; 15.5% had two partners; 7.9% had 3
partners; and 20.7% had 4 or more partners.
Table 10
Risk Factors Listed as Percentage Based on Respondents for the South Region of Florida
Risk Factor
Drug Use

Percentage Yes

Percentage No

49.8%

50.2%
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Intoxicated; Alcohol or Drug

15.0%

85%

Always Used Condoms

7.5%

92.5%

Sometimes Used Condoms

69.0%

11.0%

Never Used Condoms

16.8%

83.2%

Condom Use with Main Partner

17.3%

82.7%

Condom Use with Other Partner

38.2%

61.8%

Anonymous Partner

44.6%

55.4%

Meet Through the Internet

32.9%

67.1%

New Partner <90 days

42.6%

57.4%

Multiple Partners

28.5%

71.5%

Met Partner in Bar

19.3%

80.7%

Met Partner in Bath

8.3%

91.7%

0%

100%

Paid for Sex

2.0%

98.0%

Was Paid for Sex

4.0%

96.0%

Vaginal or Anal with Woman

19.4%

80.6%

Oral Sex with Woman

21.2%

78.8%

Unprotected Sex with Woman

17.2%

82.8%

Vaginal or Anal with Man

86.4%

13.6%

Oral Sex with Man

77.3%

22.7%

Unprotected Sex with Man

65.3%

34.7%

Men Having Sex with Men

55.3%

44.7%

Had a History of STD’s

66.7%

33.3%

Has had an STD in the last 12 Months

33.1%

66.9%

Incarcerated in the Last 12 Months

4.6%

95.4%

Sexual Assault

2.0%

98.0%

Knew self-HIV status

Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
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Study Results for Research Question 1
Research Question 1: Are there differences in using last-line-of-antibiotic-defense
between Florida as a whole and each of the eight regions?
Hypothesis 1
H0: There is no statistical significance between each of the eight different regions
and Florida as a whole for the last-line-of-antibiotic-defense associated with
gonococcal infections.
Ha: There is a statistical significance between each of the eight different regions
and Florida as a whole for the last-line-of-antibiotic-defense associated with
gonococcal infections.
Findings
Based on the findings the null hypothesis can be rejected when applied to the
Northwest, Northeast, North Central, East Central, West Central, Southeast, and South
regions but must be accepted for the Southwest region. The results supporting these
findings are as follows.
Chi-square and cross tabulations were conducted to compare the last-line-ofantibiotic-defense between Florida as a whole and the eight different regions. There is a
statistically significant association between Florida and the Northwest Region in regard
to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 14.652, p < 0.05. The results of
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a
lower rate for the Northwest region (68.2%) versus Florida (84.8%) (Table A1 Appendix
A). There is a statistically significant association between Florida and the North Central
Region in regard to the last-line-of-antibiotic-defense: χ 2 (4, N = 29245) = 28.914, p <
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0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a higher rate for the North Central Region (69.3%) versus Florida
(81.7%) (Table A2 Appendix A). There is a statistically significant association between
Florida and the Northeast Region in regard to the last-line-of-antibiotic-defense: χ 2 (4, N
= 33564) = 28.796, p < 0.05. The results of the cross tabulation indicate that the last-lineof-antibiotic-defense was prescribed at a lower rate for the Northeast Region (70.0%)
versus Florida (80.4%) (Table A3 Appendix A). There is a statistically significant
association between Florida and the West Central Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 64192) = 56.274, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the West Central Region (69.5%) versus Florida (84.4%) (Table A4 Appendix A).
There is a statistically significant association between Florida and the East Central
Region in regard to the last-line-of-antibiotic-defense: χ 2 (4, N = 48836) = 61.793, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a lower rate for the East Central Region (69.8%) versus Florida
(73.6%) (Table A5 Appendix A). There is not a statistically significant association
between Florida and the Southwest Region in regard to the last-line-of-antibiotic-defense:
χ2 (4, N = 48836) = 61.793, p > 0.05. The results of the cross tabulation indicate that the
last-line-of-antibiotic-defense was prescribed at a lower rate for the Southwest region
(70%) versus Florida (90.2%) (Table A6 Appendix A). There is a statistically significant
association between Florida and the Southeast Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 18037) = 54.963, p < 0.05. The results of the cross
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tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the Southwest Region (68.2%) versus Florida (84.6%) (Table A7 Appendix A). There
is a statistically significant association between Florida and the South Region in regard to
the last-line-of-antibiotic-defense: χ2 (4, N = 64110) = 103.973, p < 0.05. The results of
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a
lower rate for the South Region (69.6%) versus Florida (73.7%) (Table A8 Appendix A).
Study Results for Research Question 2
Research Question 2: Are there differences in using last-line-of-antibiotic-defense
among the eight Florida regions?
Hypothesis 2:
H0: There is no statistical significance between the eight Florida regions in regard
to the last-line-of-antibiotic-defense for gonococcal infections.
Ha: There is a statistical significance between the eight Florida regions in regard
to the last-line-of-antibiotic-defense for gonococcal infections.
Findings
Based on the findings the null hypothesis can be rejected. The results supporting
the findings are the following. Chi-square and a cross tabulations were conducted to
compare the last-line-of-antibiotic-defense between the eight different regions.
Northwest Region
There is a statistically significant association between the Northwest Region and
the North Central Region in regard to the last-line-of-antibiotic-defense: χ 2 (4, N =
16945) = 36.322, p < 0.05. The results of the cross tabulation indicate that the last-line-
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of-antibiotic-defense was prescribed at a lower rate for the Northwest Region (84.4%)
versus the North Central Region (85.4%). There is not a statistically significant
association between the Northwest Region and the Northeast Region in regard to the lastline-of-antibiotic-defense: χ2 (4, N = 16946) = 6.601, p > 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the Northwest Region (78.8%) versus the Northeast Region (84.9%). There is a
statistically significant association between the Northwest Region and the West Central
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 12.021, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a lower rate for the Northwest Region (80.6%) versus the West Central
Region (85%). There is a statistically significant association between the Northwest
Region and the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4,
N = 16944) = 10.894, p < 0.05. The results of the cross tabulation indicate that the lastline-of-antibiotic-defense was prescribed at a higher rate for the Northwest Region
(84.4%) versus the East Central Region (69.5%). There is a statistically significant
association between the Northwest Region and the Southwest Region in regard to the
last-line-of-antibiotic-defense: χ2 (4, N = 8409) = 10.768, p < 0.05. The results of the
cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher
rate for the Northwest Region (73.6%) versus the Southwest Region (69.8%). There is a
statistically significant association between the Northwest Region and the Southeast
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) = 13.113, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
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was prescribed at a higher rate for the Northwest Region (85%) versus the Southeast
Region (84.7%). There is not a statistically significant association between the Northwest
Region and the South Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N =
16946) = 3.950, p > 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a lower rate for the Northwest Region (80.2%)
versus the South Region (84.9%).
Northeast Region
There is a statistically significant association between the Northeast Region and
the North Central Region in regard to the last-line-of-antibiotic-defense: χ 2 (4, N =
29244) = 30.497, p < 0.05. The results of the cross tabulation indicate that the last-lineof-antibiotic-defense was prescribed at a higher rate for the Northeast Region (81.6%)
versus the North Central Region (80.1%). There is not a statistically significant
association between the Northeast Region and the Northwest Region in regard to the lastline-of-antibiotic-defense: χ2 (4, N = 16946) = 6.601, p > 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the Northeast Region (78.8%) versus the Northwest Region (84.9%). There is a
statistically significant association between the Northeast Region and the West Central
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 33567) = 104.433, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a higher rate for the Northeast Region (81.6%) versus the West Central
Region (80.9%). There is a statistically significant association between the Northeast
Region and the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4,
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N = 33564) = 18.613, p < 0.05. The results of the cross tabulation indicate that the lastline-of-antibiotic-defense was prescribed at a lower rate for the Northeast Region (71.3%)
versus the East Central Region (80.2%). There is not a statistically significant association
between the Northeast Region and the Southwest Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 8409) = 8.017, p > 0.05. The results of the cross tabulation
indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate for the
Northeast Region (90%) versus the Southwest Region (73.4%). There is a statistically
significant association between the Northeast Region and the Southeast Region in regard
to the last-line-of-antibiotic-defense: χ2 (4, N = 18037) = 30.101, p < 0.05. The results of
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a
higher rate for the Northeast Region (85.9%) versus the Southeast Region (78.4%). There
is a statistically significant association between the Northeast Region and the South
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 33565) = 17.710, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a lower rate for the Northeast Region (79.3%) versus the South Region
(80.3%).
North Central Region
There is a statistically significant association between the North Central Region
and the Northwest Region in regard to the last-line-of-antibiotic-defense: χ 2 (4, N =
16945) = 36.322, p < 0.05. The results of the cross tabulation indicate that the last-lineof-antibiotic-defense was prescribed at a higher rate for the North Central Region
(85.4%) versus the Northwest Region (84.4%). There is a statistically significant
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association between the North Central Region and the Northeast Region in regard to the
last-line-of-antibiotic-defense: χ2 (4, N = 29244) = 30.497, p < 0.05. The results of the
cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower
rate for the North Central Region (80.1%) versus the Northeast Region (81.6%). There is
a statistically significant association between the North Central Region and the West
Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 29245) =
10.644, p < 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a higher rate for the North Central Region (81.6%)
versus the West Central Region (81.1%). There is a statistically significant association
between the North Central Region and the East Central Region in regard to the last-lineof-antibiotic-defense: χ2 (4, N =29242) = 23.896, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the North Central Region (74.5%) versus the East Central Region (81.2%). There is
not a statistically significant association between the North Central Region and the
Southwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8408) =
1.672, p > 0.05. The results of the cross tabulation indicate that the last-line-of-antibioticdefense was prescribed at a higher rate for the North Central Region (90.5%) versus the
Southwest Region (80.5%). There is a statistically significant association between the
North Central Region and the Southeast Region in regard to the last-line-of-antibioticdefense: χ2 (4, N = 18036) = 12.749, p < 0.05. The results of the cross tabulation indicate
that the last-line-of-antibiotic-defense was prescribed at a higher rate for the North
Central Region (90.5%) versus the Southeast Region (80.5%). There is a statistically
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significant association between the North Central Region and the South Region in regard
to the last-line-of-antibiotic-defense: χ2 (4, N = 29243) = 13.432, p < 0.05. The results of
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a
lower rate for the North Central Region (80.1%) versus the South Region (81.1%).
West Central Region
There is a statistically significant association between the West Central Region
and the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N =
16946) = 12.021, p < 0.05. The results of the cross tabulation indicate that the last-lineof-antibiotic-defense was prescribed at a higher rate for the West Central Region (85%)
versus Northwest Region (80.6%) the. There is a statistically significant association
between the West Central Region and the Northeast Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 33567) = 104.433, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the West Central Region (80.9%) versus the Northeast Region (81.6%). There is a
statistically significant association between the West Central Region and the North
Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 29245) =
10.644, p < 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a lower rate for the West Central Region (81.1%)
versus the North Central Region (81.6%). There is a statistically significant association
between the West Central Region and the East Central Region in regard to the last-lineof-antibiotic-defense: χ2 (4, N = 48839) = 20.258, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
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for the West Central Region (72.6%) versus the East Central Region (83.1%). There is
not a statistically significant association between the West Central Region and the
Southwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8409) =
8.838, p > 0.05. The results of the cross tabulation indicate that the last-line-of-antibioticdefense was prescribed at a higher rate for the West Central Region (90.3%) versus the
Southwest Region (78.7%). There is a statistically significant association between the
West Central Region and the Southeast Region in regard to the last-line-of-antibioticdefense: χ2 (4, N = 18037) = 25.723, p < 0.05. The results of the cross tabulation indicate
that the last-line-of-antibiotic-defense was prescribed at a higher rate for the West Central
Region (85.5%) versus the Southeast Region (79%). There is a statistically significant
association between the West Central Region and the South Region in regard to the lastline-of-antibiotic-defense: χ2 (4, N = 64113) = 33.992, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate
for the West Central Region (73.9%) versus the South Region (84.7%).
East Central Region
There is a statistically significant association between the East Central Region and
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16944) =
10.894, p < 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a lower rate for the East Central Region (69.5%)
versus the Northwest Region (84.4%). There is a statistically significant association
between the East Central Region and the Northeast Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 33564) = 18.613, p < 0.05. The results of the cross
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tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate
for the East Central Region (80.2%) versus the Northeast Region (71.3%). There is a
statistically significant association between the East Central Region and the North
Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N =29242) =
23.896, p < 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a higher rate for the East Central Region (81.2%)
versus the North Central Region (74.5%). There is a statistically significant association
between the East Central Region and the West Central Region in regard to the last-lineof-antibiotic-defense: χ2 (4, N = 48839) = 20.258, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate
for the East Central Region (83.1%) versus the West Central Region (72.6%). There is a
statistically significant association between the East Central Region and the Southwest
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8407) = 9.747, p < 0.05.
The results of the cross tabulation indicate that the last-line-of-antibiotic-defense was
prescribed at a higher rate for the East Central Region (90.5%) versus the Southwest
Region (80.5%). There is a statistically significant association between the East Central
Region and the Southeast Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N
= 18037) = 25.723, p < 0.05. The results of the cross tabulation indicate that the last-lineof-antibiotic-defense was prescribed at a higher rate for the East Central Region (85.4%)
versus the Southeast Region (76.2%). There is not a statistically significant association
between the East Central Region and the South Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 48838) = 5.146, p > 0.05. The results of the cross tabulation

119
indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate for the East
Central Region (90.5%) versus the South Region (80.5%).
Southwest Region
There is a statistically significant association between the Southwest Region and
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8409) =
10.768, p < 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a lower rate for the Southwest Region (69.8%)
versus the Northwest Region (73.6%). There is not a statistically significant association
between the Southwest Region and the Northeast Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 8409) = 8.017, p > 0.05. The results of the cross tabulation
indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate for the
Southwest Region (73.4%) versus Northeast Region (90%) the. There is not a statistically
significant association between the Southwest Region and the North Central Region in
regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8408) = 1.672, p > 0.05. The
results of the cross tabulation indicate that the last-line-of-antibiotic-defense was
prescribed at a lower rate for the Southwest Region (80.5%) versus the North Central
Region (90.5%). There is not a statistically significant association between the Southwest
Region and the West Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4,
N = 8409) = 8.838, p > 0.05. The results of the cross tabulation indicate that the last-lineof-antibiotic-defense was prescribed at a higher rate for the Southwest Region (78.7%)
versus the West Central Region (90.3%). There is a statistically significant association
between the Southwest Region and the East Central Region in regard to the last-line-of-
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antibiotic-defense: χ2 (4, N = 8407) = 9.747, p < 0.05. The results of the cross tabulation
indicate that the last-line-of-antibiotic-defense was prescribed at a lower rate for the
Southwest Region (80.5%) versus the East Central Region (90.5%). There is a
statistically significant association between the Southwest Region and the Southeast
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 8409) = 13.287, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a lower rate for the Southwest Region (85.3%) versus the Southeast
Region (90.5%). There is not a statistically significant association between the Southwest
Region and the South Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N =
8409) = 4.268 p > 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a lower rate for the Southwest Region (76.5%)
versus the South Region (90.3%).
Southeast Region
There is a statistically significant association between the Southeast Region and
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) =
13.113, p < 0.05. The results of the cross tabulation indicate that the last-line-ofantibiotic-defense was prescribed at a lower rate for the Southeast Region (84.7%) versus
the Northwest Region (85%). There is a statistically significant association between the
Southeast Region and the Northeast Region in regard to the last-line-of-antibioticdefense: χ2 (4, N = 18037) = 30.101, p < 0.05. The results of the cross tabulation indicate
that the last-line-of-antibiotic-defense was prescribed at a lower rate for the Southeast
Region (78.4%) versus the Northeast Region (85.9%). There is a statistically significant
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association between the Southeast Region and the North Central Region in regard to the
last-line-of-antibiotic-defense: χ2 (4, N = 18036) = 12.749, p < 0.05. The results of the
cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a lower
rate for the Southeast Region (80.5%) versus the North Central Region (90.5%). There is
a statistically significant association between the Southeast Region and the West Central
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 18037) = 25.723, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a lower rate for the Southeast Region (79%) versus the West Central
Region (85.5%). There is a statistically significant association between the Southeast
Region and the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4,
N = 18037) = 25.723, p < 0.05. The results of the cross tabulation indicate that the lastline-of-antibiotic-defense was prescribed at a lower rate for the Southeast Region (76.2%)
versus the East Central Region (85.4%). There is a statistically significant association
between the Southeast Region and the Southwest Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 8409) = 13.287, p < 0.05. The results of the cross tabulation
indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate for the
Southeast Region (90.5%) versus the Southwest Region (85.3%). There is a statistically
significant association between the Southeast Region and the South Region in regard to
the last-line-of-antibiotic-defense: χ2 (4, N = 16037) = 17.020, p < 0.05. The results of
the cross tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a
lower rate for the Southeast Region (79.7%) versus the South Region (85.2%).
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South Region
There is not a statistically significant association between the South Region and
the Northwest Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 16946) =
3.950, p > 0.05. The results of the cross tabulation indicate that the last-line-of-antibioticdefense was prescribed at a higher rate for the South Region (84.9%) versus the
Northwest Region (80.2%). There is a statistically significant association between the
South Region and the Northeast Region in regard to the last-line-of-antibiotic-defense: χ2
(4, N = 33565) = 17.710, p < 0.05. The results of the cross tabulation indicate that the
last-line-of-antibiotic-defense was prescribed at a higher rate for the South Region
(80.3%) versus the Northeast Region (79.3%). There is a statistically significant
association between the South Region and the North Central Region in regard to the lastline-of-antibiotic-defense: χ2 (4, N = 29243) = 13.432, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate
for the South Region (81.1%) versus the North Central Region (80.1%). There is a
statistically significant association between the South Region and the West Central
Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 64113) = 33.992, p <
0.05. The results of the cross tabulation indicate that the last-line-of-antibiotic-defense
was prescribed at a higher rate for the South Region (84.7%) versus the West Central
Region (73.9%).
There is not a statistically significant association between the South Region and
the East Central Region in regard to the last-line-of-antibiotic-defense: χ2 (4, N = 48838)
= 5.146, p > 0.05. The results of the cross tabulation indicate that the last-line-of-
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antibiotic-defense was prescribed at a lower rate for the South Region (80.5%) versus the
East Central Region (90.5%). There is not a statistically significant association between
the South Region and the Southwest Region in regard to the last-line-of-antibioticdefense: χ2 (4, N = 8409) = 4.268 p > 0.05. There is a statistically significant association
between the South Region and the Southeast Region in regard to the last-line-ofantibiotic-defense: χ2 (4, N = 16037) = 17.020, p < 0.05. The results of the cross
tabulation indicate that the last-line-of-antibiotic-defense was prescribed at a higher rate
for the South Region (85.2%) versus the Southeast Region (79.7%).
Study Results for Research Question 3
Research Question 3: What are the statistically significant factors associated with being
treated with last-line-of-antibiotic-defense in each of the eight regions and the
state of Florida?
Hypothesis 3:
H0: There are no statistically significant factors associated with being treated with
last-line-of-antibiotic-defense in the eight regions.
Ha: There are statistically significant factors associated with being treated with
last-line-of-antibiotic-defense in the eight regions.
Findings
There is statistical significance between the initial treatment and statistically
significant risk factors and demographics per region. Based on these findings the null
hypothesis can be rejected. The results supporting these findings area as follows. Multiple
logistic regression models were conducted for each of the eight regions and Florida as a
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whole. Race/ethnic populations, age range, gender, men who have sex with men, sexual
orientation, and pregnancy in relationship to the prescribed last-line-of-antibiotic-defense
were compared. There are 27 identified significant risk factors that were also compared to
the last-line-of-antibiotic-defense.
State of Florida
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are race/ethnicity, age
range, gender, pregnancy, always use condoms, HIV self-aware, oral sex with female,
unprotected anal or vaginal sex with a male, history of a prior STD, and had an STD in
the last 12 months from the time of the infection (Table B1 Appendix B). The multiple
logistic regression for Florida there are ten statistically significant variables. Of those ten
statistically significant variables three have an increased likelihood of being prescribed
the last-line-of-antibiotic-defense. This then indicates that these particular variables could
be indicative of the probability of developing drug resistance for gonococcal infections.
These variables are age range which has a 3.4% increase likelihood of being prescribed
the last-line-of-antibiotic-defense, oral sex with a female has a 22.1% greater likelihood
of receiving the last-line-of-antibiotic-defense, and sex with a male has a 16.6% greater
likelihood of being prescribed the last-line-of-antibiotic-defense. Race/ethnicity, gender,
pregnancy, always using condoms, knowing your HIV status, history of a prior STD,
history of a prior STD within 90 days, and gender may all be protective factors Since
these are less likely to be prescribed the last-line-of-antibiotic-defense. It appears that
gender would be the greatest protective factor. Within gender alone as an internal
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comparison an odds ratio was conducted for males versus females (female versus male,
OR = 0.756 (95% CI: 0.742, 0.770). Females have a less likelihood of being prescribed
the last-line-of-antibiotic-defense versus males (OR = 0.944 (95% CI: 0.941, 0.948)) and
males have a 5.96% greater likelihood of being prescribed the last-line-of-antibioticdefense.
Northwest Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are age range, men who
have sex with men, sexual orientation, pregnancy, sometimes use condoms, never use
condoms, HIV self-aware, oral sex with female, unprotected anal or vaginal sex with a
male, and had history of a prior STD (Table B2 Appendix B). In the Northwest Region
there are eight statistically significant risk factors based on the multiple logistic
regression. Of the eight variables four variables have an increased likelihood of being
prescribed the last-line-of-antibiotic-defense. Age groups have only a 2.3% increase
likelihood of being prescribed the last-line-of-antibiotic-defense. If a person had a history
of a prior STD have a 25.1% chance increased likelihood of being prescribed the lastline-of-antibiotic-defense. Those who only use condoms sometimes have a 135.6%
increased chance of being prescribed the last-line-of-antibiotic-defense. Those who never
use condoms have a 137.2% increase chance of being prescribed the last-line-ofantibiotic-defense. This then indicates that these particular variables could be indicative
of the probability of developing drug resistance for gonococcal infections. The remaining
variables such as knowing HIV status, pregnancy, sexual orientation, and men who have
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sex with men are more likely to be protective factors, with men who have sex with men
being the greatest protective factor.
Northeast Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are age range, gender,
sexual orientation, pregnancy, sometimes use condoms, new partner within 90 days at the
time of the infection, number of sex partners, HIV self-aware, oral sex with female, and
incarcerated within the last 12 months from the time of infection (Table B3 Appendix B).
The multiple logistic regression for the Northeast Region indicates that there are ten
statistically significant risk factors. There are three risk factors that are at an increased
risk of being prescribed the last-line-of-antibiotic-defense. Age range has a 6.2%
increased risk of being prescribed the last-line-of-antibiotic-defense. The number of sex
partners have a 14% increase of being prescribed the last-line-of-antibiotic-defense.
Having oral sex with a female is a 149.4% increase chance of being prescribed the lastline-of-antibiotic-defense. There are seven factors that may have a protective effect these
are gender, sexual orientation, pregnancy, sometimes using condoms, new partner within
90 days, knowing HIV status, and incarcerated within the last 12 months. Of these factors
gender has the greatest protective effect. Within gender alone as an internal comparison,
an odds ratio was conducted for males versus females (female versus male, OR = 0.616
(95% CI: 0.584, 0.651). Females have a less likelihood of being prescribed the last-lineof-antibiotic-defense versus males (OR = 0.911 (95% CI: 0.901, 0.920)) and males have a
9.79% greater likelihood of being prescribed the last-line-of-antibiotic-defense.
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North Central Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are race/ethnicity,
gender, men who have sex with men, sexual orientation, pregnancy, condom use with
other partners, HIV self-aware, and oral sex with male (Table B4 Appendix B). The
multiple logistic regression for the North Central Region indicates that there are nine
statistically significant risk factors. There is only one risk factor that are at an increased
risk of being prescribed the last-line-of-antibiotic-defense. Those who used condoms with
their other partner had a 99.3% increased risk of being prescribed the last-line-ofantibiotic-defense. There are eight factors that may have a protective effect these are
race/ethnics, gender, men who have sex with men, sexual orientation, pregnancy,
knowing HIV status, and oral sex with a male. Of these factors, pregnancy has the
greatest protective effect.
West Central Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are race/ethnicity, age
range, gender, men who have sex with men, sexual orientation, pregnancy, condom use
with other partners, HIV self-aware, and vaginal or anal sex with a female (Table B5
Appendix B). The multiple logistic regression for the West Central Region indicates that
there are eight statistically significant risk factors. There is only one risk factor that are at
an increased risk of being prescribed the last-line-of-antibiotic-defense. Age range had a
4.0% increased risk of being prescribed the last-line-of-antibiotic-defense. There are
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seven factors that may have a protective effect, and these are race/ethnics, gender, men
who have sex with men, sexual orientation, pregnancy, knowing HIV status, and vaginal
or anal sex with a female. Of these factors, pregnancy has the greatest protective effect.
East Central Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are race/ethnicity, age
range, gender, pregnancy, drug use, always use condoms, HIV self-aware, and victim of
sexual assault (Table B6 Appendix B). The multiple logistic regression for the East
Central Region indicates that there are eight statistically significant risk factors. There are
two risk factors that are at an increased risk of being prescribed the last-line-of-antibioticdefense. Age range had a 4.7% increased risk of being prescribed the last-line-ofantibiotic-defense. Condom use always had a 77.6% increased risk of being prescribed
the last-line-of-antibiotic-defense. There are six factors that may have a protective effect,
and these are race/ethnics, gender, pregnancy, drug use, knowing HIV status, and victim
of sexual assault. Of these factors, pregnancy has the greatest protective effect.
Southeast Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are age range, men who
have sex with men, sexual orientation, pregnancy, HIV self-aware, was paid for sex,
vaginal or anal sex with a man, incarcerated within the last 12 months from the time of
infection, and victim of sexual assault (Table B7 Appendix B). The multiple logistic
regression for the Southeast Region indicates that there are nine statistically significant
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risk factors. There two risk factors that are at an increased risk of being prescribed the
last-line-of-antibiotic-defense. Age range had an 8.1% increased risk of being prescribed
the last-line-of-antibiotic-defense. Those who were incarcerated within the last 12 months
of the time of the infection had a 29.3% increased risk of being prescribed the last-lineof-antibiotic-defense. There are seven factors that may have a protective effect, and these
are men who have sex with men, sexual orientation, pregnancy, knowing HIV status, was
paid for sex, vaginal or anal sex with a male, and victim of sexual assault. Of these
factors, victim of sexual assault has the greatest protective effect.
Southwest Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are age range, sexual
orientation, pregnancy, oral sex with a female, and a history of a prior STD (Table B8
Appendix B). The multiple logistic regression for the Southwest Region indicates that
there are five statistically significant risk factors. There are two risk factors that are at an
increased risk of being prescribed the last-line-of-antibiotic-defense. Age range had an
4.9% increased risk of being prescribed the last-line-of-antibiotic-defense. Those who
had oral sex with a female had a 141.2% increased risk of being prescribed the last-lineof-antibiotic-defense. There are three factors that may have a protective effect, and these
are sexual orientation, pregnancy, and those who had a history of a prior STD within the
last 12 months from the time of the infection. Of these factors, pregnancy has the greatest
protective effect.
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South Region
The results of the multiple logistic regression indicate that some of the
demographics and risk factors are statistically significant. These are race/ethnicity, age
range, gender, men who have sex with men, sexual orientation, pregnancy, HIV selfaware, and was paid for sex (Table B9 Appendix B). The multiple logistic regression for
the South Region indicates that there are eight statistically significant risk factors. There
are three risk factors that are at an increased risk of being prescribed the last-line-ofantibiotic-defense. Age range had an 5% increased risk of being prescribed the last-lineof-antibiotic-defense. Men who have sex with men had an 48.7% increased risk of being
prescribed the last-line-of-antibiotic-defense. Sexual orientation had a 16% increased risk
of being prescribed the last-line-of-antibiotic-defense. There are five factors that may
have a protective effect, and these are race/ethnicity, gender, pregnancy, knowing HIV
status, and was paid for sex. Of these factors, gender has the greatest protective effect.
Within gender alone as an internal comparison, an odds ratio was conducted for males
versus females (female versus male, OR = 0.829 (95% CI: 0.799, 0.860). Females have a
less likelihood of being prescribed the last-line-of-antibiotic-defense versus males (OR =
0.952 (95% CI: 0.942, 0.961)) and males have a 5.2% greater likelihood of being
prescribed the last-line-of-antibiotic-defense.
Risk-factor comparisons for the Regions
Every region with the accept of the North Central Region shares one common
increased risk factor of statistical significance that has an increased likelihood for being
prescribed the last-line-of-antibiotic-defense. That risk factor is age ranges. The North

131
Central Region also has age range as an increased likelihood for being prescribed the lastline-of-antibiotic-defense but based on a p-value of 0.05 it was not considered
statistically significant. Had the p-value been 0.10 then it would have been considered
statistically significant. The Northwest Region, the North Central Region, and the East
Central Region, shared some level of condom use as having an increased likelihood for
being prescribed the last-line-of-antibiotic-defense. The North East Region and the
Southwest Region shared oral sex with a female as having an increased likelihood for
being prescribed the last-line-of-antibiotic-defense.
Protective Factor Comparisons for the Regions
All regions shared a statistically significant protective factor and that was
pregnancy. There were other statistically significant protective factors that had
commonality in the Regions. All regions except for the Southwest Region shared the
protective factor and a reduced risk for being prescribe the last-line-of-antibiotic-defense
for those who knew their HIV status. There were other shared common protective factors
for some of the Regions. Race/ethnics was shared for the North Central Region, the West
Central Region, the East Central Region, and the South Region. Gender was shared for
the Northeast Region, the North Central Region, the West Central Region, the East
Central Region, and the South Region. Sexual orientation was shared with the Northwest
Region, the North Central Region, the West Central Region, Southeast Region, and the
Southwest Region. The South East Region and the South Region shared those who were
paid for sex as a protective factor. The remaining statistically significant protective
factors within each region are unique to those areas.
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Protective and Risk-factor comparisons for the Regions
In some instances, a protective factor in one region became a risk factor in
another region. Men who have sex with men is considered a protective factor in the
Northwest Region, the North Central Region, the West Central Region, and the Southeast
Region but is a risk factor in the South Region. Sexual orientation is considered a
protective factor in the Northwest Region, the North East Region, the North Central
Region, the West Central Region, Southeast Region, and the Southwest Region but is a
risk factor in the South Region. Incarcerated within the last 12 months from the time of
the infection was a protective factor in the Northeast Region but was a risk factor in the
Southeast Region.
Risk-factor comparisons for the Regions and State
Florida and every region with the accept of the North Central Region shares one
common increased risk factor of statistical significance that has an increased likelihood
for being prescribed the last-line-of-antibiotic-defense. That risk factor is age ranges. The
state of Florida, the North East Region, and the Southwest Region shared oral sex with a
female as having an increased likelihood for being prescribed the last-line-of-antibioticdefense. No other increased likelihood for being prescribed the last-line-of-antibioticdefense risk factors were shared among Florida and the regions (Table 11). Florida and
regions had unshared risk factors for the increased likelihood for being prescribed the
last-line-of-antibiotic-defense. For instance, Florida had vaginal or anal sex unprotected
with a male; the Northwest Region had for those who had history of STD any time in
their past; the Northeast Region had an increased risk for a number of sex partners; the
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Southeast Region had an increased risk for those who incarcerated within the last 12
months since the time of the infection; and the South region had an increased risk for
those men who had sex with men and sexual orientation (Table 11).
Protective Factor Comparisons for the Regions and State
Florida and all regions shared a statistically significant protective factor and that
was pregnancy. There were other statistically significant protective factors that had
commonality in the Regions and the State. Florida and all regions except for the
Southwest Region shared the protective factor and a reduced risk for being prescribe the
last-line-of-antibiotic-defense for those who knew their HIV status. There were other
shared common protective factors for some of the Regions and State. Race/ethnics was
shared for the state of Florida, the North Central Region, the West Central Region, the
East Central Region, and the South Region. Gender was shared for the state of Florida,
the Northeast Region, the North Central Region, The West Central Region, the East
Central Region, and the South Region. Sexual orientation was shared with the Northwest
Region, the North Central Region, the West Central Region, Southeast Region, and the
Southwest Region. Florida and the Southwest Region shared history of an STD in the last
12 months from the time of infection as a protective factor. The South East Region and
the South Region shared those who were paid for sex as a protective factor. The
remaining statistically significant protective factors within Florida and each region are
unique to those areas (Table 11).
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Protective and Risk-factor Comparisons for the Regions and State
In some instances, a protective factor in one region or the state became a risk
factor in another region or for the State. Condom use always is a protective factor in
Florida but a risk factor in the East Central Region. In Florida having a history of an STD
at any time is a protective factor but is a risk factor in the Northwest Region. Also, in
Florida always using condoms is a protective factor but in the East Central Region it is
considered a risk factor. A similar comparison but not exact is that vaginal or anal
unprotected sex with a male is a risk factor in the state of Florida, but vaginal or anal sex
with a male is considered a protective factor in the Southeast Region (Table 11).
Table 11
Risk Factors are in Red and Protective Factors in Black for Florida and Eight Regions
State of
Florida

Northwest
Region

Northeast
Region

Race/ Ethnics
Age Range

Age Range

Gender

West
Central
Region

East
Central
Region

Race/
Ethnics

Race/
Ethnics
Age Range

Race/
Ethnics
Age
Range
Gender

Age Range
Gender

Men who have
Sex with Men

Pregnancy

North
Central
Region

Sexual
Orientation
Pregnancy

Sexual
Orientation
Pregnancy

Condom Use
Sometimes
Condom Use
Never

Condom Use
Sometimes

Gender
Men who
have Sex
with Men
Sexual
Orientation
Pregnancy

Condom Use
Always

Condom
Use with
other
Partner
New Partner
w/in 90 days
No. of Sex
Partners

Gender
Men who
have Sex
with Men
Sexual
Orientation
Pregnancy

Pregnancy
Drug Use
Condom
Use
Always

Southeast
Region

Age Range
Men who
have Sex
with Men
Sexual
Orientation
Pregnancy

Southwest
Region

South
Region

Age Range

Race/
Ethnics
Age Range

Sexual
Orientation
Pregnancy

Gender
Men who
have Sex
with Men
Sexual
Orientation
Pregnancy
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Aware of HIV
Status

Aware of HIV
Status

Aware of
HIV Status

Aware of
HIV Status

Aware of
HIV Status

Aware of
HIV
Status

Aware of
HIV Status

Aware of
HIV Status

Was Paid for
Sex

Was Paid
for Sex

Vaginal or
Anal Sex
with
Female
Oral Sex with
Female

Oral Sex
with Female

Oral Sex
with Female
Oral Sex
with Male
Vaginal or
Anal Sex
with Male

Vaginal or
Anal Sex with
Male
Unprotected
History of an
STD
History of an
STD in the
Last 12
Months

History of an
STD
History of an
STD in the
Last 12
Months
Incarcerated
in the last 12
months
Victim
Sexual
Assault

Incarcerated
in the last 12
months
Victim
Sexual
Assault

Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
Summary
The data provided by Florida presented significant findings. These findings
indicate that there are statistically significant predictive risk factors related to
antimicrobial resistant gonorrhea. The findings also indicate that there are variations
between Florida as a whole and the individual regions. No region, nor Florida shared the
exact same results. Each had its own unique and specific risk factors. Thus, further
supporting the intended purpose of this study. The research questions were able to be
successfully answered and provided statistically significant insight. The results of this
will be discussed further in Chapter 5.

Aware of
HIV Status
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Chapter 5: Discussion
Introduction
The purpose of this study was to identify at-risk groups for contracting drugresistant gonorrhea. Drug resistance is driven by overuse of antibiotics. The CDC as well
as work conducted by Alirol et al. (2017), Barbee (2014), Chesson et al. (2014), Hooke
et. al. (2013), Kirkcaldy (2016), Marti et al. (2016), Tapsall et al. (2009), Tuite et al.
(2017), Unemo and Shafer (2014), Ventola (2015), Whiley et al. (2012), and Wi et al.
(2017), indicated that there is only one effective last-line-of-antibiotic-defense left and
continued use of this last-line-of-antibiotic-defense will lead to complete drug resistance.
Unless new antibiotics are derived, it is only a matter of time before there is no cure. In
March of 2018, the first fully drug-resistant strain of gonorrhea emerged (Ducharme,
2018). Since there is currently only one CDC recommended treatment for drug-resistant
gonorrhea, aggressive targeted interventions will be the next step. It is important to
identify who these at-risk individuals are. The identification process was based on the
prescribed last-line-of-antibiotic-defense. Comparisons were conducted between the lastline-of-antibiotic-defense and demographic and risk factors to provide statistically
significant models. This information can now be used to develop targeted interventions.
As mentioned in earlier chapters, demographics change throughout the state of
Florida. The state was split into eight different regions as assigned by the FDOH (Figure
1). The results indicated that each region has differences from one another and the state
of Florida. The statistically significant factors are not fully uniform from region to region,
nor in comparison to the state. Although there are some similar characteristics, findings
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indicate that those who are at-risk for contracting drug-resistant gonococcal infections
vary differently among the different regions and Florida.
The secondary data on risk factors for gonococcal infection were provided by the
FDOH for this study. The data were statistically evaluated to identify the statistically
significant at-risk groups for contracting drug-resistant strains of gonorrhea for Florida as
well as eight different regions of the state. The concept of contracting drug-resistant
strains can be looked at in two different ways: (a) One can directly contract a drugresistant strain from someone who is carrying the drug-resistant strain. (b) The
gonococcal strain can become drug resistant within the individual (Reygaert, 2018). This
can occur through transduction between reservoir bacteria in the Neisseria genus (Igawa,
2018; Wadsworth, Arnold, Sater, & Grad, 2018). Currently, gonorrhea has begun to
become resistant to the last line of antibiotic treatment and it is also believed to be driven
through reservoir bacteria in the Neisseria genus (Igawa, 2018; Martin et al., 2019). A
study by Sánchez-Busó and Harris (2019) looked at genomics to understand the pathway
mechanisms. They indicated that not only is drug-resistant gonorrhea being passed in
high-risk groups, but it may also be silently spreading in the low-risk groups, thus leading
to a public health crisis.
Since Florida stopped monitoring for drug resistance in 2013, and tested for drug
resistance only in select populations, this study was challenging to conduct. First, the
drug-resistant gonococcal data were biased and could not be used because not all infected
individuals were tested. The state only tested those groups that were identified as high
risk by the CDC and those demographic groups do not necessary coincide with the
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diverse demographics within the state of Florida. Additionally, there was only one testing
site in the entire state of Florida from the 1990’s to 2013. This testing site was located in
the South Region making it difficult for individuals residing in other areas of the state to
access. Because there was no significant data directly related to drug resistance, this
study took a different approach that was supported by the literature and evaluated risk
factors and demographics that were at-risk for being prescribed the last-line-of-antibioticdefense. This in turn elucidates the most likely groups to develop, contract, and evolve
drug-resistant gonorrhea. The findings were then used to develop a predictive model for
drug resistance for Florida and the eight Florida regions. Ultimately the goal is to utilize
these findings to create targeted interventions to prevent, slow, or even stop the spread of
drug-resistant variants in the state of Florida.
Interpretation of the Findings
There were descriptive statistics that were incorporated into the interpretation of
the findings. The biggest populations for contracting gonorrhea were heterosexuals
(74.2%), African American (52.9%), males (54.3%) and under the age of 30 years (73%).
The highest concentration of infections were those ages 20 to 24 years. Other key factors
that stood out was that unprotected sex (94.7%) and having a history of an STD (60.2%).
Preventative measures would focus on these key demographics and risk factors. There
also needs to be intervention focus on those who have had and STD. This information can
be presented at the time of diagnosis with emphasis on drug resistance. Safe sex practices
will always need emphasis
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The descriptive statistics elucidated some interesting findings per each region.
The Northwest Region’s largest populations for contracting gonorrhea were
heterosexuals (89.2%), African Americans (43.7%), females (52.1%), and those under the
age of 30 years (76.8%). The highest concentration of infections were those ages 20 to 24
years (33.4%). Other key factors that stood out was that unprotected sex either vaginal or
anal with a man and having a history of an STD. The Northeast Region’s largest
populations for contracting gonorrhea were heterosexuals (79.1%), African Americans
(67.5%), males (51.5%), and those under the age of 30 years (73.7%). The highest
concentration of infections was individual between ages 20 to 24 years (33.2%). Other
key factors that stood out were that unprotected sex either vaginal or anal with a man,
oral sex with a man, and having a history of an STD. The North Central Region’s largest
populations for contracting gonorrhea were heterosexuals (88.7%), African Americans
(59%), females (52.6%), and those under the age of 30 years (90.5%). Other key factors
was sex while intoxicated and drug use among the infected. As for age, the highest
concentration of infections were those ages 20 to 24 years (37.2%). Other key factors that
stood out was that unprotected sex either vaginal or anal with a man, oral sex with a man,
and having a history of an STD.
The West Central Region’s largest populations for contracting gonorrhea were
heterosexuals (79.4%), African Americans (53.3%), males (52.2%), and those under the
age of 30 years (74.1%). As for age, the highest concentration of infections were those
ages 20 to 24 years (32.2%). Other key factors that stood out was that unprotected sex
either vaginal or anal with a man, oral sex with a man, and having a history of an STD.
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Drug use was also a factor in this region. The East Central Region’s largest populations
for contracting gonorrhea were heterosexuals (79.4%), African Americans (53.3%),
males (52.1%) and those under the age of 30 years (74.1%). As for age, the highest
concentration of infections were those ages 20 to 24 years (32.3.%). Other key factors
that stood out was that unprotected sex either vaginal or anal with a man, oral sex with a
man, and having a history of an STD. Drug use was also a factor in this region.
The Southeast Region’s largest populations for contracting gonorrhea were
heterosexuals (86.6%), African Americans (58%), males (52.3%), and those under the
age of 30 years (72.4%). As for age, the highest concentration of infections were those
ages 20 to 24 years (31.9%). Other key factors that stood out was that unprotected sex
either vaginal or anal with a man, oral sex with a man, and having a history of an STD.
Drug use was also a factor in this region. The Southwest Region’s largest populations for
contracting gonorrhea were heterosexual (85.7%), African Americans (45.2%), males
(50.8%) and those under the age of 30 years (75.8%). As for age, the highest
concentration of infections were those ages 20 to 24 years (32.4%). Other key factors that
stood out were unprotected sex either vaginal or anal with a man, oral sex with a man,
and having a history of an STD. Drug use was also a factor in this region. The South
Region’s largest populations for contracting gonorrhea were homosexuals (48.2%),
African American (47.4%), males (63.9%) and those under the age of 30 years (67.2%).
It is also important to note that 20.3% of the infected population was Hispanic. As for
age, the highest concentration of infections were those ages 20 to 24 years (28.8%).
There is a larger increase in the Hispanic population in this area in comparison to other
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regions. Other key factors that stood out was that unprotected sex either vaginal or anal
with a man, oral sex with a man, and having a history of an STD. Drug use was also a
factor in this region.
Overview
All of the regions and Florida share some commonalities, but none are exactly the
same to each other. This indicates that each region and Florida, each have their own
unique risk factors. The core common demographics for gonococcal infections are those
African American and those under the age of 30 years with the highest concentration in
the age range of 20 to 24 years. Gender changes depending on region but begins to
concentrate in males as one moves south in the State. Along this southern movement drug
use, men who have sex with men, and the infections in the Hispanic population became
more prominent. This is reflective of the demographic changes that occur when one
moves from the northern end to the southern end of the State. The northern end of the
state to the central and west central area is primarily farming, rural, and is considered
conservative. As one moves south the state becomes more populated and drifts to a less
conservative, high paced, wealthy, and celebratory atmosphere. Risk factors that were
consistent across the regions and the state were lack of condom use (safe sex practices)
and had a history of a prior STD. This is an important finding. Repeated gonococcal
infections in the same population coupled with the use of last-line-of-antibiotic-defense,
which the dominantly prescribe medication in all regions and the State, increases the
chances of developing drug-resistant strains.
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Research Question 1: Are there differences in using last line antibiotic defense between
Florida as a whole and each of the eight regions?
The differences were compared using Chi-square and cross-tabulation analysis.
The findings support that there are variations among the regions in relationship to the
state indicating that last-line-of-antibiotic-defense may drive drug resistance differently
by region verses the State. Comparing the state to all the regions, across the board the
state as a whole the last-line-of-antibiotic-defense was prescribed higher in compared to
some regions and lower compared to other regions. For instance, with ethnics, the lastline-of-antibiotic-defense was prescribed higher in the Northwest, Northeast, North
Central, West Central, Southeast, and Southwest Regions than the state of Florida,
whereas the last-line-of-antibiotic-defense was prescribed at a lower rate for the East
Central and South Regions than the state of Florida. These findings were statistically
significant for every region except for the Southwest region.
Research Question 2: Are there differences in using last-line-of-antibiotic-defense
among the eight Florida regions?
The regions were compared to one another using Chi-square and cross tabulation
analysis. The regions were compared to each other. The East Central region was
prescribed the last-line-of-antibiotic-defense at a higher rate than five of the seven other
regions. The South region was prescribed the last-line-of-antibiotic-defense at a higher
rate than four of the seven other regions. The Northwest, Northeast, and North Central
regions were prescribed the last-line-of-antibiotic-defense at a rate higher than three of
the seven other regions. The West Central region was prescribed the last-line-of-
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antibiotic-defense at a rate higher than two of the seven other regions. The Southeast
region was prescribed the last-line-of-antibiotic-defense at a rate higher than one of the
seven other regions. The Southwest region was prescribed the last-line-of-antibioticdefense at a rate lower than the seven other regions. Based on these findings it can be
elucidated that the East Central and South regions have a high probability of developing
drug resistance strains of gonorrhea. This indicates that residents in these regions are at a
higher risk of contracting drug-resistant gonorrhea.
Research Question 3: What are the statistically significant factors associated with being
treated with last-line-of-antibiotic-defense in each of the eight regions and the
state of Florida?
A multiple logistic regression calculation was conducted to identify predictive
risk and demographic factors. Inclusive a calculation for Florida was conducted to use as
a comparison.
Northwest Region
The final results indicate for the Northwest Region, there were four risk factors
contributing to drug resistance by being prescribed the last line of antibiotic treatment.
They were age, sometimes using condoms, never using condoms, and history of an STD.
Overall, the age groups that had the highest rates among the total infected population
were those between the ages of 20 to 24 years then followed by 16 to 19 years and 25 to
29 years. These age groups not only were the majority of the infection, but they were
most often prescribed the last-line-of-antibiotic-defense at rates of 80% or greater. The
lack of condom use leading to unprotected sex, is a risk factor. Having a prior history of
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an STD is also a risk factor. Contrary to the CDC statement that men who have sex with
men are at-risk it seems that in this region men who have sex with men are a protective
factor. Inclusive of protection is sexual orientation, awareness of HIV status, and
pregnancy. Targeted intervention for the Northwest Region should focus on individuals
ages 16 to 29 years and who have had a history of a prior STD. In addition, emphasis
needs to focus on condom use. This would also reduce the chance of drug resistance.
Northeast Region
The final results indicate for the Northeast Region, there were three risk factors
contributing to drug resistance by being prescribed the last line of antibiotic treatment.
These were age, number of sex partners, and oral sex with a female. Overall, the age
groups that had the highest rates of gonococcal infections were those between the ages of
20 to 24 years then followed by 16 to 19 years and 25 to 29 years. These age groups not
only were the majority of the infection, but they were most often prescribed the last-lineof-antibiotic-defense at rates of 79% or greater. The number of sex partners and oral sex
with a female are also considered a risk factor compared to other factors. Protective
factors are gender, sexual orientation, pregnancy, sometimes using condoms, new partner
within the first 90 days, aware of HIV status, and incarcerated within 12 months of the
time of the infection. Other protective factors such as sexual orientation and awareness of
the HIV status may contribute to a greater awareness of sexually transmitted diseases
thus greater care maybe utilized during sexual contact. If a targeted intervention would be
created for the Northeast Region, it is recommended that it be focused an age, especially
those between the ages of 16 and 29 years.
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North Central Region
Interestingly, in this region the only risk factor is the lack of condom use with the
other partner in relationship to their main partner where condom use was regularly
practiced. Age would have been a risk factor if p<0.10 instead of p<.05. There were no
other significant risk factors. The rest were protective factors such as race/ethnics,
gender, men who have sex with men, sexual orientation, pregnancy, oral sex with men,
and aware of HIV status. This may be due to the remoteness of the North Central Region
in comparison to the rest of the state of Florida. There are two semi-major cities:
Tallahassee and Gainesville. Tallahassee is the capital of Florida and the population is
only considered large when government is in session and Florida state University is
hosting courses. Gainesville population is only considered large when the University of
Florida is hosting courses. During the offseason, the population decreases in those areas.
In addition, during the reporting of an infection, a patient’s home location is normally
reported. Considering these two cities are transient due to the two universities and
government headquarters, the reporting of the infection may be assigned to a different
geographical location in the State. As for targeted intervention, this region hosts the two
of the three largest universities in Florida targeted intervention should still focus on
young adults, the age groups between the age of 16 and 29 years. Although age was
considered statistically not significant based on a p< 0.05 if one were to base statistical
significance on a p<0.10 being statistically significant then age would be considered
statistically significant. Greater than 80% of the individuals in these age categories
received the last-line-of-antibiotic-defense.
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West Central Region
The final results indicate for the West Central Region, there were two risk factors
contributing to drug resistance by being prescribed the last line of antibiotic treatment.
These are age. Overall, the age groups that had the highest rates of gonococcal infections
were those between the ages of 20 to 24 years then followed by 16 to 19 years and 25 to
29 years. These age groups not only were the majority of the infection, but they were
often prescribed the last-line-of-antibiotic-defense at rates of 84% or greater. Protective
factors include race/ethnics, gender, men who have sex with men, sexual orientation,
pregnancy, aware of HIV status, and vaginal or anal sex with a female. If a targeted
intervention were created for the West Central Region, it is recommended that it be
focused a specific age group, especially those between the ages of 16 and 29 years.
Southeast Region
The final results indicate for the Southeast Region, there are two risk factors
contributing to drug resistance by being prescribed the last line of antibiotic treatment.
These were age and incarcerated within the last 12 months from the time of the infection.
Overall, the age groups that had the highest rates of gonococcal infections were those
between the ages of 20 to 24 years then followed by 16 to 19 years and 25 to 29 years.
These age groups not only were the majority of the infection, but they were often
prescribed the last-line-of-antibiotic-defense at rates of 72% or greater. This was much
lower than in other regions, none the less still a high level overall. Protective factors
include gender, men who have sex with men, sexual orientation, pregnancy, aware of
HIV status, was paid for sex, and vaginal or anal sex with a male. Although it may be
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considered a risk factor, an individual who is paid for sex may be more aware of the
possibilities of STD infections and will take additional precautions. If a targeted
intervention would be created for the Southeast Region, it is recommended that it be
focused some specific age groups, especially those between the ages of 16 and 29 years.
Southwest Region
The final results indicate for the Southwest Region, there are two risk factors
contributing to drug resistance by being prescribed the last line of antibiotic treatment.
These were age and oral sex with a female. Overall, the age groups that had the highest
rates of gonococcal infections were those between the ages of 20 to 24 years then
followed by 16 to 19 years and 25 to 29 years. These age groups not only were the
majority of the infection, but they were often prescribed the last-line-of-antibioticdefense at rates of 85% or greater. Protective factors sexual orientation, pregnancy, aware
of HIV status, and had a history of an STD in the last 12 months from the time of the
infection. If a targeted intervention would be created for the southwest region, it is
recommended that it be focused some specific age groups, especially those between the
ages of 16 and 29 years.
South Region
The final results indicate for the South Region, there are three risk factors
contributing to drug resistance by being prescribed the last line of antibiotic treatment.
These were age, men who have sex with men (MSM), and sexual orientation. Overall, the
age groups that had the highest rates of gonococcal infections were those between the
ages of 20 to 24 years then followed by 16 to 19 years and 25 to 29 years. These age
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groups not only were the majority of the infection, but they were often prescribed the
last-line-of-antibiotic-defense at rates of 85% or greater. Additionally, the South Region
which encompasses a large LGBT population which host large city-wide events
regularly. It is also an international tourist hotspot. Fort Lauderdale, Miami, Miami
Beach, and Key West are located in this region. These cities are known for extravagant
lifestyles and nightlife. Miami hosts a large Latin American population and the culture
celebrates regularly and extravagantly in Miami. Brazilian Carnival and Carnival de
Barranquilla are some of the largest Latin costume-based festivals that attract a variety of
individual. The free-living lifestyle is well known in the south region and among the
LGBT community. Thus, LGBT population can be considered at-risk in this region.
Protective factors race/ethnics, gender, pregnancy, aware of HIV status, and was paid for
sex. If a targeted intervention would be created for the southwest region, it is
recommended that it be focused an age, especially those between the ages of 16 and 29
years.
State of Florida
The final results indicate for the state of Florida, the risk factors contributing to
drug resistance by being prescribed the last line of antibiotic treatment were 1) age range,
2) oral sex with a female, and 3) unprotected vaginal or anal sex with a male. These
groups are most at-risk for contracting or developing drug resistance. Overall, the age
groups that had the highest rates of gonococcal infections were those between the ages of
20 to 24 years then followed by 16 to 19 years and 25 to 29 years. These age groups not
only were the majority of the infection, but they were often prescribed the last-line-of-

149
antibiotic-defense at rates of 80% or greater. This then can be interpreted that those in
these age categories are most likely to contract or develop drug-resistant strains of
gonorrhea. Oral sex is often performed without a condom and can lead to infections.
Having unprotected vaginal or anal sex with a male is also a mechanism for transmission
of the infections. This can include females or males having unprotected sex with a male.
Again, having unprotected sex can drive infections. From a Statewide perspective,
targeting the ages 16 to 29 years would have the greatest impact. These are the highest
groups for infection as well as being prescribed the last-line-of-antibiotic-defense.
Adding condom use will reduce the chances of contracting drug-resistant gonorrhea as
well as evolving drug-resistant gonorrhea. This is evident since in Florida results, always
using condoms is considered a protective factor. Interesting enough knowing one’s HIV
status was a protective factor not only in the state but in all regions. This may indicate
that those who are aware of their HIV status may be more aware of other infections and
are more cautious in their sexual behaviors. The same holds true for those who had a
history of an STD at any time in their life. This also seems to be a protective factor
indicating that they may be more aware of infections. Race/ethnics and gender were also
considered protective factors. In Florida and all Regions pregnancy is also a protective
factor. Upon further investigation the last-line-of-antibiotic-defense at times is avoided if
possible, for pregnant women since those particular antibiotics are not approved to be
prescribed to a woman when pregnant unless there is no other option (Davis et al., 1996).
In 2019, after the time of the data for this study, the next generation (third variation of the
medication) of last-line-of-antibiotic-defenses have been approved to be used with
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pregnant women (Arumugham & Cascella, 2019). In the future pregnancy may become a
risk factor, but at the time of this study it is considered a protective factor.
The over-arching result of these comparisons were compiled into Table 11. There
is a commonality among all the regions and Florida as well as differences. The most
common contributing risk factor for driving drug resistance would be age range. From
there, secondarily would-be condom use. Each region and Florida had unique risk factors
that differed among each other. This indicates that each region and the State are not the
same and targeted interventions need to be developed to target each specifically. These
results are discussed further in the Developing Targeted Intervention section.
Limitation of the Study
The intent of this study was to identify what demographic and risk factor groups
would be most likely to contract drug-resistant variants of gonorrhea. The difficulty with
this type of study is that there is little to no data tracking drug resistance in the state of
Florida. The state had two tracking locations for drug resistance. They were West Palm
Beach from 1987 to 1998 and then Miami from 1998 to 2013. Since 2013 there has been
no tracking of drug resistance for the State. These locations are in the southern end of
Florida making it difficult for people in the rest of the state to access limiting it to those
in the southern parts of the State. Testing at these locations were not broad reaching. If
the patient did not fit the CDC recommendations such as men who have sex with men,
pregnant, or sex workers then they were not tested. The testing itself was biased. This
may have been due to limited funding. This biased data was not sufficient to conduct
analysis and was not used for this study. This study was looking at factors outside of the
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recommendations by the CDC to identify unknowns and populations that were most
likely missed due to bias and biased testing.
The next option was to look at prescribing of the last-line-of-antibiotic-defense
treatment as a driving force of drug resistance. From a biological standpoint this is the
most logical route. The CDC as well as other researchers have indicated that unless new
antibiotics are developed to specifically fight gonorrhea, the last line of antibiotic
treatment will soon fail. Currently the last line is cefixime and ceftriaxone either in
combination with each other or in combination with other antibiotics such as doxycycline
or azithromycin. Eventually continued use of antimicrobials will lead to the evolution of
resistance to that antimicrobial. This study evaluated the prescribed last line of antibiotic
treatment as the dependent variable against the different demographic and risk factors as
a predictor for drug resistance. Not everyone in the data set received the last line of
antibiotic treatment. This then provided a yes versus no evaluation that could then be tied
to driving forces of antibiotic resistance. There were also other limitations to the
prescribed last line of antibiotic treatment data. This information was limited to only
initial prescribed treatment. There was no method to identify if the prescribed treatment
worked or if further treatments were needed.
There were other limitations with the data. The data collected was only for those
who were infected and tested positive for gonorrhea. There was no data regarding those
who were not infected or may have tested negative. This limited comparisons and
negated some of the research questions. As for the data itself, all sections were
completed. There was no missing data. But what was often recorded was either “did not
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report” or “refused to answer.” These were treated as a no or negative answer since there
was no method to prove that the answers were a positive answer. Due to security and
privacy issues, no personal data were released. There was no method to contact the
infected individual to gain additional information. This limited the research to only the
data that was provided. The data failed to identify if the person infected was a repeat
gonococcal infection specifically. The data did indicate if they have had an STD in the
past or within the last 12 months since the time of their infection, but never identified the
type of STD infection. This would have been helpful to look at repeat gonococcal
infections coupled with last line of antibiotic treatment as a driving force for
antimicrobial resistance.
The data itself may have other biases. Gonococcal infections are mandatory to
report in the state of Florida. The information is required by Florida but is reported
remotely by many different health care workers across the State. Some data entry sections
were stated in ambiguity which could cause confusion among the reporters. There were at
times double negative statements. For instance, when it came to drug use, the section was
stated as “did not use drugs.” A person who did use drugs would have a no answer and
someone who does not use drug would have a yes answer. This could cause some
confusion when filling out the data quickly, leading to recording bias. Without the
reporters carefully reading and understanding what was being asked, it could have been
reported incorrectly. Again, due to security and privacy issues, there was no method in
which to confirm if the reporting was done correctly. The data set held over 37 million
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data points combined with no connective data being included, making it impossible to
confirm that every data point was entered correctly.
Florida Department of Health specifically stated that some additional data were
not going to be supplied. They specifically stated that no data with anyone under the age
of 16 years was going to be provided. They did not state directly why this was so, but it
was elucidated that it could be a number of the following reasons such as indicating
sexual molestation of a minor, they did not want information regarding gonococcal
infections with minors reported to the public, or worries over community concerns. This
limited the data to those 16 years and older and primarily adults. This limits an
understanding to what extent if any are gonococcal infections affecting high school aged
individuals. It is not known if interventions are necessary for freshman and sophomore
aged high school students since this data were not made available by the State.
Regardless of some of the limiting factors, there was enough data to successfully develop
a predictive model for at-risk groups for driving and contracting drug-resistant gonorrhea
infections.
Recommendations
Developing Targeted Interventions
No model is ever perfect. When determining who is most likely at risk for drugresistant gonorrhea, there are many factors that need to be considered. The data that was
provided by Florida was evaluated until the statistics in conjunction with statistical
significance elucidated targeted risk factors and demographic groups that should be the
focus for intervention in the immediate future. The statistics indicated that given a
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statewide initiative it would be best to focus funding and person power at age range with
emphasis on condom use. It seems that those under the age of 30 years had the highest
number of gonorrhea infections. The most significant were those between the ages of 20
to 24 years followed secondarily by those between the ages of 16 to 19 years, and thirdly
those between the ages of 25 to 29 years. Additionally, these were not only the majority
of those who contracted gonorrhea, but they were also the highest groups that were
prescribed the last line of antibiotic treatment. What this means is that this particular age
group will be driving drug resistance and thus spreading drug-resistant gonorrhea to
others within that age category. For the state of Florida, the mean age for a man to be
married for the first time is 29.4 years and for a woman it is 28.2 years (United States
Census Bureau, 2019). Marriage in general is a commitment to monogamy, which
virtually eliminates STD infections provided each person is committed to the relationship
in that manner. It can be concluded that those under the age of 30 years especially those
between the ages of 20 to 24 years and 16 to 19 years will be the most likely to contract
drug-resistant strains of gonorrhea. There are three mechanisms in which to avoid the
spread of drug-resistant strains of gonorrhea. The mechanisms are abstinence, proper use
of barriers such as dental dams and condoms, and a committed monogamist relationship
that has had STD testing prior to sexual contact.
Within each region there are a few additional areas of focus to be included in an
intervention strategy. The Northwest region would need to be age range and condom use.
Additionally, there seems to be a lack of follow-up education after an infection. Having a
prior STD does not dissuade individuals from becoming infected again, creating an
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additional risk factor for drug resistance. For the Northwest Region, there would need to
be an educational program that focuses on the dangers of contracting STD’s repetitively.
Northeast Region has a slightly different necessary focus. The additional focus beyond
age range and condom use which must be inclusive in the intervention, would be the
number of sex partners someone has. Intervention in this area would have to educate the
public that the more sex partners you have not only are you more likely of contracting
gonorrhea, but you may end up contracting a drug-resistant strain that is incurable. North
Central Region just slightly fell short for age range as being statistically significant
(p=0.079). It is the opinion of this author that it should still be included as a risk factor
for intervention purposes. The other aspect was condom usage with another partner. This
indicates that the individual has a second relationship outside of the primary and may be
careless with the second individual. Same as with Florida the North Central Region needs
to focus on the under 30 years of age and condom usage. The only area of focus for the
West Central Region is age range. This means that those under the age of 30 are at most
risk for drug-resistant gonorrhea. East Central Region is similar to Florida and that is
those who are at risk are at 30 years of age and under and proper use of condoms should
be added to the intervention programs. The Southeast region also identifies the at-risk
category for those who are under the age of 30 years but differs in the fact that it includes
those who were incarcerated within 12 months of the infection. This may mean that there
is a lack of STD education for those who have been incarcerated. It would be beneficial
as part of release programs to teach those individuals that not only are they at risk for
contracting gonorrhea they may also be at-risk for contracting drug-resistant strains.
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Southwest Region will also need to focus on intervention strategies for those under the
age of 30 years. As for the South Region this is where the most drastic shift in at-risk
groups exists. The South Region shares the same at-risk category for age range with all
the other regions and the state as a whole. Where it differs is that men who have sex with
men (MSM) and sexual orientation become a risk factor. The South Region of Florida is
well known for its high LGBT populations of which the CDC has identified as a-risk. As
mentioned earlier this is also the location of the only testing site for drug-resistant strains
thus why the collected drug-resistant data would be biased. For the South Region focus
should be on those under the age of 30 years, men who have sex with men, and men who
identify as homosexual or bisexual.
Positive Social Change Implications
Any infectious disease can be stopped if there is no receptive host. There are
many issues with gonorrhea such as its asymptomatic behavior. From an infectious
standpoint, this pathogen is passed through sexual contact. Unfortunately, even in this
most modern of times the act of sex, discussion of sex, or thought of sex is considered a
taboo topic in many social settings. The discussion of sex often becomes non-existent
when the topic of sexually transmitted infections (STI) is introduced. In Florida there is
little to no discussion with the public regarding these easily avoidable infections. If
individuals would just practice safe sex, have regular medical testing for STI’s, and have
monogamous relationships, most if not all of the STI’s would become eradicated. This is
not an unreasonable objective. In order to achieve this possibility, the population needs to
understand the importance of infection avoidance. The statistically significant risk
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populations in each region need to be educated on the risks of contracting drug-resistant
variants and it needs to be done in a direct non-pacifistic manner. It is extremely
important that the information is presented to them with methods that would require
behavioral modification. As presented in this study the over-arching risk group is age
range. The highest incidences and the most prescribed group for last-line-of-antibioticdefense are those under the age of 30 years with highest concentration in those between
the age of 20 to 24 years followed by 16 to 19 years and then 25 to 29 years. In the
current age of social media where interactive connections are just a cell phone tap away,
there has been a growing trend of “no strings attached” hook-up apps. These apps such as
Tinder, Plenty O’ Fish, FET Life, Wild, Adult Friend Finder, and the like, all lead to
quick sexual encounters without regrets or worries. The greatest demographic group
which is highly versed in these phone-based connection apps and use them regularly are
those who are between the ages of 16 to 29 years. The highest category of infection and
being prescribed the last-line-of-antibiotic-defense is the age group of 20 to 24 years
followed by 16 to 19 years and then 25 to 29 years. Since gonorrhea can be asymptomatic
an individual who is sexually active may be a “super spreader” of this infection.
Additionally, the spread is greatly attributed to the manner in which people interact with
each other sexually, interventions of this magnitude will only be successful if the societal
understandings, approaches, discussions, and attitudes towards sex, change. There needs
to be a well-driven-home message that casual sex in this day and age can lead to
gonorrhea infections that are uncurable and the message needs to reach those especially
under the age of 30 years.
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Conclusion
This study answered the question of who would be most at-risk for contracting or
developing drug-resistant strains of gonorrhea in each region and Florida. Each region
and Florida have unique risk factors that differ from each. Although each has its own
unique risk factors, there was a common risk factor shared. In all statistical models
conducted in this research, age was the most common and repetitive risk factor. Often
individuals have sexual relationships within their age groups. Connecting high rates of
prescribing last-line-of-antibiotic-defense with high rates of infection within the same
group, there is a significant chance that the group will develop drug-resistance and then
pass the drug-resistant variant to others within the group. Florida needs to focus on safe
sex practices and emphasize that contracting drug-resistant gonorrhea is possible and
most likely for those under the age of 30 years. Considering the average age of first
marriages in the state are is 29.4 years for a male and 28.2 years for a woman. There is a
significant chance that those below these ages are sexually active. With the many
different “hook up” sites promoting random inconsequential sexual encounters, just
supports that under the age of 30 years are most like to be the driving force. Coupled with
age, each region needs to focus on the additional risk factors unique to each. The
combined effort will maximize the success of prevention.
Future studies would focus on of those who have contracted gonorrhea, identify
who has contracted drug-resistant strains and who has contracted regular strains in all
infected individuals and not just select groups. This would provide a more precise
understanding of who is at-risk of contracting and spreading drug-resistant gonococcal
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infections. But before this type of study can be conducted Florida needs to test for drugresistant strains in all infected individuals. This would provide a stronger identification of
who would be at-risk for contracting drug-resistant strains. With this knowledge more
realistic interventions can be conducted. Although the United States is a diverse nation,
nationwide focus is not always effective. Regional and community-based focus should be
the goal.
A second area of future research in gonococcal infections would focus on the
local communities and identify clusters of gonococcal infections. The state had expressed
concerns that this could be culturally problematic. Areas with heavy religious influence
may not appreciate studies such as this in their community. Although identifying clusters
is helpful, there may be community resistance. Being able to identify clusters would
significantly narrow the focus of intervention and culturally sensitive interventions could
be created.
A third area of future research would evaluate the influences of “hook up” sites
and apps on the contraction and spread of gonococcal infections. Many of these sites are
how individuals, especially those 30 years and under, meet others for sexual connections
or long-term relationships. Within the research it would also be interesting to see if these
sites drive drug resistance or pass drug-resistant strains. Through these sites it could be
possible to perform contact tracing, infection tracking, and cluster mapping.
A final area of future research is to evaluate comorbidity. The study would
identify if there were other STD infections at the time of the gonococcal infection
occurred. Gonorrhea is known to be asymptomatic in many cases. It would be interesting
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to study if gonococcal infections had influence on other infections such as HIV/AIDS.
Questions such as does a gonococcal infection make it easier to contract other STD’s
such as HIV/AIDS? Do some individuals contract other STD’s at the same time they
contracted gonorrhea? These areas of research would help develop a better understanding
of how gonorrhea spreads, becomes drug resistant, and is influenced by anthropogenic
means for the state of Florida.
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a Whole with the Eight Regions
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Table A1
Results of Cross Tabulation Comparing Florida as a Whole with the Northwest Region
for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense Northwest Region

Northwest
Region
Last Line
Antibiotic

Did Not Report

Last-line-ofantibioticdefense

Not Effective
Antibiotic

Total

Count
Within Northwest
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within Northwest
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within Northwest
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within Northwest
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total

Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense
Total
352
937
146
1435
24.5%
65.3%
10.2% 100.0%
9.4%

8.1%

9.0%

8.5%

2.1%
3196
22.2%

5.5%
9804
68.2%

0.9%
1379
9.6%

8.5%
14379
100.0%

85.0%

84.8%

84.8%

84.9%

18.9%
213
18.8%

57.9%
817
72.2%

8.1%
102
9.0%

84.9%
1132
100.0%

5.7%

7.1%

6.3%

6.7%

1.3%
3761
22.2%

4.8%
11558
68.2%

0.6%
1627
9.6%

6.7%
16946
100.0%

100.0
%

100.0%

100.0%

100.0%

22.2%

68.2%

9.6%

100.0%
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Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
Table A2
Results of Cross Tabulation Comparing Florida as a Whole with the North Central
Region for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense North Central Region

North
Central
Region
Last Line
Antibiotic

Did Not Report

Last-line-ofantibioticdefense

Not Effective
Antibiotic

Total

Count
Within North Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within North Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within North Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within North Central
Region Last-line-ofantibiotic-defense

Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense
Total
712
2368
339
3419
20.8%
69.3%
9.9%
100.0%
11.5%

11.7%

11.8%

11.7%

2.4%
4967
20.9%

8.1%
16475
69.3%

1.2%
2342
9.8%

11.7%
23784
100.0%

80.0%

81.7%

81.8%

81.3%

17.0%
529
25.9%

56.3%
1330
65.1%

8.0%
183
9.0%

81.3%
2042
100.0%

8.5%

6.6%

6.4%

7.0%

1.8%
6208
21.2%

4.5%
20173
69.0%

0.6%
2864
9.8%

7.0%
29245
100.0%

177
100.0% 100.0%

Within state of Florida 100.0 100.0%
Last Line of Antibiotic
%
Treatment
Total
21.2%
69.0%
9.8%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS

100.0%

version 25.
Table A3
Results of Cross Tabulation Comparing Florida as a Whole with the Northeast Region
for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense Northeast Region

Northeast
Region
Last Line
Antibiotic

Did Not Report

Last-line-ofantibioticdefense

Not Effective
Antibiotic

Count
Within Northeast
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within Northeast
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within Northeast
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total

Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense
Total
791
2483
337
3611
21.9%
68.8%
9.3%
100.0%
11.6%

10.6%

10.4%

10.8%

2.4%
5520
20.4%

7.4%
18929
70.0%

1.0%
2597
9.6%

10.8%
27046
100.0%

81.2%

80.4%

80.3%

80.6%

16.4%
487
16.8%

56.4%
2121
73.0%

7.7%
299
10.3%

80.6%
2907
100.0%

7.2%

9.0%

9.2%

8.7%

1.5%

6.3%

0.9%

8.7%
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Total

Count
6798
23533
3233
33564
Within Northeast
20.3%
70.1%
9.6%
100.0%
Region Last-line-ofantibiotic-defense
Within state of Florida 100.0 100.0%
100.0% 100.0%
Last Line of Antibiotic
%
Treatment
Total
20.3%
70.1%
9.6%
100.0%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.
Table A4
Results of Cross Tabulation Comparing Florida as a Whole with the West Central Region
for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense

West
Central
Region
Last Line
Antibiotic

Did Not Report

Last-line-ofantibioticdefense

Not Effective
Antibiotic

Count
Within West Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within West Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within West Central
Region Last-line-ofantibiotic-defense

Last-line- Not LastDid
ofline-ofNot
antibiotic- antibioticReport defense
defense
Total
823
3547
446
4816
17.1%
73.7%
9.3%
100.0%
6.1%

7.9%

7.8%

7.5%

1.3%
11767
21.6%

5.5%
37867
69.5%

0.7%
4841
8.9%

7.5%
54475
100.0%

86.5%

84.4%

84.8%

84.9%

18.3%
1006
20.5%

59.0%
3473
70.9%

7.5%
422
8.6%

84.9%
4901
100.0%

179
7.4%
7.6%

Within state of Florida 7.4%
7.7%
Last Line of Antibiotic
Treatment
Total
1.6%
5.4%
0.7%
Total
Count
13596
44887
5709
Within West Central
21.2%
69.9%
8.9%
Region Last-line-ofantibiotic-defense
Within state of Florida 100.0
100.0%
100.0%
Last Line of Antibiotic
%
Treatment
Total
21.2%
69.9%
8.9%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS

7.6%
64192
100.0%
100.0%
100.0%

version 25.
Table A5
Results of Cross Tabulation Comparing Florida as a Whole with the East Central Region
for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense

East
Central
Region
Last Line
Antibiotic

Did Not Report

Last-line-ofantibioticdefense

Count
Within East Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment
Total
Count
Within East Central
Region Last-line-ofantibiotic-defense
Within state of Florida
Last Line of Antibiotic
Treatment

Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense
Total
2467
6542
737
9746
25.3%
67.1%
7.6%
100.0%
22.0%

19.4%

18.9%

20.0%

5.1%
7842
22.0%

13.4%
24826
69.8%

1.5%
2922
8.2%

20.0%
35590
100.0%

70.1%

73.6%

74.8%

72.9%
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Total
16.1%
50.8%
6.0%
Count
884
2369
247
Within East Central
25.3%
67.7%
7.1%
Region Last-line-ofantibiotic-defense
Within state of Florida 7.9%
7.0%
6.3%
Last Line of Antibiotic
Treatment
Total
1.8%
4.9%
0.5%
Total
Count
11193
33737
3906
Within East Central
22.9%
69.1%
8.0%
Region Last-line-ofantibiotic-defense
Within state of Florida 100.0 100.0%
100.0%
Last Line of Antibiotic
%
Treatment
Total
22.9%
69.1%
8.0%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS
Not Effective
Antibiotic

72.9%
3500
100.0%
7.2%
7.2%
48836
100.0%
100.0%
100.0%

version 25.
Table 1
Results of Cross Tabulation Comparing Florida as a Whole with the Southwest Region
for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense

Southwest
Region
Last Line
Antibiotic

Did Not Report

Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense
Total
38
213
32
283
13.4%
75.3%
11.3%
100.0%

Count
Within Southwest
Region Last-line-ofantibiotic-defense
Within state of Florida 2.8%
Last Line of Antibiotic
Treatment
Total
0.5%
Count
1270

3.6%

2.9%

3.4%

2.5%
5327

0.4%
1009

3.4%
7606

181
Last-line-ofantibioticdefense

Within Southwest
16.7%
70.0%
13.3%
Region Last-line-ofantibiotic-defense
Within state of Florida 92.1%
90.2%
90.0%
Last Line of Antibiotic
Treatment
Total
15.1%
63.3%
12.0%
Not Effective
Count
71
369
80
Antibiotic
Within Southwest
13.7%
71.0%
15.4%
Region Last-line-ofantibiotic-defense
Within state of Florida 5.1%
6.2%
7.1%
Last Line of Antibiotic
Treatment
Total
0.8%
4.4%
1.0%
Total
Count
1379
5909
1121
Within Southwest
16.4%
70.3%
13.3%
Region Last-line-ofantibiotic-defense
Within state of Florida 100.0 100.0%
100.0%
Last Line of Antibiotic
%
Treatment
Total
16.4%
70.3%
13.3%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS

100.0%
90.5%
90.5%
520
100.0%
6.2%
6.2%
8409
100.0%
100.0%
100.0%

version 25.
Table A7
Results of Cross Tabulation Comparing Florida as a Whole with the Southeast Region
for the Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense Southeast Region

Southeast
Region
Last Line
Antibiotic

Did Not Report

Count
Within Southeast
Region Last-line-ofantibiotic-defense

Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense
Total
133
728
85
946
14.1%
77.0%
9.0%
100.0%
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Within state of Florida 3.2%
5.9%
5.1%
Last Line of Antibiotic
Treatment
Total
0.7%
4.0%
0.5%
Last-line-ofCount
3641
10383
1414
antibioticWithin Southeast
23.6%
67.3%
9.2%
defense
Region Last-line-ofantibiotic-defense
Within state of Florida 88.6%
84.6%
85.1%
Last Line of Antibiotic
Treatment
Total
20.2%
57.6%
7.8%
Not Effective
Count
334
1156
163
Antibiotic
Within Southeast
20.2%
69.9%
9.9%
Region Last-line-ofantibiotic-defense
Within state of Florida 8.1%
9.4%
9.8%
Last Line of Antibiotic
Treatment
Total
1.9%
6.4%
0.9%
Total
Count
4108
12267
1662
Within Southeast
22.8%
68.0%
9.2%
Region Last-line-ofantibiotic-defense
Within state of Florida 100.0 100.0%
100.0%
Last Line of Antibiotic
%
Treatment
Total
22.8%
68.0%
9.2%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS

5.2%
5.2%
15438
100.0%
85.6%
85.6%
1653
100.0%
9.2%
9.2%
18037
100.0%
100.0%
100.0%

version 25.
Table A8
Results of Cross Tabulation Comparing Florida as a Whole with the South Region for the
Last-line-of-antibiotic-defense
Last-line-of-antibiotic-defense
Last-line- Not LastDid
ofline-ofNot antibiotic- antibioticReport defense
defense

Total

183
South
Region
Last Line
Antibiotic

Count
2561
9228
1369
Within South Region
19.5%
70.1%
10.4%
Last-line-of-antibioticdefense
Within state of Florida 18.8%
20.6%
24.0%
Last Line of Antibiotic
Treatment
Total
4.0%
14.4%
2.1%
Last-line-ofCount
10415
33050
3996
antibioticWithin South Region
21.9%
69.6%
8.4%
defense
Last-line-of-antibioticdefense
Within state of Florida 76.6%
73.7%
70.2%
Last Line of Antibiotic
Treatment
Total
16.2%
51.6%
6.2%
Not Effective
Count
616
2547
328
Antibiotic
Within South Region
17.6%
73.0%
9.4%
Last-line-of-antibioticdefense
Within state of Florida 4.5%
5.7%
5.8%
Last Line of Antibiotic
Treatment
Total
1.0%
4.0%
0.5%
Total
Count
13592
44825
5693
Within South Region
21.2%
69.9%
8.9%
Last-line-of-antibioticdefense
Within state of Florida 100.0 100.0%
100.0%
Last Line of Antibiotic
%
Treatment
Total
21.2%
69.9%
8.9%
Note: Table created from data provided by FDOH STARS system and using IBM SPSS
version 25.

Did Not Report

13158
100.0%
20.5%
20.5%
47461
100.0%
74.0%
74.0%
3491
100.0%
5.4%
5.4%
64110
100.0%
100.0%
100.0%
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Appendix B: Results of the Multiple Regression for Florida and the Eight Regions
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Table B1
All Results of the Multiple Logistic Regression for Florida
Multiple Logistic Regression for the state of Florida

Race/Ethnicity
Age Range
Gender
Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner
Condom Use
with Other
Partners
Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet

95% C.I.for EXP(B)
Lower
Upper
.883
.901
1.028
1.039
.491
.598
.923
1.019

B
-.114
.033
-.613
-.030

S.E.
.005
.003
.050
.025

df
1
1
1
1

Sig.
.000
.000
.000
.227

Exp(B)
.892
1.034
.542
.970

.006

.008

1

.430

1.006

.991

1.023

-.391
.006
.031

.013
.045
.052

1
1
1

.000
.891
.547

.677
1.006
1.032

.660
.921
.932

.694
1.099
1.142

-.134

.065

1

.040

.875

.770

.994

-.053

.071

1

.450

.948

.826

1.089

.053

.070

1

.449

1.054

.919

1.209

-.059

.056

1

.293

.942

.844

1.053

.122

.077

1

.110

1.130

.973

1.313

-.013

.061

1

.830

.987

.876

1.112

.070

.068

1

.300

1.073

.939

1.226

New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female
Oral Sex with
Female
Unprotected
Vaginal or Anal
Sex with Female
Vaginal or Anal
Sex with Male
Oral Sex with
Male
Unprotected
Vaginal or Anal
Sex with Male
Vaginal or Anal
Sex with Male
who has Sex
with Male
History of Prior
STD
History of Prior
STD Within Last
12 Months
Incarcerated
Within Last 12
Months
Victim of Sexual
Assault

-.036

.077

1

.640

.965

.830

186
1.122

-.013

.008

1

.133

.988

.972

1.004

.012
.035
-.085
-.051
-.124
-.039

.130
.122
.013
.081
.070
.061

1
1
1
1
1
1

.929
.777
.000
.528
.079
.526

1.012
1.035
.918
.950
.883
.962

.784
.814
.895
.812
.769
.853

1.305
1.316
.943
1.113
1.014
1.085

.200

.081

1

.014

1.221

1.042

1.432

-.098

.073

1

.175

.906

.786

1.045

-.005

.049

1

.926

.995

.904

1.096

.010

.077

1

.895

1.010

.868

1.176

.154

.070

1

.029

1.166

1.016

1.338

-.061

.061

1

.318

.941

.835

1.060

-.167

.025

1

.000

.846

.806

.888

-.248

.046

1

.000

.781

.713

.854

-.075

.051

1

.143

.928

.840

1.025

-.061

.070

1

.385

.941

.819

1.080
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Constant
-.106 .034
1
.002
.899
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B2
All Results of the Multiple Logistic Regression for the Northwest Region
Multiple Logistic Regression for the Northwest Region

Race/Ethnicity
Age Range
Gender
Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner
Condom Use
with Other
Partners

95% C.I.for EXP(B)
Lower
Upper
.952
1.030
1.023
1.077
.548
2.635
.353
.778

B
-.010
.048
.184
-.646

S.E.
.020
.013
.401
.201

df
1
1
1
1

Sig.
.619
.000
.647
.001

Exp(B)
.990
1.050
1.202
.524

-.510

.051

1

.000

.601

.543

.664

-.444
-.172
.187

.054
.222
.220

1
1
1

.000
.437
.395

.642
.842
1.206

.577
.545
.784

.713
1.300
1.855

-.610

.321

1

.057

.543

.289

1.020

.857

.417

1

.040

2.356

1.041

5.335

.864

.315

1

.006

2.372

1.279

4.399

-.260

.273

1

.342

.771

.452

1.317

.251

.335

1

.453

1.286

.667

2.479

Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet
New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female
Oral Sex with
Female
Unprotected
Vaginal or Anal
Sex with Female
Vaginal or Anal
Sex with Male
Oral Sex with
Male
Unprotected
Vaginal or Anal
Sex with Male
Vaginal or Anal
Sex with Male
who has Sex
with Male
History of Prior
STD
History of Prior
STD Within Last
12 Months

.392

.294

1

.183

1.480

.831

188
2.633

-.030

.254

1

.906

.970

.590

1.596

.025

.292

1

.932

1.025

.578

1.819

.064

.039

1

.101

1.066

.988

1.150

-.583
.629
-.194
-.620
.079
.297

.345
.321
.084
.397
.282
.326

1
1
1
1
1
1

.092
.050
.022
.119
.779
.362

.558
1.875
.824
.538
1.083
1.346

.284
1.000
.699
.247
.623
.710

1.099
3.516
.972
1.172
1.883
2.551

-.319

.491

1

.516

.727

.278

1.902

.343

.464

1

.460

1.410

.568

3.501

-.568

.377

1

.132

.567

.271

1.186

.499

.446

1

.263

1.647

.687

3.950

.463

.453

1

.307

1.589

.654

3.863

-.390

.277

1

.159

.677

.393

1.165

.224

.092

1

.015

1.251

1.045

1.499

-.198

.282

1

.483

.820

.472

1.426

189
1.217

Incarcerated
-.295 .250
1
.239
.745
.456
Within Last 12
Months
Victim of Sexual -.364 .232
1
.116
.695
.441
1.094
Assault
Constant
-.544 .222
1
.014
.580
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B3
All Results of the Multiple Logistic Regression for the Northeast Region
Multiple Logistic Regression for the Northeast Region

Race/Ethnicity
Age Range
Gender
Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner

95% C.I.for EXP(B)
Lower
Upper
.944
1.003
1.046
1.078
.317
.665
.697
1.014

B
-.028
.060
-.779
-.173

S.E.
.015
.008
.189
.096

df
1
1
1
1

Sig.
.075
.000
.000
.070

Exp(B)
.973
1.062
.459
.841

-.146

.029

1

.000

.864

.816

.915

-.703
.012
.106

.035
.234
.209

1
1
1

.000
.959
.611

.495
1.012
1.112

.462
.640
.738

.530
1.600
1.675

.245

.398

1

.538

1.278

.586

2.786

-.536

.266

1

.044

.585

.348

.985

-.401

.317

1

.206

.669

.359

1.247

.173

.395

1

.660

1.189

.549

2.578

Condom Use
.469
with Other
Partners
Sex with
.289
Anonymous
Partner
Sex with Partner -.251
Met Via Internet
New Partner
-.712
Within the Last
90 Days
Number of Sex
.223
Partners
Pick Up in Bar
.161
Pick Up in Bath
1.170
HIV Self-Aware -.160
Paid for Sex
-.530
Was Paid for Sex -.308
Vaginal or Anal
-.244
Sex with Female
Oral Sex with
.914
Female
Unprotected
-.373
Vaginal or Anal
Sex with Female
Vaginal or Anal
.048
Sex with Male
Oral Sex with
.144
Male
Unprotected
-.063
Vaginal or Anal
Sex with Male
Vaginal or Anal
.404
Sex with Male
who has Sex
with Male
History of Prior
-.079
STD

.298

1

.116

1.598

.891

190
2.864

.312

1

.353

1.335

.725

2.460

.329

1

.446

.778

.408

1.484

.351

1

.043

.491

.246

.977

.047

1

.000

1.250

1.140

1.371

.504
.744
.041
.357
.319
.243

1
1
1
1
1
1

.749
.116
.000
.138
.335
.316

1.175
3.222
.852
.589
.735
.783

.438
.750
.787
.292
.393
.486

3.153
13.839
.923
1.186
1.374
1.262

.355

1

.010

2.494

1.244

4.998

.237

1

.117

.689

.433

1.097

.216

1

.824

1.049

.687

1.602

.283

1

.610

1.155

.664

2.010

.235

1

.788

.939

.592

1.489

.387

1

.297

1.497

.701

3.200

.079

1

.315

.924

.792

1.078

191
1.542

History of Prior
.096
.172
1
.576
1.101
.786
STD Within Last
12 Months
Incarcerated
-.655 .245
1
.007
.519
.322
.839
Within Last 12
Months
Victim of Sexual -.657 .502
1
.190
.518
.194
1.386
Assault
Constant
.317
.112
1
.005
1.373
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B4
All Results of the Multiple Logistic Regression for the North Central Region
Multiple Logistic Regression for the North Central Region

Race/Ethnicity
Age Range
Gender
Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never

95% C.I.for EXP(B)
Lower
Upper
.922
.985
.998
1.036
.418
.909
.546
.806

B
-.048
.017
-.483
-.410

S.E.
.017
.010
.198
.099

df
1
1
1
1

Sig.
.005
.079
.015
.000

Exp(B)
.953
1.017
.617
.663

-.226

.031

1

.000

.797

.750

.848

-1.325
-.046
.123

.041
.220
.215

1
1
1

.000
.834
.567

.266
.955
1.131

.245
.620
.742

.288
1.471
1.724

-.042

.241

1

.863

.959

.597

1.539

.142

.335

1

.671

1.153

.598

2.221

.511

.278

1

.066

1.667

.966

2.876

Condom Use
with Main
Partner
Condom Use
with Other
Partners
Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet
New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female
Oral Sex with
Female
Unprotected
Vaginal or Anal
Sex with Female
Vaginal or Anal
Sex with Male
Oral Sex with
Male
Unprotected
Vaginal or Anal
Sex with Male

-.004

.232

1

.986

.996

.632

192
1.570

.690

.289

1

.017

1.993

1.131

3.512

.131

.308

1

.670

1.140

.623

2.085

-.039

.318

1

.903

.962

.516

1.794

-.591

.428

1

.167

.554

.239

1.281

-.047

.088

1

.595

.954

.804

1.133

.723
-.650
-.094
.795
-.115
-.153

.826
.745
.043
.471
.348
.332

1
1
1
1
1
1

.381
.383
.027
.092
.741
.644

2.060
.522
.910
2.215
.892
.858

.409
.121
.837
.879
.451
.447

10.390
2.247
.990
5.580
1.762
1.646

.205

.379

1

.590

1.227

.583

2.581

-.685

.384

1

.075

.504

.237

1.070

-.342

.251

1

.173

.711

.435

1.162

-.864

.346

1

.012

.421

.214

.830

.413

.369

1

.262

1.512

.734

3.113

193
2.807

Vaginal or Anal
.390
.327
1
.233
1.478
.778
Sex with Male
who has Sex
with Male
History of Prior
.009
.131
1
.947
1.009
.781
1.304
STD
History of Prior
-.266 .216
1
.219
.766
.502
1.171
STD Within Last
12 Months
Incarcerated
-.219 .309
1
.479
.804
.439
1.471
Within Last 12
Months
Victim of Sexual -.494 .402
1
.219
.610
.277
1.341
Assault
Constant
.636
.119
1
.000
1.888
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B5
All Results of the Multiple Logistic Regression for the West Central Region
Multiple Logistic Regression for the West Central Region

Race/Ethnicity
Age Range
Gender
Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High

95% C.I.for EXP(B)
Lower
Upper
.919
.961
1.028
1.053
.470
.781
.602
.778

B
-.062
.039
-.502
-.380

S.E.
.011
.006
.130
.065

df
1
1
1
1

Sig.
.000
.000
.000
.000

Exp(B)
.940
1.040
.605
.684

-.134

.021

1

.000

.874

.839

.911

-.835
-.043
-.028

.029
.124
.136

1
1
1

.000
.731
.838

.434
.958
.973

.410
.752
.746

.459
1.221
1.269

Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner
Condom Use
with Other
Partners
Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet
New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female
Oral Sex with
Female
Unprotected
Vaginal or Anal
Sex with Female
Vaginal or Anal
Sex with Male
Oral Sex with
Male

.024

.140

1

.863

1.024

.779

194
1.347

.281

.183

1

.126

1.324

.924

1.896

.101

.176

1

.566

1.106

.784

1.560

.183

.130

1

.161

1.200

.930

1.549

.296

.197

1

.133

1.344

.914

1.977

.007

.134

1

.957

1.007

.774

1.310

-.025

.166

1

.882

.976

.705

1.351

.088

.178

1

.623

1.091

.770

1.547

.012

.011

1

.249

1.012

.991

1.034

-.623
.810
-.111
.260
-.223
-.375

.369
.433
.038
.226
.195
.155

1
1
1
1
1
1

.092
.061
.003
.248
.253
.015

.537
2.249
.895
1.298
.800
.687

.260
.962
.832
.834
.546
.507

1.106
5.256
.964
2.019
1.173
.931

.290

.210

1

.168

1.336

.885

2.017

.087

.190

1

.648

1.091

.752

1.582

-.108

.122

1

.376

.897

.706

1.141

-.046

.186

1

.807

.955

.663

1.377

195
1.637

Unprotected
.160
.170
1
.345
1.174
.842
Vaginal or Anal
Sex with Male
Vaginal or Anal
-.061 .149
1
.685
.941
.703
1.261
Sex with Male
who has Sex
with Male
History of Prior
-.077 .063
1
.224
.926
.818
1.048
STD
History of Prior
-.009 .099
1
.930
.991
.817
1.203
STD Within Last
12 Months
Incarcerated
-.058 .120
1
.629
.944
.746
1.194
Within Last 12
Months
Victim of Sexual -.408 .234
1
.081
.665
.421
1.052
Assault
Constant
.159
.080
1
.047
1.172
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B6
All Results of the Multiple Logistic Regression for the East Central Region
Multiple Logistic Regression for the East Central Region

Race/Ethnicity
Age Range
Gender
Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use

95% C.I.for EXP(B)
Lower
Upper
.857
.894
1.035
1.059
.178
.270
.885
1.097

B
-.133
.046
-1.520
-.015

S.E.
.011
.006
.107
.055

df
1
1
1
1

Sig.
.000
.000
.000
.790

Exp(B)
.875
1.047
.219
.986

.016

.017

1

.369

1.016

.982

1.051

-1.669
-.311

.031
.128

1
1

.000
.015

.188
.733

.177
.570

.200
.942

Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner
Condom Use
with Other
Partners
Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet
New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female
Oral Sex with
Female
Unprotected
Vaginal or Anal
Sex with Female

-.037

.133

1

.783

.964

.742

196
1.252

.575

.200

1

.004

1.776

1.200

2.629

-.285

.192

1

.139

.752

.516

1.096

-.094

.229

1

.682

.910

.581

1.427

.293

.176

1

.097

1.340

.949

1.893

-.132

.207

1

.523

.876

.585

1.314

.055

.174

1

.752

1.057

.752

1.485

.100

.190

1

.600

1.105

.761

1.604

.380

.220

1

.084

1.462

.950

2.251

-.014

.034

1

.682

.986

.923

1.054

.447
-.050
-.220
-.308
-.044
-.141

.328
.267
.036
.186
.180
.167

1
1
1
1
1
1

.172
.853
.000
.098
.807
.399

1.564
.952
.802
.735
.957
.869

.823
.564
.748
.510
.673
.626

2.973
1.606
.861
1.058
1.361
1.205

.146

.228

1

.522

1.157

.740

1.808

.108

.218

1

.622

1.113

.726

1.707

197
1.391

Vaginal or Anal
.058
.139
1
.675
1.060
.808
Sex with Male
Oral Sex with
.141
.217
1
.516
1.152
.752
1.764
Male
Unprotected
-.182 .200
1
.363
.834
.564
1.234
Vaginal or Anal
Sex with Male
Vaginal or Anal
.077
.173
1
.659
1.080
.769
1.516
Sex with Male
who has Sex
with Male
History of Prior
-.017 .051
1
.741
.983
.890
1.087
STD
History of Prior
-.083 .117
1
.479
.921
.732
1.158
STD Within Last
12 Months
Incarcerated
.028
.130
1
.828
1.029
.797
1.328
Within Last 12
Months
Victim of Sexual -.999 .265
1
.000
.368
.219
.619
Assault
Constant
2.017 .070
1
.000
7.513
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B7
All Results of the Multiple Logistic Regression for the Southeast Region
Multiple Logistic Regression for the Southeast Region

Race/Ethnicity
Age Range
Gender
Men Sex with
Men

B
.031
.078
.076
-.417

S.E.
.023
.011
.256
.124

df
1
1
1
1

Sig.
.165
.000
.766
.001

Exp(B)
1.032
1.081
1.079
.659

95% C.I.for EXP(B)
Lower
Upper
.987
1.078
1.059
1.104
.653
1.782
.517
.840

Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner
Condom Use
with Other
Partners
Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet
New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female
Oral Sex with
Female

-.270

.039

1

.000

.763

.708

198
.823

-.161
.122
-.090

.074
.105
.139

1
1
1

.030
.245
.519

.851
1.130
.914

.736
.920
.696

.984
1.388
1.200

-.186

.208

1

.371

.830

.553

1.248

-.120

.204

1

.559

.887

.594

1.325

-.291

.232

1

.209

.747

.474

1.178

-.036

.162

1

.825

.965

.702

1.325

.355

.237

1

.134

1.426

.896

2.267

-.293

.174

1

.091

.746

.530

1.048

.136

.175

1

.437

1.146

.813

1.616

.258

.221

1

.242

1.295

.840

1.997

.013

.010

1

.194

1.013

.993

1.033

.669
.607
-.204
.346
-.431
-.049

.578
.603
.065
.203
.187
.193

1
1
1
1
1
1

.247
.315
.002
.089
.021
.801

1.953
1.835
.815
1.413
.650
.952

.629
.562
.717
.949
.450
.653

6.061
5.985
.927
2.103
.938
1.390

-.322

.198

1

.104

.725

.492

1.068

199
2.374

Unprotected
.410
.232
1
.078
1.506
.956
Vaginal or Anal
Sex with Female
Vaginal or Anal
-.345 .170
1
.042
.708
.508
.988
Sex with Male
Oral Sex with
.247
.204
1
.226
1.280
.858
1.910
Male
Unprotected
.092
.200
1
.647
1.096
.740
1.623
Vaginal or Anal
Sex with Male
Vaginal or Anal
-.152 .149
1
.309
.859
.642
1.151
Sex with Male
who has Sex
with Male
History of Prior
-.066 .095
1
.486
.936
.777
1.128
STD
History of Prior
-.055 .122
1
.654
.947
.745
1.203
STD Within Last
12 Months
Incarcerated
.257
.124
1
.038
1.293
1.014
1.648
Within Last 12
Months
Victim of Sexual -.592 .268
1
.027
.553
.327
.936
Assault
Constant
-1.085 .200
1
.000
.338
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B8
All Results of the Multiple Logistic Regression for the Southwest Region
Multiple Logistic Regression for the Southwest Region

Race/Ethnicity
Age Range
Gender

B
.032
.048
-.351

S.E.
.038
.020
.562

df
1
1
1

Sig.
.411
.017
.532

Exp(B)
1.032
1.049
.704

95% C.I.for EXP(B)
Lower
Upper
.957
1.113
1.009
1.092
.234
2.119

Men Sex with
Men
Sexual
Orientation
Pregnant
Drug Use
Sex While
Intoxicated OR
High
Condom Use
Always
Condom Use
Sometimes
Condom Use
Never
Condom Use
with Main
Partner
Condom Use
with Other
Partners
Sex with
Anonymous
Partner
Sex with Partner
Met Via Internet
New Partner
Within the Last
90 Days
Number of Sex
Partners
Pick Up in Bar
Pick Up in Bath
HIV Self-Aware
Paid for Sex
Was Paid for Sex
Vaginal or Anal
Sex with Female

-.408

.267

1

.126

.665

.394

200
1.122

-.270

.070

1

.000

.763

.665

.875

-.719
-.028
-.021

.187
.201
.222

1
1
1

.000
.890
.924

.487
.973
.979

.338
.656
.634

.703
1.442
1.512

.456

.272

1

.093

1.578

.927

2.687

.145

.325

1

.656

1.156

.611

2.184

-.083

.323

1

.796

.920

.489

1.732

.080

.202

1

.693

1.083

.729

1.608

-.097

.322

1

.764

.908

.483

1.707

-.315

.254

1

.214

.730

.444

1.200

-.119

.296

1

.687

.887

.496

1.586

-.104

.285

1

.715

.901

.515

1.575

-.105

.116

1

.363

.900

.717

1.129

.147
-.274
.007
-.214
.313
.043

.445
.417
.098
.342
.296
.259

1
1
1
1
1
1

.741
.511
.944
.532
.291
.868

1.159
.760
1.007
.808
1.367
1.044

.484
.335
.831
.413
.765
.628

2.773
1.722
1.221
1.579
2.444
1.735

201
5.161

Oral Sex with
.881
.388
1
.023
2.412
1.128
Female
Unprotected
-.137 .260
1
.597
.872
.524
1.450
Vaginal or Anal
Sex with Female
Vaginal or Anal
-.271 .270
1
.317
.763
.449
1.296
Sex with Male
Oral Sex with
.087
.342
1
.800
1.091
.557
2.134
Male
Unprotected
.466
.346
1
.178
1.593
.809
3.138
Vaginal or Anal
Sex with Male
Vaginal or Anal
-.348 .253
1
.169
.706
.430
1.159
Sex with Male
who has Sex
with Male
History of Prior
-.149 .159
1
.350
.862
.631
1.177
STD
History of Prior
-.484 .244
1
.047
.616
.382
.994
STD Within Last
12 Months
Incarcerated
.317
.232
1
.171
1.373
.872
2.163
Within Last 12
Months
Victim of Sexual .007
.280
1
.981
1.007
.581
1.744
Assault
Constant
-.564 .470
1
.230
.569
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.
Table B9
All Results of the Multiple Logistic Regression for the South Region
Multiple Logistic Regression for the South Region

Race/Ethnicity

B
-.140

S.E.
.011

df
1

Sig.
.000

Exp(B)
.869

95% C.I.for EXP(B)
Lower
Upper
.851
.888

Age Range
.049
Gender
-2.105
Men Sex with
.397
Men
Sexual
.149
Orientation
Pregnant
-1.375
Drug Use
-.011
Sex While
-.072
Intoxicated OR
High
Condom Use
-.214
Always
Condom Use
.045
Sometimes
Condom Use
.064
Never
Condom Use
-.131
with Main
Partner
Condom Use
-.031
with Other
Partners
Sex with
.038
Anonymous
Partner
Sex with Partner .113
Met Via Internet
New Partner
-.019
Within the Last
90 Days
Number of Sex
-.003
Partners
Pick Up in Bar
-.144
Pick Up in Bath
.389
HIV Self-Aware -.151
Paid for Sex
.333
Was Paid for Sex -.433

.005
.083
.040

1
1
1

.000
.000
.000

1.050
.122
1.487

1.040
.103
1.375

202
1.060
.143
1.609

.014

1

.000

1.160

1.130

1.192

.033
.105
.124

1
1
1

.000
.915
.562

.253
.989
.931

.237
.806
.730

.270
1.214
1.186

.173

1

.217

.807

.575

1.134

.185

1

.808

1.046

.727

1.505

.168

1

.703

1.066

.767

1.482

.166

1

.431

.878

.634

1.214

.180

1

.863

.970

.681

1.379

.144

1

.790

1.039

.784

1.377

.156

1

.467

1.120

.825

1.519

.172

1

.912

.981

.700

1.375

.007

1

.638

.997

.983

1.010

.296
.300
.027
.184
.157

1
1
1
1
1

.626
.195
.000
.071
.006

.866
1.476
.860
1.395
.649

.484
.819
.815
.973
.476

1.547
2.657
.907
2.000
.883

203
1.002

Vaginal or Anal
-.277 .143
1
.052
.758
.573
Sex with Female
Oral Sex with
-.197 .161
1
.222
.822
.599
1.126
Female
Unprotected
.112
.162
1
.490
1.118
.814
1.537
Vaginal or Anal
Sex with Female
Vaginal or Anal
.128
.119
1
.283
1.136
.900
1.434
Sex with Male
Oral Sex with
.243
.187
1
.192
1.276
.885
1.839
Male
Unprotected
-.224 .161
1
.163
.799
.583
1.095
Vaginal or Anal
Sex with Male
Vaginal or Anal
-.148 .132
1
.262
.862
.666
1.117
Sex with Male
who has Sex
with Male
History of Prior
-.049 .048
1
.302
.952
.867
1.045
STD
History of Prior
-.030 .108
1
.782
.971
.786
1.198
STD Within Last
12 Months
Incarcerated
-.072 .116
1
.536
.931
.742
1.168
Within Last 12
Months
Victim of Sexual .206
.137
1
.132
1.228
.940
1.606
Assault
Constant
2.017 .070
1
.000
7.514
Note: Table created from data provided by FDOH STARS system and using IBM
SPSS version 25.

